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Abstract
Meningococcal disease (MD) remains a major source of mortality and morbidity in 
adolescence despite the introduction in some countries of the seroGroup C conjugate 
vaccine. This study is the first which comprehensively assesses the outcomes of MD 
in adolescence. In pursuing this aim, a population-based matched cohort study was 
undertaken and 101 sex and age matched case-control pairs (aged 15-19 years at 
disease) from 6 regions of England (representing 65% of the population of England) 
were followed up 18-36 months after MD (46% males). Educational, social and 
vocational function, mental health, social support, cognitive and quality of life data 
were collected using standardised questionnaires and neuropsychological tests. In 
addition, demographic and disease factors associated with outcome were also 
examined.
The results show that 57% (N=58) of cases had physical sequelae ranging from minor 
scarring to bilateral amputations. Survivors had greater mental fatigue, lower social 
support, greater reduction in quality of life, and lower educational attainment 
compared with controls. Cognitive testing revealed no overall change in intellectual 
ability; however, cases had deficits in aspects of memory (short and long-term), 
attention (selective and sustained), cognitive flexibility and psychomotor speed. 
Greater cognitive deficit was associated with a younger age at diagnosis. Cases with 
SeroGroup C disease had greater physical sequelae than those with B disease. MD 
status increased the risk of depression. Only 53/101 cases reported any medical 
follow-up after MD.
The findings suggest that survivors of MD in adolescence have a disturbing series of 
deficits including poorer physical and mental health, quality of life and educational 
achievement. SeroGroup C is associated with poorer outcome. Of concern, medical 
care is poor after discharge from hospital. Routine follow up of adolescent survivors 
is essential to address issues and concerns that are important for adolescent MD 
survivors and to mitigate or prevent physical and psychosocial morbidity after MD.
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Structure of dissertation
This thesis comprises five sections.
Section A  (Background) comprises two chapters. Chapter 1 provides an overview of 
Meningococcal Disease (MD), and in particular, describes the microbiological 
characteristics of Neisseria meningitides, the transmission and pathogenesis of 
meningococci, and outlines the risk factors associated with the disease. The chapter 
further discusses the pathophysiology of the disease, and the epidemiology of MD. 
Chapter 2 reviews the outcomes of MD and in particular focuses on the design of 
outcome investigations with reference to the effects of MD in adolescence.
Section B  (Methods) comprises Chapter 3 and deals with the aims of the study, its 
design characteristics, and the outcomes measured. It further provides a summary of 
the aims of both the cross-sectional and longitudinal analyses undertaken by the study.
Section C (Results) consists of Chapters 4 and 5 both of which describe the findings 
of the study. Chapter 4 deals primarily with the outcomes of the cross-sectional 
analyses and concludes with summarising the associations of identified deficits on 
functioning. Chapter 5 discusses the outcomes of the longitudinal analyses and 
highlights the differences between cases and controls in health behaviours.
Section D (Conclusions) includes Chapters 6 and 7. Chapter 6 focuses on the results 
of the study under review, provides a discussion of the issues emerging from the 
evidence obtained and highlights the implications of the results for future practice and 
further research. The discussion also focuses on the methodology of the study and 
addresses its strengths and limitations. Chapter 7 provides a conclusion to the thesis 
drawing on the salient findings of the study and outlines future research directions.
Section E  includes the references.
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SECTION A
"Few infections can cause the civil, medical, and social stress that occurs when 
serious meningococcal disease enters a community” (Apicella 1995).
CHAPTER 1 -  OVERVIEW OF MENINGOCOCCAL DISEASE
1.1 Introduction and aims
Invasive meningococcal disease (MD) is an infectious and potentially life-threatening 
systemic infection causing septicaemia and/or meningitis. It is caused by the 
bacterium Neisseria meningitidis and is globally endemic with periodic epidemics in 
developing and to a lesser extent, developed countries (Jones and Mallard 1993; 
Ramsay et al. 1997). It is the most common cause of bacterial meningitis worldwide, 
with over 500,000 cases reported annually (Hubert and Caugant 1997;Ramsay et al. 
1997; Tikhomirov et al. 1997; World Health Organisation 2002b). Overall mortality 
in population-based studies including all ages is approximately 7% (Erickson and De 
Wals 1998). The World Health Organization estimated that MD was the cause of
171,000 deaths worldwide in 2000 (WHO 2005).
While the primary incidence peak for MD is in children aged <5 years, there is a 
secondary peak in older teenagers and, the case-fatality rate can be up to five times 
higher among 15-24 year olds compared with other age groups (Harrison et al. 2001 ; 
Jones and Mallard 1993). The reasons for the peak of MD in teenagers are poorly 
understood. Greater transmission of meningococci has been implicated, (Coen et al. 
2000) as prevalence of carriage increases especially through childhood (Cartwright et 
al. 1987).
Throughout the 1990s, the incidence of MD in adolescents and young adults increased 
in comparison to the general population in the UK, (Jones and Mallard 1993) and in 
many other European countries (Connolly and Noah 1999), including the United
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States (Harrison et al. 2001 ;Rosenstein et al. 1999). Despite the introduction of a 
highly effective conjugated meningococcal C vaccine (Bose et al. 2003), high rates of 
meningococcal disease remains as seroGroup B disease remains a major cause of 
death and morbidity in adolescents (Ramsay et al. 2001;Trotter et al. 2002). In 2003- 
04 there were on average 223 annual cases of invasive MD in 10-19 year olds in 
England and Wales (Health Protection Agency 2007a).
Significant physical sequelae of MD are believed to occur in 3-15% of cases of all 
ages in developed countries (Baraff et al. 1993; Erickson and De Wals 1998). 
However, in more recent studies the proportion of survivors with long-term sequelae 
was estimated at 13% in individuals under the age of 18 years (Stovall and Schutze 
2002) and 20% in young adults (Erickson et al. 2001).
Adolescents aged 15 years or older appear more likely than infants and children to 
have the septicaemic form of the disease (Harrison et al. 2001), thereby increasing the 
risk of cognitive impairment, epilepsy, vasculitis arthritis, and sensorineural hearing 
loss, in addition to the physical sequelae (Baraff et al. 1993). Adolescents appear to 
be at greater risk of scarring, amputations and hearing loss post-MD (Erickson and De 
Wals 1998). Hiey may also have the highest case-fatality rate of any age group 
(Harrison et al. 2001).
Little is known of the long-term effects of MD in adolescence, or of which factors 
increase the risk of poor outcomes. Outcome studies have examined MD alongside 
variant aetiologies of bacterial meningitis in young children and have primarily 
focused on physical sequelae (Baraff et al. 1993; Fellick et al. 2001). Results are 
unlikely to be generalisable to adolescents and young adults.
Vocational, educational, and cognitive outcomes have not been studied in adolescence 
although there are anecdotal reports that adolescent MD survivors believe that the 
illness affected their educational success and vocational choices (Sander et al. 1984a).
Neurological functions such as concentration, memory and attention remain sensitive 
to trauma in adolescence (Brown 2000;Tapert and Brown 1999) therefore the impact
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of MD may be particularly problematic during adolescent transitions into higher 
education, adult employment and social relations.
Moreover, there is evidence that during adolescence important structural changes take 
place in the brain suggesting it is vulnerable to damage (Giedd et a i 1999). 
Septicaemia may cause cerebral insult due to vasculitis and cerebral hypotension, the 
release of inflammatory factors within the brain, and the occurrence of small septic 
infarcts. This is more likely to cause damage during the period of development of 
formal operational thought. However, detailed studies of the outcomes of MD in 
adolescence have not been published. Moreover, a consistent and specific profile of 
neuropsychological abnormalities has not been established in adolescent survivors of 
MD.
Adolescence is traditionally viewed as a time of physical and emotional change, 
optimal health with low levels of morbidity, and is typified by attempts to establish 
autonomy and independence, close personal relationships and define work goals 
(Erickson 1959). Attainment of all these goals is fundamental to a successful passage 
through adolescence: life-threatening illnesses such as MD can potentially 
compromise these achievements. Clarifying the extent of complications in teenage 
survivors is critical to the development of relevant interventions to aid recovery and 
improve quality of life in the years that follow such a life threatening illness.
This thesis describes a prospective matched cohort study undertaken to examine the 
hypotheses that survivors of MD in adolescence have poorer educational, vocational, 
social and psychological function, quality of life and cognitive function than matched 
controls. In addition, that poorer outcome is seen in those with seroGroup C disease 
whether meningitis septicaemia or mixed. Whether medical follow-up was achieved 
was also examined in survivors and its impact on outcome was assessed.
The following provides an overview of the historical background of MD, the 
transmission and pathogenesis and the risk factors associated with the disease. The 
chapter further discusses the pathophysiology and the epidemiology of MD to inform 
discussion on outcomes.
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1.2 Historical summary
Descriptions of illness resembling meningococcal disease (MD) have been reported 
throughout history (Willis 1684). However, it was not until 1806 that Vieusseux 
reported the first clear account of an outbreak of MD during an epidemic of spinal 
meningitis in Eaux Vives on the outskirts of Geneva, Switzerland. This was the first 
well-documented description of an outbreak of MD. It resulted in 33 deaths 
(Vieusseux 1806). In the same year and independent of Vieusseux, a description of an 
outbreak of MD was reported from New England, USA (Danielson and Mann 1806). 
This was the first report of the disease in the New World.
In 1884 the Italian pathologists Marchiafava and Angelo Celli first described 
intracellular oval micrococci within leucocytes in the samples of Cerebral Spinal 
Fluid (CSF) from patients dying with meningits (Marchiafava and Celli 1884).
Further outbreaks of MD were comprehensively documented by, Hirsch, a medical 
historian, in Europe, Africa, Asia and the Americas. These occurred throughout the 
19th century and he described principal epidemic periods of "cerebro-spinal 
meningitis" with very high case fatality rates (Hirsch 1886).
A breakthrough came in 1887 when Anton Weichselbaum, a Viennese pathologist and 
bacteriologist, first identified the bacterium causing MD in the CSF of six of eight 
patients of primary, sporadic meningitis when a coccoid bacterium was isolated from 
meningeal exudates (Weichselbaum 1887). This was the first isolation of a 
meningococcus. The organism was then called Diplococciis intracellular is 
meningitidis, which became known as Neisseria meningitidis after the German 
scientist and clinician, Albert Neisser who discovered the Neisseria group of bacteria.
Asymptomatic carriage was identified in 1896 in Europe (Kiefer 1896) and was 
linked with the incidence of MD some years later (Bruns and Hohn 1908).
Despite the numerous historical milestones in understanding MD, invasive infection 
continues to be a serious and life-threatening disease and in 1919 Herrick stated: “no 
other infection so quickly slays”(Herrick 1919). Nearly 90 years later, this still holds
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true as it remains the commonest cause of bacterial meningitis worldwide (Hubert and 
Caugant 1997;Ramsay et al. 1997; Tikhomirov et al. 1997;World Health Organisation 
2002a).
1.3 Microbiological characteristics
Neisseria meningitidis, also known as the meningococcus is an aerobic, bean-shaped 
gram-negative, bacterium that occurs in pairs (diplococci) and can be encapsulated or 
unencapsulated (Stephens et al. 2007a). See Figure 1.1. It is related to several 
nonpathogenic Neisseria species, such as N. lactamica. MD is the collective name for 
the pathological syndromes caused by N. meningitidis (Stollenwerk et al. 2004).
The meningococcus is highly pathogenic and virulent and exclusively a human 
pathogen. It is also very fragile as it does not survive well outside the human host and 
needs certain growth conditions for it to multiply. Meningococci can infect diverse 
sites within the human host, although primarily they infect the upper respiratory tract, 
as they need a fairly solid yet moist basis to grow. Invasive strains produce a 
polysaccharide capsule, whereas strains carried asymptomatically are often acapsular 
(Yazdankhah and Caugant 2004).
Figure 1.1 -  Electron microscopy of a pair of meningococci
Source: Meningitis UK
The meningococcus has an inner (cytoplasmic) membrane containing water, salts, 
deoxyribose nucleic acid (DNA), ribose nucleic acid (RNA), various structures (e.g. 
ribosomes), proteins, enzymes, and other substances necessary for life (Vogel and
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Frosch 1999). It also has an outer membrane separated from the inner membrane by a 
cell wall. The outer membrane contains protein structures and toxic 
lipopolysaccharides (or endotoxin), that enable the bacteria to interact with the host 
cells as well as perform other functions. It is surrounded by an antiphagocytic 
polysaccharide capsule, which is important in the pathogenesis of MD. There are five 
different protein structural classes within outer membrane proteins (OMPs), which 
link together to form a mesh, giving the bacterium its shape. There is also a thin layer 
of peptidoglycan in the periplasmic space (Morley and Pollard 2001).
Meningococci are classified by using serologic methods and come in many different 
forms with different strains classified based on their antigenically and chemically 
distinct capsular structure (Rosenstein et al 2001). They are divided into various 
subgroups; called seroGroups (see Figure 1.2).
Figure 1.2
Neisseria meningitidis Group poiysacchahoe 
(XB.C,eiO
OumrmaMyaneproWir 
<OMP ’-Sp srstype 4 wros^Aype
Source: Meningitis Trust
At least 13 different seroGroups of meningococci have been thus far identified 
namely. A, B, C, D, E29, H, I, K, L, W135, X, Y and Z. They can be further 
subdivided and classified based on identification of the different types of outer 
membrane proteins (OMPs): 20 serotypes, 10 serosubtypes, and 13 immunotypes 
designated by the letter L have been identified (Pollard and Levin 2000;van Deuren 
et al 2000). Chromosomal DNA (genotype) also differentiates the bacteria.
An example of the standard classification on type of meningococci (each separated by 
a colon) is B: 4: PI.4, denoting seroGroup B, serotype 4, and serosubtype PI.4 (van
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Deuren et al. 2000). Knowledge of the exact capsular and genetic structure of a strain 
is essential to the development of treatments, especially vaccination strategies. An 
individual, genetically unique bacterium is known as a strain, which essentially clones 
itself in the course of a disease in order to spread.
Meningococci are genetically diverse with only a small subset of genotypes associated 
with invasive disease (van Deuren et al. 2000).
Most cases of invasive disease worldwide are caused by seroGroups A, B, C, Y and to 
a lesser extent, W135 (Pollard and Levin 2000) and more recently seroGroup X has 
emerged (Rosenstein et al. 2001; Stephens 2007b). SeroGroups B and C are 
responsible for the overwhelming majority of cases in the United Kingdom (Health 
Protection Agency 2007b)
Meningococci have the ability to exchange genetic material and so can switch 
serogroups: under immune pressure a ‘capsule switch’ may occur, changing for 
example from seroGroup B to C or vice versa in order to survive (Caugant 
1998;Swartley er a/. 1997).
1.4 Transmission and pathogenesis
1.4.1 Transmission
Transmission of meningococci, may be person to person by direct close contact or by 
aerosol droplets from the upper respiratory tract through coughing, sneezing or via the 
spread of saliva from someone who is carrying the organism (Cartwright 1995b), 
leading to colonisation or carriage (Stephens et al. 2007b). It has been proposed that 
some climatological conditions for example, temperature and humidity, can enable 
meningococci to survive in respiratory droplets (van Deuren et al. 2000). Close 
contacts include household members, and anyone who has been directly exposed to 
the person’s oral or nasal secretions.
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Meningococci adhere to the surface of the naso-oropharyngeal mucosal lining of the 
upper respiratory tract (the principal reservoir), for example, the throat and nose. This 
is where the bacteria typically reside and to a much lesser extent, the urogenital tract 
and anal canal. Adherence to the mucosal cells occurs via the pili found in virtually all 
gram-negative bacteria which are long thin tubular protein protrusions within the 
meningococcus that extend from the surface to allow for this initial binding (Feigin 
1992;Heckels 1989).
1.4.2 Colonisation
The pathophysiologic process of MD commences with colonisation of the upper 
respiratory tract (Nassif et al. 2002). Colonisation or carriage of meningococci may be 
transient, persist for several weeks or even years, providing an ongoing source of 
infection for others. The bacteria can flourish without disease ever breaking out and 
then spontaneously disappears. Carriage is a prerequisite for invasive disease 
(Goldschneider e/fl/. 1969).
Infection in the majority of cases results in asymptomatic carriage rather than invasive 
disease as serum antibodies attach to the surface of the bacteria: immune responses 
usually ensure that the bacteria are killed before they can cause disease (Cartwright 
1995b). The majority of strains isolated from most adults and children have been 
found to be non-pathogenic (Bevanger et a l 1998;Cartwright et al. 1987;Gold et al. 
1978). In fact, carrier status appears to provide some protection to those who harbour 
the bacteria in their upper respiratory tracts (Goldschneider et al. 1969).
Carriage of meningococci is relatively common and at any one time, meningococci 
colonise 8-25% of healthy individuals in their nasopharynx in a harmless way 
(Cartwright 1995b; Stephens 1999), with systemic infection occurring in less than 1% 
of colonised persons (Aycock and Mueller 1950).
The number of individuals in a population who are "carriers” varies greatly depending 
on the region of the world, the season and the age of the individuals. Worldwide there 
is said to be approximately 500 million carriers of the bacterium in their nasopharynx 
(Almeida-Gonzalez et al. 2004).
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It is not fully known why some people become ill whilst others are only infected and 
remain well. This pool of healthy asymptomatic carriers is why the infection spreads. 
While the events, which enable certain strains of meningococci to pass through the 
nasopharyngeal membrane into the bloodstream, remain poorly understood, it is clear 
that survival in the bloodstream, and the ability to multiply to high numbers, are an 
essential requirement for severe disease to occur. What is known is that damage to 
the physical integrity of the naso-oropharyngeal ciliated epithelium is fundamental for 
meningococcal invasiveness (Rayner et al. 1995) in order to enable the meningococci 
to gain access to the bloodstream (Cartwright et al. 1987; Mueller et al.
2006; Stephens et al. 2007a; Yazdankhah and Caugant 2004). Persons newly 
colonised with meningococci are much more at risk of developing the disease than 
those with an established colonisation particularly if acquisition with a particularly 
virulent clone occurs (Edwards et al. 1977;Marks et al. 1979). Only a small 
proportion of carried strains are responsible for most cases of invasive disease 
(Bygraves ût/. 1999).
A number of factors have been linked to increased carriage rates:
1.4.2.1 Age and gender
Carriage of meningococci is highest among teenagers and young adults aged 15 to 24 
years (as high as 24% to 37%) (Cartwright 1995b; Coen et al. 2000;Trotter et al.
2005) who play an important role in the transmission of virulent strains across the 
population (Trotter et al. 2005). Rates are lowest in children under 5 years of age (2% 
to 3%), and less than 10% in older age groups (Bevanger et al. 1998;Cartwright et al. 
1987;Caugant et al. 1994; Ceesay et al. 1993;Public Health Laboratory Service 
Meningococcus Forum. 2002).
A number of studies have found that more males than females are likely to be carriers 
(Cartwright et al. 1987;Caugant et al. 1994; Gilmore et al. 1999;Neal et al. 2000).
1.4.2.2 Socioeconomic deprivation and overcrowding
Carriage rates have been found to be higher in lower socioeconomic groups (Baker et 
a/. 2000; Fontanals er a/. 1995;Moodley e/fl/. 1999;Stanwell-Smith er a/. 1994) 
(Krizova and Kriz 1999). This may simply be due to overcrowding as other studies
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have found increased carriage in people who are brought together from different 
places, for example military recruits, pilgrims, boarding school students, or prisoners 
(Goldschneider et al. 1969;Moore et al. 1989; Pether et al. 1988;Schubiger et al.
1986; Tappero et al. 1996). This could be one of the reasons why carriage rates are 
much higher in younger people as they are more likely to move into boarding schools, 
universities (or at least attend classes for many hours per day) and the armed forces 
where carriage rates up to 50% have been found (Farrell and Dahl 1966).
1.4.2.S Social and health risk behaviours
Other factors linked to increased pharyngeal carriage rate are active cigarette smoking 
and passive exposure to smoke with numerous studies to support this, both in adults 
and children (Blackwell et al. 1992;Blackwell and Weir 1990;Caugant et al. 
1994;Fischer e/a/. 1997; Haneberg ef a/. 1983; Kremastinou er a/. 1994;Riordan ef a/. 
1998; Simons 2001 ;Stanwell-Smith et al. 1994; Stuart et al. 1989a).
It has been suggested that smokers may be more densely colonised by a variety of 
potentially pathogenic bacteria and also that passive smoking can coat mucosal 
surfaces of the nasopharynx which enhances the binding of potentially pathogenic 
bacteria (Haneberg e/fl/. 1983)
A large British study (MacLennan et al. 2006), examined carriage and social 
behaviour in 14,000 British teenagers aged 15 to 19 years of age. The young people 
who were assessed either attended school or college full-time but none were at 
university. The authors reported that attendance at pubs/clubs, intimate kissing of 
multiple partners, and active cigarette smoking, increased the risk of meningococcal 
carriage, as did exposure to passive smoking. However, in contrast to previous studies 
no association was found between increased carriage and gender, social deprivation, 
or home crowding. The authors concluded that social behaviour is largely responsible 
for the increase in meningococcal carriage seen in teenagers and is likely to explain 
the peak in MD attack rates in teenagers.
Other studies have also found increased carriage rates amongst those who attend night 
clubs or bars (Caugant et al. 1994;Conyn-van Spaendonck et al. 1999; Imrey et al. 
1995;Imrey et al. 1996; Neal et al. 2000), places often frequented by young people.
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Other factors found to increase carriage rates include stress and preceding viral 
infections (Cartwright et al. 1991b; Conyn-van Spaendonck et at. 1999;Dominguez et 
a l 2001 ;Haneberg et al. 1983; Raza et al. 1999), which may alter the integrity of the 
mucosal surface of the nasopharynx or influence local or systemic immunity.
Treatments for reducing the nasopharyngeal carriage of Neisseria meningitidis 
involve antibiotics such as rifampin, ciprofloxacin, and ceftriaxone which have been 
found to be 90%-95% effective (Deal and Sanders 1969; Gaunt and Lambert 
1988;Schwartz et al. 1988).
1.4.3 Risk factors associated with MD
Why some individuals are susceptible to invasive disease is not clearly understood 
although a number of risk factors have been implicated and many of the factors that 
increase carriage of meningococci are also risk factors for invasive disease. This 
section will explore risk factors for MD, and those associated more specifically with 
young people.
1.4.3.1 Age and gender
Although MD can affect people at any age certain groups seem to be at increased risk 
of contracting the disease, for example studies conducted in the USA and the UK have 
found that males were at a higher risk of contracting MD than females (Abbott et ai 
1985; Fallon et al. 1984;Klein et a i 1986). Furthermore, although children < 5 years 
of age are at the highest risk for getting the disease, rates fall through later childhood 
and begin to rise again in early adolescence, peaking between the ages of 15 and 19 
years indicating that teenagers are particularly vulnerable (Morley and Booy 1997). 
This may well be due to the social and behavioural changes, which occur in this age 
group contributing to their susceptibility of MD.
1.4.3.2 Medical conditions
A number of medical conditions have also been found to increase the risk of 
developing MD. For example, chronic underlying illness has also been found to 
increase susceptibility to meningococcal infection in older patients (Stephens et a l 
1995) as well as certain genetic risk factors (Hibberd et al. 1999).
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Further, infections such as viral (influenza A virus), adenovirus, parainfluenza, 
rhinovirus, mycoplasma, and respiratory syncytial virus and other upper respiratory 
tract infections have been found to precede the disease in all ages (Bruce et al.
2001 ;Cartwright et al. 1991a; Haneberg et al. 1983;Harrison et al. 1991 ;Kriz et al. 
2000;Levitt et al. 1970;Moore et al. 1990;Robinson et al. 2001; Tully et al. 
2006;Watson et al. 1996;Young et al. 1972). Infection with Epstein-Barr virus has 
also been implicated in increase risk of MD (Evans and Niederman 1998).
A recent study investigating the risk and protective factors in a large sample [144 case 
control pairs] of adolescents (aged 15-19 years) found that preceding upper 
respiratory infection was an important risk factor for MD in this age group (Tully et 
al. 2006).
Other studies have pointed to rare immune defects as increasing susceptibility to 
pathogenic and non-pathogenic strains of N. meningitidis but these only represent a 
small proportion of the overall number of cases (Hoare 1999; Rosenstein et al. 
2001;Schwartz et al. 1989; Stephens 1999; World Health Organisation 2002a). For 
example, complement deficiencies (Ellison et al. 1983), functional or anatomical 
asplenia (as in the case of patients with sickle cell disease) (Figueroa and Densen 
1991; Franke and Neu 1981) and persons with immature or dysfunctional humoral 
immunity (Goldschneider et al. 1969) were found to increase susceptibility to MD.
1.4.3.3 Lifestyle and environmental factors
Certain lifestyle and environmental factors characteristically of adolescents and young 
adults pose an increased risk for acquiring the disease These include residential 
accommodation with young people from geographically diverse areas (i.e. schools, 
colleges, university halls of residence or military barracks), which are places where 
the opportunity for spread is increased (Fischer et al. 1997; Harrison et al. 2001).
Studies on university students residing on campus are clear examples of the influence 
of crowded living conditions increasing the risk of meningococcal infection (Bruce et 
al. 2001 ; Jackson et al. 1995). Outbreaks in UK university students in recent years 
have drawn attention to the risk in this group with large numbers of cases reported for 
example, at Cardiff University (Anonymous 1996) and in November 1996 and
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October 1997 at the University of Southampton (Anonymous 1997), involving a total 
of 13 cases in students, 5 of whom died. It is unclear why particular halls of residence 
should have a greater risk of cases or clusters of disease than others. Although 
students tend to share beverages or utensils, go to bars, actively or passively smoke 
and practice irregular sleeping patterns, precise mechanisms are unclear.
In the large population-based study examining risk and protective factors in 15-19 
year old survivors (Tully et al. 2006), university and school students were found to be 
at higher risk of MD than people in employment. But contrary to the above studies the 
authors did not find that living in dormitory-style accommodation increased risk, 
however numbers were small (7% of cases, 6% of controls).
Overcrowding has been a known risk factor since World War I, where it was found to 
increase susceptibility of MD amongst military recruits (Blackwell et al. 1992; Hirsch 
1886;Riordan et al. 1998). Prison inmates experiencing crowding may also be at 
increased risk (Thomas et al. 1991). In military camps, large numbers of young adult 
males (a group with a high meningococcal carriage rate) are brought into close 
proximity for periods of several months, this favours enhanced transmission of 
meningococci.
The incidence of disease is higher in the winter in for example, Europe and North 
America, which may be due to crowding of people in poorly ventilated houses, where 
spread of virulent meningococci is enhanced. In addition, close proximity to a person 
diagnosed with disease (e.g., being a household contact) significantly increases the 
risk of developing disease (DeWals et al. 1981 ;Meningococcal Disease Surveillance 
Group 1974).
Interestingly, in a study examining risk and protective factors in 15-19 year old MD 
survivors (Tully et al. 2006), religious observance was associated with protection 
from MD, which has been supported by other studies (Fischer et al. 1997). Religious 
observance has been found to have beneficial immune effects (Koenig et al. 1997). 
Attendance at religious event may be associated with other lifestyle factors that 
promote health and protect against infection (McCullough et al. 2000).
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1.4.3.4 Health risk behaviours
Several health behaviours in adolescents have been demonstrated to increase the risk 
of infection for example, intimate kissing with multiple partners, was significant in 
the study examining the risk and protective factors for MD (Tully et al. 2006).
Kissing on the mouth has been suggested to be a risk factor in children (Stanwell- 
Smith et a l 1994), although no evidence supporting this was found in adolescents in 
the same study.
Smoking has been described as being responsible for as much as almost one third of 
all cases of MD (Rosenstein et al. 2001). Smoking marijuana has also been linked to a 
number of cases of MD in the USA (Krause et al. 2001). Contact with smokers has 
been found to be associated with increased risk of MD in adolescents (Coen et al. 
2006).
In children aged less than 5 years, passive smoking in the home (30 or more cigarettes 
daily) was found to be associated with MD (Stanwell-Smith et al. 1994). Other studies 
have also found that passive smoking increases the carriage rate (Haneberg et al. 
1983;Robinson et al. 2001;Stuart et a l 1988;Stuart et a l 1989). This may be due to 
smoke interfering with ciliary action, increasing mucus production and decreasing 
macrophage production, thereby decreasing the body’s local defence against potential 
pathogens (Crofton and Douglas 1981).
In contrast, other studies in adolescents and young adults found no significant role for 
active or passive smoking (Bruce et a l 2001 ;Nelson et al. 2001 ;Tully et al. 2006).
Other factors linked to increased risk of MD include social deprivation (Cartwright 
1995b; Foster et a l 1971;Jones et al. 1997;Stuart et a l 1988), stress from certain life 
events; relationship problems, and legal disputes (Stanwell-Smith et al. 1994). 
Climate and damp living conditions have also all been associated with increased risk 
(Haneberg et al. 1983; Stanwell-Smith et al. 1994; Stuart et al. 1988;Young et a l 
1972).
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1.5 Pathophysiology
1.5.1 Development of MD
Invasive MD only occurs only when there is exposure to and colonisation with a 
virulent strain, and invasion of the meningococcus in the bloodstream (van Deuren et 
al. 2000). These processes are influenced by the characteristics of the strain of 
meningococci, (e.g. the virulence), environmental factors (for example, climate and 
social conditions) and lastly host factors, for example the immune status of the patient 
(Achtman 1995). The incubation period is 2-10 days, but usually three to five days 
(Boutet et al. 2001) with signs and symptoms developing over this period.
Once the meningococcus has reached the bloodstream a wide range of clinical 
syndromes can result, but most commonly meningitis and / or septicaemia 
(meningococcaemia) (Edwards and Baker 1981;Kirsch et al. 1996). Less frequently, 
infection causes pneumonia, septic arthritis, conjunctivitis, and pericarditis.
1.5.2 Diagnosis
Laboratory confirmation of MD is important for the identification and management of 
cases and outbreaks, as well as for regional and national surveillance and detection of 
epidemiologic trends over time. Confirmation requires bacteriological isolation of N. 
meningitidis bacteria from a sterile site, such as blood or cerebrospinal fluid (CSF), or 
synovial, pericardial, and pleural fluid. Skin scrapings may also yield positive 
microscopy of culture from a petechial or purpuric lesion. However, in patients with 
meningococcal meningitis, skin lesions infrequently reveal meningococci with CSF 
offering the best chance of yielding an organism for culture (Frieling et al. 1996). 
Because lumbar puncture is not advisable in patients with circulatory compromise or 
any evidence of raised Intra Cranial Pressure (ICP) (Nadel 2001) early diagnosis is 
not always possible.
Polymerase chain reaction (PCR) testing to identify the capsular serogroup by 
meningococcal DNA in blood or CSF has been shown to be a reliable tool for rapid 
diagnosis and as such has become the gold standard for specific diagnosis of MD
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(Carrol et al. 2000). Indeed one study demonstrated that performing PCR assays of 
blood or CSF in probable cases of MD can contribute significantly to case 
ascertainment (Carrol et at. 2000). PCR tests have been used widely in the UK since 
late 1996 (Rosenstein et al. 2001). Subtyping of the invasive strain may also be 
indicated when clusters of cases occur to determine whether they are caused by a 
single strain.
Rapid administration of antibiotics is recommended when the diagnosis of MD is 
suspected which is good practice for the patient although it may prevent laboratory 
diagnosis. Antibiotics can potentially alter the Gram staining characteristics of the 
organism as the meningococcus is extremely sensitive (Wylie et al. 1997). Lack of a 
definitive diagnosis may underestimate the true burden of disease in the population. 
As a result blood cultures or CSF are reported to be rarely positive after antibiotic 
treatment (Baines and Hart 2003), although others report that meningococcal DNA 
can be found in the CSF up to 96 hours after commencing antibiotics (Ragunathan et 
al. 2000). Furthermore, prior antibiotic administration has been shown not to 
jeopardise skin biopsy specimens (Frieling et al. 1996).
In England and Wales meningococcal septicaemia and meningococcal meningitis are 
statutorily notifiable diseases under the Public Health (Infectious Disease) regulation 
1988 (HMSO 1988) and under Scottish legislation as meningococcal infection. 
Clinicians are required to notify suspected cases to the regional consultant in 
communicable disease control or the consultant in public health medicine.
Information is then collected on individual patient factors and sent to the regional and 
national epidemiology centres where it is further integrated with laboratory results 
(Health Protection Agency Meningococcus Forum 2006).
1.5.3 Clinical Presentation of Invasive MD
Clinical syndromes caused by N. meningitidis include meningitis, with or without 
septicaemia, relatively mild bacteraemia, fulminant meningococcemia, 
meningoencephaltis, pneumonia, septic arthritis, as well as other presentations 
(Apicella 2000). Most commonly meningococcal infection presents as meningococcal
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meningitis (MM) occurring in about 60% of patients or meningococcal septicaemia 
(MS), also known as meningococcaemia, presenting in approximately 
5 to 20% of patients (Edwards and Baker 1981 ; Kirsch et al. 1996;Rosenstein et al. 
1999). Mixed presentation of septicaemia and meningitis occurs in approximately 
10% of cases (Brandtzaeg 2006).
Adolescents 15 years or older are more likely than infants and children to have the 
septicaemic form of the disease (40% vs. 20% respectively) and as a result they are at 
greater risk of a fatal outcome (22.5% vs. 4.6% respectively) (Harrison et al. 2001). 
Overall, case fatality rates of MD have remained stable over the last 20 years, at 9 to 
12 %, with a rate of up to 40% among patients with meningococcal septicaemia 
(Rosenstein and Perkins 2000).
Early symptoms of MD are usually vague and are rarely classical. As a result the 
disease is often misdiagnosed as something less serious such as influenza or an upper 
respiratory tract infection (Apicella 2000; Dashefsky et al. 1983;Gedde-Dahl et al. 
1990;Shapiro et al. 1986;Sullivan and LaScolea, Jr. 1987). This presents a difficult 
task for the General Practitioner (GP) who is often the first person a patient sees and 
who has the difficult task of differentiating the symptoms of MD from what appears 
to be a less serious illness.
However, symptoms can progress very rapidly and vary according to the number of 
bacteria present, the organs that have become infected, whether septicaemia occurred, 
the strain of the disease, as well as other contributing factors.
A number of host and clinical factors have been implicated in the outcome of MD. 
For example, numerous studies have found age to be a factor with a fatal outcome 
reported to be highest in infants, adolescents and patients >50 years of age (Anderson 
1978;Fallon et al. 1984;Halstensen et al. 1987;Harrison et al. 2001 ; Riordan et al. 
1995;Scholten er fl/. 1994;Spanjaard ût/. 1987;Thomson e/a/. 1991).
The clinical presentation of MD has also been shown to affect outcome with case 
fatality rates highest in patients presenting with septicaemia compared to mixed 
disease or meningitis alone (Anderson 1978;Barquet et al. 1999; Riordan et al. 
1995;Thomson et al. 1991). Clinical features found to predict poor prognosis include
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the presence of shock, the absence of meningism, rapidly progressive purpuric rash, 
low peripheral white blood cell count, thrombocytopenia, and a depressed conscious 
level (Nadel et al. 1995;Stiehm and Damrosch 1966). Features found to predict 
permanent and disabling sequelae post MD include focal neurologic signs and 
haemorrhagic diathesis (Barquet et at. 1999).
1.5.3.1 Meningococcal meningitis
Meningococcal meningitis (MM) is predominately a central nervous system infection 
and is fatal in up to 10% of cases (Kirsch et al. 1996). However, with appropriate 
antibiotics and good clinical surveillance, the mortality rate can be as low as 1 to 2% 
(van Deuren et al. 2000).
Wide presentations can occur in all ages and in the early stages is often non-specific 
and not associated with petechiae (Thomson and Riordan 2000). Patients may present 
with sudden onset of fever, headache, meningism and signs of cerebral dysfunction 
but usually it develops over several days (Thomson and Riordan 2000). Other 
symptoms include nausea and vomiting, which are often accompanied by 
photophobia. In some patients, seizures often accompany these symptoms. After the 
disease has taken hold, a rash may appear. Although typical of septicaemia, the rash 
can appear in both meningitis (including pure meningitis) and septicaemia (Cartwright 
1995b). The meningococcal rash is non-blanching, that is it does not fade under 
pressure.
Infants and the elderly may not present with the classic symptoms and signs of MM 
(Tunkel and Dolin 2000) with meningism absent in neonates and also absent often in 
infants (Saez-Llorens and McCracken 1990).
Patients with meningitis usually have a low concentration of meningococci and 
endotoxin in plasma but higher concentrations and build up in the cerebral spinal fluid 
(CSF), (Brandtzaeg e/ a/. 1989a; Brandtzaeg e/a/. 1992; van Deuren a/. 1995), 
leading to overt meningitis within 24 to 36 hours (Brandtzaeg et al. 1992). Since the 
skull cannot expand, cerebral oedema may result in increased intracranial pressure 
(Ashwal et al. 1990), although most patients who present with MM have only a 
mildly raised Intra Cranial Pressure (ICP) (Odio et al. 1991). The mortality rate of 1%
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to 2% is often due to severe cerebral oedema leading to herniation (Conner and 
Minielly 1980;Nassif e/a/. 2002;Stephenson 1998).
Due to the proliferation of meningococci in the meninges (see Figure 1.3) (Herrick 
1919;Nassif and So 1995) high concentrations of endotoxin (van Deuren et al 1995) 
tend to result.
Figure 1.3 -  High concentration of meningococci and endotoxin in 
cerebrospinal fluid
Source : ht^>://www.stephensanigfoundation.org.au/thedisease.php
1.5.3.2 Meningococcal Septicaemia
Meningococcal septicaemia (MS) can kill more rapidly than arguably any other 
infectious disease and without meningitis is the most fatal of the meningococcal 
syndromes, occurring with higher frequency during adolescence (Harrison et al 
2001;Harrison and Broome 1987). Early recognition is critical to implement prompt 
antibiotic therapy and supportive care. The case fatality rate can be as high as 53% in 
severe cases (Kirsch et al 1996).
MS develops very rapidly with some patients progressing to fulminant septic shock 
requiring full intensive care support within 24 hours. MS is characterised by abrupt 
onset of fever, malaise, myalgia and sometimes headache, and sometimes seizures. It 
is characterised by a purpuric or petechial rash (although in some cases this does not 
appear until the disease is quite advanced), which may progress to fulminant 
septicaemia. This involves the rapid proliferation of meningococci in the circulation 
(see Figure 1.4), resulting in high concentrations of meningococcal endotoxin (van
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Deuren et al. 2000). The severity of MS has been shown to be directly related to 
levels of circulating endotoxin (Brandtzaeg et al. 1989a;Brandtzaeg et al. 1989b; 
Brandtzaeg et al. 1992).
Figure 1.4 -  Rapid proliferation of meningococci in the bloodstream
Source : http://www.stephensanigfbundation.org.au/thedisease.plq)
When purpura fulminans occurs, some tissues are irreversibly destroyed due to 
thrombosis within the microvasculature, combined with vasoconstriction and 
ischaemia in peripheries. Haemorrhagic necrosis in skin and clotting in small vessels 
can lead to loss of skin, digits or limbs.
Hypotension, acute adrenal haemorrhage (Waterhouse-Friderichsen syndrome), and 
profound shock also characterise fulminant MS (Brandtzaeg et al. 1989a;Brandtzaeg 
et al. 2001;Brandtzaeg 2006; Hackett et al. 2002). Shock is caused by capillary 
leakage, inappropriate vascular tone, intravascular micro thrombi, and myocardial 
dysfunction leading to hypotension and a reduction in circulation in most parts of the 
body, resulting in loss of consciousness and multi organ failure (Rosenstein et al. 
2001). It is very difficult to correct the shock and other effects of endotoxin with 
treatment which is the reason that so many people with MS die (Public Health 
Laboratory Service (PHLS) Communicable Disease Surveillance Centre 2001).
Approximately half of patients (Roos et al. 1997) and more specifically children and 
young adults (Anderson et al. 1997) develop a prominent petechial or purpuric rash, 
primarily on the extremities when the bacteria enter the bloodstream and multiply 
uncontrollably. This damages the walls of the blood vessels and causes bleeding into
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the skin. The rash may start as a faint pink rash or as red or purple pinpricks on the 
skin and then develop into the distinctive purple lesions (see Figure 1.5).
Figure 1.5 -  Progression of petechial and purpuric rash
Source : http://www.stephensanigfoundation.org.au/thedisease.php
A recent study of 448 patients examined the clinical recognition of MD in children 
and adolescents aged <16 years (Thompson et al 2006). It identified three important 
clinical features before admission to hospital: leg pain, cold hands and feet and 
abnormal skin colour -  that are signs of early MD in children and adolescents. These 
symptoms generally occur within the first 12 hours of the onset of MD. Cold hands, 
feet, and abnormal skin colour are features of early sepsis that represent changes in 
the peripheral circulation. In light of the findings, the authors argued for a diagnostic 
paradigm shift in order to speed up diagnosis as the classic symptoms of rash, 
meningism and impaired consciousness generally occur later in the pre-hospital 
illness and that primary care clinicians are over-reliant on using these three symptoms 
to diagnose MD in children. They further stated that parents may be influenced by 
doctors or public health campaigns to seek medical advice only on the appearance of 
features such as rapidly evolving rash and consequently clinicians and parents may be 
falsely reassured by the absence of these features.
1.5.3.3 Mild systemic meningococcal infection
Mild systemic meningococcal infection occurs more fi-equently than fulminant disease 
and is defined by the presence of meningococci in the blood and the absence of septic 
shock, distinct meningitis, or both. Provided that antibiotics are given before shock 
develops , there is low mortality (Brandtzaeg et al. 2001;van Deuren et al 2000).
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1.53.4 Localised meningococcal syndromes
Less commonly, individuals may present with metastatic and local infections in 
various sites of the body. For example, up to 15% of patients with MD present with 
pneumonia (Griffiss et al. 1991 ;Racoosin et al. 1998;Rosenstein et al. 1999). 
Meningococcal pneumonia occurs principally in immunocompromised or elderly 
patients (5%-15% of cases), (Blaser et al. 1984;Schaad 1980; Stephens et al. 1995; 
Wells and Gibbons 1997).
Others can present with conjunctivitis, myocarditis, otitis media, epiglottis or arthritis 
(Schaad 1980). Endophthalmitis, and cellulitis have been reported occasionally (Lin et 
al. 1995;Odegaard 1983;Sleep and Graham 1997), while adenitis, or pelvic 
inflammatory disease have also been reported (Anderson and Lind 1994;Ball and 
Young 1974;Barquete/fl/. 1990;Cher a/. 1993;Gelfand a/. 1998;Sacks 1986).
Shock is usually absent and almost all patients can be cured with antibiotics. 
Occasionally such infections may be preceded by invasive disease or may cause 
secondary cases.
1.6 Prevention
1.6.1 Chemoprophylaxis
The principal way to prevent secondary MD is antimicrobial chemoprophylaxis of 
close contacts of an infected patient, for example household members and anyone 
who has been directly exposed to an infected person’s oral secretions (Connolly and 
Noah 1999; Rosenstein et al. 1999). Although the risk to contacts is low, the highest 
documented absolute and relative risk is to people who live in the same household as 
a case of MD (De Wals et al. 1981 ;Hastings et al. 1997). The case is likely to have 
acquired the invasive strain from a close contact, typically in the same household, 
who is an asymptomatic carrier. (Cartwright et al. 1991b; Kristiansen et al. 1998).
Chemoprophylaxis aims to reduce the risk of invasive disease by eradicating carriage 
in the group of close contacts at highest risk. Close contacts of the index patient are 
more likely to harbour virulent meningococci in their nasopharynx
37
(The M eningococcal Disease Surveillance Group 1974).
However, chemoprophylaxis needs to be commenced as soon as possible, ideally 
within 24 hours after identification of the index patient and certainly not more than 14 
days after the onset of MD as thereafter it has been found to have little or no benefit 
(Advisory Committee on Immunization Practices 1997). The highest risk of secondary 
infection in untreated households is observed in the first 48 hours after onset of the 
disease in the index case (De Wals et al. 1981).
Rifampin, ciprofloxacin, and ceftriaxone have demonstrated 90-95% efficacy in 
reducing nasopharyngeal carriage (Rosenstein et al. 2001;van Deuren et al. 2000).
1.6.2 Vaccination
In the long term, the ultimate solution is prevention of MD by vaccination. A number 
of vaccines have been developed to protect against some forms of MD.
Vaccines come in two forms: polysaccharide vaccines, which consist of chains of 
sugar molecules derived from the surface of the corresponding organism, and 
conjugate vaccines, in which the same sugar molecules are chemically linked to a 
purified protein. The polysaccharide Neisseria meningitidis (meningococcal) vaccines 
are either bivalent (protecting against serogroups A and C) or tetravalent/quadrivalent 
(protecting against serogroups A, C, WI35 and Y). The only current meningococcal 
conjugate vaccine is MenC, protecting against seroGroup C.
The increase of MD in teenagers in the mid to late 1990s, together with a higher case 
fatality rate in the 15-19 year age group, (Connolly and Noah 1999; Harrison et al. 
2001) was a major stimulus in the United Kingdom for introducing the conjugate 
meningococcal serogroup C vaccine. The UK was the first country in the world to 
introduce mass vaccination against group C using a vaccine which is immunogenic in 
infants and primes for memory (Richmond et al. 1999). The vaccine known as MenC 
was introduced in the UK childhood vaccination programme in November 1999 
(Miller et al. 2001) and applied to all under the age of 18 years. This was eventually 
extended to all under 25s in 2002.
38

Figure 1.7 -  Laboratory weekly reports of meningococcal C disease in England 
and Wales 1997-2005
2X520C2
Source; Health Protection Agency
Ireland, Spain, Luxembourg, Belgium, and the Netherlands have also started 
immunisation programmes with a conjugate vaccine against Neisseria meningitidis 
serogroup C MD. In 2006, studies showed that protection against meningococcal 
group C wanes during the second year of life (Trotter et al 2004), therefore a booster 
dose (combined with Hib as Hib/MenC) was introduced at 12 months of age.
Vaccines that offer protection against different strains of MD include the quadrivalent 
polysaccharide (non-conjugated) vaccine made from the outer capsules of seroGroup 
A, C, W-135 and Y meningococci organisms. This vaccine has been recently 
introduced (2005) in the USA for adolescents (Bilukha and Rosenstein 2005). A 
serogroup A conjugate vaccine is currently under development which has important 
implications for alleviating disease caused by this strain in sub-Saharan Africa 
(Soriano-Gabarro et al 2004). Protection against serogroup C infection is believed to 
be of a shorter duration than that conferred by the conjugate vaccine, and the level of 
protection is inferior in young children. The protection conferred by the quadrivalent 
vaccine against seroGroups Y and W135 infection is inferred by the evidence of 
immunogenicity in adults. Therefore, efficacy in younger children is unknown, but 
expected to be similar to protection against serogroup C disease.
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The ACWY vaccine is now a visa requirement for Muslim pilgrims to Mecca and 
recommended for travel to certain countries in Sub-Saharan Africa.
Serogroup B: It is certainly encouraging that the incidence of seroGroup C has 
declined in the targeted age groups, but against this is an increase in seroGroup B 
disease (Ramsay et al. 2001) causing the highest number of cases of MD in the UK 
(EU-IBIS Network 2006). There is currently no available safe and effective vaccine to 
protect against group B MD. This is principally due to the fact that the polysaccharide 
capsule of serogroup B is poorly immunogenic in humans (Griffiss et al. 1991), and 
the use of group B capsule in a vaccine risks the induction of autoimmunity (Finne et 
al. 1983). Further, endemic serogroup B disease is caused by a very diverse group of 
strains, which complicates vaccine development (Harrison 2006).
As a direct response to national epidemics of serogroup B in Norway and Cuba, 
vaccine research has focused on preparations of outer-membrane proteins (OMPs) 
that are mostly strain-specific (Poolman 1995;Verheul et al. 1993). Efficacy of B 
vaccines are restricted to a limited range of strains (Danzig 2004;Girard et al. 2006). 
Furthermore, large-scale trials in Chile, Cuba, Norway, and Brazil have yielded 
different success rates (Bjune et al. 1991;De Moraes et al. 1992; Milagres et al. 
1994;Sierra et al. 199 l;Zollinger et al. 1991). Low efficacy has been observed in 
children younger than 4 years, which is the age group with the highest incidence of 
seroGroup B (De Moraes et al. 1992; Noronha et al. 1995). Scientists in Italy, the 
USA and the UK (Oxford) are currently applying a genomic approach to the solution 
but it will be a number of years before an effective vaccine against serogroup B is 
developed. SeroGroup B therefore still poses a large threat to adolescents in the UK 
with 111 cases reported in 15-19 year olds in 2004 in England and Wales (EU-IBIS 
Network 2006).
1.7 Treatment
MD is a medical emergency and there are very few conditions in medicine that will 
progress as quickly, in some cases only a few hours. Patients with either 
meningococcal septicaemia or meningococcal meningitis must be hospitalised. 
Admission to intensive care may be required in severe cases. Early recognition of
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meningococcal infection is critical as septicaemia spreads so quickly that within hours 
of symptoms appearing, a patient may rapidly die. The speed with which the diagnosis 
is made, antibiotics administered, and the complications of shock and multi-organ 
failure treated is likely to be a major determinant of outcome (Nadel et al. 1998). With 
early diagnosis and treatment, however, the likelihood of recovery is increased.
1.7.1 Pre-hospital antibiotics
General practitioners in the United Kingdom are currently expected to carry benzyl 
penicillin in their emergency bags and to administer prior to hospital admission 
whenever they suspect a diagnosis of MD. A recent review of 14 observational cohort 
studies was conducted to examine the evidence for the effectiveness of antibiotic 
treatment before admission and the impact on survival of patients with MD (Hahne et 
al. 2006). The authors found that oral antibiotics given before admission showed 
consistently improved survival among patients with MD who received such treatment 
compared with those who did not. Evidence from other studies supports pre-hospital 
antibiotic treatment in suspected cases of MD and has been shown to reduce case 
fatality in children by 40% (Cartwright et al. 1992;Cartwright and Kroll 1997;
Gossain et al. 1992;Strang and Pugh 1992).
Benzyl penicillin should be started as early as possible and be the first action. This is a 
life saving aspect of management. Penicillin immediately stops the multiplication of 
meningococci (Brandtzaeg et al. 1989a;Brandtzaeg et al. 2001;van Deuren et al.
2000).
In 1944, the first successful treatment of meningitis with intravenous and intrathecal 
penicillin was reported, and the first clinical trails using high doses of intravenous 
penicillin for the treatment of meningitis were reported in 1950. Since then, penicillin 
has remained the drug of choice for the treatment of MD. Very severe cases of MD 
are often treated with both penicillin and cephalosporins prior to obtaining the 
laboratory results. If the patient has a history of anaphylaxis, chloramphenicol or 
injectable cephalosporin are alternatives. However, Chloramphenicol resistance has 
been reported (Galimand et al. 1998). It is important to give injectable medication, as
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most patients given oral medication will vomit afterwards. Therefore, IM antibiotics 
are the key to early management of the disease.
In contrast, two recent studies from Denmark reported a twofold to threefold increase 
in mortality associated with antibiotics given before admission (Norgard et al.
2002;Sorensen et al. 1998). However, in a more recent study exploring the impact on 
mortality and morbidity of parenteral penicillin given to children before admission to 
hospital with suspected MD found that the children who were given parenteral 
penicillin by a GP had more severe disease on reaching hospital than those who were 
not administered penicillin before admission. The authors concluded that the 
association with poor outcome may be because children who are more severely ill are 
being given penicillin before admission (Hamden et al. 2006).
Before the 1920s, MD was fatal in up to 70 percent of cases (Flexner 1913). After the 
introduction of treatment with antibiotics such as benzyl penicillin, and 
cephalosporins, case fatality fell to around 10% and has remained so ever since.
Therefore, treatment with antibiotics is the only course of action for MD, combined 
with supportive treatment such as intravenous fluids to treat shock and prevent organ 
damage, medications such as noradrenaline (norepinephrine) for patients with very 
low blood pressure, blood products such as platelets and fresh frozen plasma, oxygen 
and ventilation by a machine to assist with breathing.
Patients who survive very severe cases of meningococcemia may have suffered severe 
necrosis of skin and underlying tissue. Skin grafts and amputation may be necessary.
1.7.1.1 Meningococcal Septicaemia
The first assessment of meningococcal septicaemia involves examining if shock is 
present. If the patient has cold peripheries, prolonged capillary refill, tachycardia, 
confusion, history of not passing urine for some time, all indicating signs of shock, 
then aggressive resuscitation needs to be initiated with rapid administration of 
antibiotics. A third-generation cephalosporin (e.g., cefotaxime, ceftriaxone) can be 
used initially in septic patients while the diagnosis is being confirmed or in countries 
such as the United Kingdom or Spain, where penicillin-resistant strains of N  
meningitidis have been isolated. In addition, vascular access is established to facilitate
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the administration of volume expanders and inotropic medications needed for 
adequate tissue perfusion.
In patients with Fulminant Meningococcal Septicaemia (FMS) and Waterhouse- 
Friderichsen syndrome due to low cortisol levels they are likely to benefit from 
glucocortoid supplementation (O'Brien and Morton 1998) or dexamethasone. 
Intensive supportive care is required for patients with FMS. Treatment is 
individualised depending on the severity of the patient. In FMS 50% of patients die 
within the first 12 hours (van Deuren et al. 2000).
1.7.1.2 Meningococcal Meningitis
In the absence of imminent cerebral herniation or shock, treatment of uncomplicated 
meningococcal meningitis demands only parenteral antibiotics and close monitoring. 
The primary goal of therapy is to achieve a rapid bactericidal effect in the CSF. Some 
investigators have suggested that antibiotics exacerbate meningeal inflammation by 
stimulating endotoxin release, (Mustafa et al. 1989), and have therefore suggested 
postponing antibiotic treatment until after dexamethasone was given (Schaad et al. 
1995). The administration of corticosteroids in patients with sepsis or bacterial 
meningitis is controversial (de Cans and van de Beek 2002).
Studies have shown that optimised transport to and prompt treatment at specialised 
units by an experienced team have resulted in lower case-fatality rates in children 
(Booy et al. 2001).
In a national blinded case-control study including 498 children (aged <17 years), the 
standard of care in the first 24 hours after admission to hospital was compared in 
children who died from MD and those who survived. Three factors were 
independently associated with an increased risk of death: not being cared for by a 
paediatrician, unsupervised junior staff, and failure of staff to administer adequate 
inotropes (Ninis et al. 2005).
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1.8 Other causes o f bacterial m eningitis
Whilst this study only examines the bacterium Neisseria meningitidis causing MD, a 
number of different bacteria have the potential to cause meningitis. In the UK, 
Neisseria meningitidis and Streptococcus pneumoniae (causing pneumococcal 
meningitis) are the leading causes of bacterial meningitis with Neisseria meningitidis 
by far the most common cause after the neonatal period (Segal and Pollard 2004).
Haemophilus influenzae type b (Hib), once an important cause of meningitis in 
children under 5, has become uncommon in industrialised countries since the 
introduction of the Hib vaccine from the late 1980s (Adams et al. 1993).
Group B Streptococcus is the leading cause of neonatal meningitis in the UK with 
other causes for example. Listeria accounting for a small number of cases overall 
(Segal and Pollard 2004) -  see Figure 1.8.
Figure 1.8 -  Notifications of specific causes of meningitis in England and Wales 
1990-2000
Source; (Segal and Pollard 2004)
1.8.1 Pneumococcal meningitis
Pneumococcal meningitis is caused by the bacterium Streptococcus pneumoniae. 
Streptococcus pneumoniae, also known as the pneumococcus, causes over one million 
deaths globally in children aged under five years (Leowski 1986). In the UK, reported
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rates are 26/100,000 for the first five years of life (Sleeman et al. 2001), with around 
30% of these cases presenting as meningitis (Shackley et al. 2000).
Streptococcus pneumoniae is the second most common cause of bacterial meningitis 
Neisseria meningitidis in children under 2 years of age (Schuchat et al. 1997). 
There are at least 90 different strains, or serotypes, of pneumococcal bacteria, based 
on differences in the bacterial polysaccharide or 'sugar coat'. However, most disease is 
caused by only a few strains (Department of Health 2004a).
Reported rates of S. pneumoniae in the UK are 183 per 100,000 in the first week of 
life, and 26 per 100,000 for the first five years of life (Sleeman et al. 2001), with 
approximately 30% of cases presenting as meningitis (Shackley et al. 2000). The 
highest incidence is found in children less than 2 years of age. Incidence decreases in 
subsequent age groups to a low level in young adults but again increases in the elderly 
due to health conditions that compromise the immune system.
During 2000,4744 laboratory isolates of S. pneumoniae from blood, CSF or other 
normally sterile sites were reported to the Health Protection Agency Communicable 
Disease Surveillance Centre (HPA CDSC) from laboratories in England and Wales 
(George and Melegara 2003).
Pneumococcal meningitis causes greater morbidity and mortality than most other 
types of bacterial meningitis, with death rates as high as 30%, compared to 3-13% for 
meningococcal meningitis, (Baraff et al. 1993;Grimwood et al. 1996;Laupland et al. 
1998;Neuman and Wald 2001; Short and Tunkel 2000;Usen et al. 1998). 
Pneumococcal meningitis may affect individuals of any age, but is seen most 
frequently at the extremes of age, in very young children and in elderly adults. Death 
rates are highest in very young children and in elderly patients and those with serious 
conditions such as chronic illness or impaired immunity. Often pneumococcal 
meningitis is not accompanied by septicaemia.
Furthermore, survivors of pneumococcal meningitis are more likely to have after 
effects and have the highest rate of complications of all meningitides, with a higher 
risk of permanent neurological damage, spasticity / paresis, also epilepsy and of
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particular importance hearing problems that often are bilateral and profound (Baraff et 
al. 1993;Jadavji e/n/. 1986; Komelisse e/n/. 1995).
In developing countries, Streptococcus pneumoniae is one of the most important 
causes of severe illness and death in young infants (World Health Organisation.
1999).
Antibiotics are the cornerstone of treatment for pneumococcal meningitis but in the 
UK prevention by vaccination started in 2002, when a pneumococcal conjugate 
vaccine became available and recommended for immunisation of at-risk groups under 
the age of two years. In 2004, the conjugate vaccine policy was extended to at-risk 
children under five years of age. In 2003, pneumococcal polysaccharide immunisation 
was recommended for all people aged 65 years and over. In Scotland and Northern 
Ireland, the vaccination scheme has already been implemented in full. In England and 
Wales, the vaccination programme was phased in over three years (Department of 
Health 2004a).
1.8.2 Meningitis caused by Haemophilus influenzae type B (Hib)
Haemophilus influenzae (Hib) disease is the term used to describe infections caused 
by the group of bacteria Haemophilus influenzae. There are six strains of 
Haemophilus influenzae bacteria known to cause disease. The strain that used to cause 
the most disease in the UK is type b, usually referred to as Hib. Hib is spread by 
coughing, sneezing or close contact with an infected person. Hib is an infection that 
can present as meningitis, septicaemia and pneumonia, all of which are fatal if not 
treated quickly.
Prior to the availability and introduction of conjugate vaccines in October 1992, 
approximately one in 600 children developed some form of Hib disease by their fifth 
birthday (Booy et a l 1993;Howard et al. 1991). Children under four years of age were 
at most risk from Hib disease. More than two-thirds of cases were in children less 
than two years of age and those most at risk were infants aged 10-11 months (Booy et 
al 1993).
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Hib infection was the most common cause of bacterial meningitis in children in 
England and Wales. Studies in the US found that up to 45 children in every 100 
suffered long-term neurological problems following Hib meningitis (Sell, 1987). 
There were around 30 deaths every year in England and Wales and about 80 children 
were left with deafness and permanent brain damage (Howard et al. 1991; Tudor- 
Williams e/ a/. 1989).
Hib infections fell dramatically with the implementation of the vaccine programme in 
the UK (see Figure 1.9) and has remained at very low rates, although, a slight 
resurgence in cases was noted in 2003 which led to with a Hib booster vaccine 
campaign for children less than four years of age. The vaccine is now given to 
children as part of their routine immunisations which has resulted in Hib being 
virtually eliminated in the UK, North America, northern Europe, Australia, and New 
Zealand (Robbins et at. 1996).
Whilst Hib meningitis has been virtually eliminated in developed countries, in 
developing countries it is still a leading cause of bacterial meningitis, responsible for 
over 200, 000 cases and more than 40 000 deaths annually (Mulholland et al.
1997;Salisbury 1998). Ninety per cent presenting with Hib meningitis are under 5 
years of age and the peak age group affected is 6-11 months. The case fatality rate is 
approximately 5-20% with complications occurring in approximately 20-30%, the 
most common being hearing loss (Salisbury 1998).
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Figure 1.9 -  Laboratory reports of Hib disease in England and Wales 1990-2005
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Reported cases of MD and other bacterial meningitis in England and Wales from 1999 
to 2003 are shown in Figure 1.10, showing that meningococci caused the most 
disease.
The “other bacterial” category includes mainly uncommon types which are not 
counted separately, e.g. Group B Streptococcal (GBS), E. coli, and Staphylococcal.
1.8.3 Other bacterial causes of meningitis
Examples of other bacteria causing meningitis include Mycobacterium tuberculosis, 
which is comparatively rare. Those at risk include the elderly and those who have an 
underlying Tuberculosis infection. The infection starts usually in the lungs and travels 
to the brain via the bloodstream. It develops much more slowly than other bacterial 
forms and can be difficult to diagnose. The Bacillus Calmette-Guerin (BCG) vaccine 
is routinely given to all children in the UK and has shown to be 77% effective against. 
disseminated tuberculosis (Colditz et al. 1994). Group B Streptococcal (GBS) - is a 
common cause of severe early (less than seven days of age) infection and can cause 
sepsis and meningitis. Currently, antenatal antibiotic therapy is the main preventative 
strategy (Segal and Pollard 2004).
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Figure 1.10 -  Reported cases of MD and other bacterial meningitis
England & Wales, 1999 - 2003 ~
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1.9 Epidemiology of Meningococcal Disease
1.9.1 General Overview
The epidemiology of MD is serogroup specific and surveys have revealed that a few 
specific pathogenic clonal complexes spread the disease worldwide (Wang et al. 
1992). Characterising strains involved in invasive disease is an essential aspect of 
epidemiological surveillance.
The distribution of five clinically significant strains (A, B, C, Y, and W-135) are 
responsible for approximately 95% of infection worldwide, with B and C responsible 
for the majority of cases in developed countries, including the UK, the rest of Europe 
and the Americas (Raghunathan et al. 2006; Rosenstein et al. 2001), see Figure 1.11.
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Figure 1.11 -  Global serogroup distribution o f invasive MD
Source: (Stephens 2007b)
Within serogroups A, B, and C, most disease is caused by a limited number of groups 
of genetically related bacteria which have more recently been referred to as hyper 
invasive lineages (Maiden et al. 1998).
Annual incidence rates in developed countries are between 1-4/100,000 to 10- 
25/100,000 (Morley and Booy 1997). In sub-Saharan Africa where epidemics caused 
by serogroup A are frequent, incidence rates have been known to increase to well 
above 200 / 100,000 (Morley and Booy 1997). The divergence in incidence rates 
around the world reflects the different pathogenic properties of N. meningitidis strains 
and different geographical, socioeconomic, environmental, and climatological 
conditions that enhance transmission (Stephens 1999).
In developed countries, MD is endemic although small clusters occur affecting any 
age group. However, there is a distinct bimodal distribution in age with the greatest 
proportion of invasive MD occurring in children < 5 years of age (Cartwright 1999) 
followed by adolescents and young adults (Goldschneider et al. 1969; Ramsay et al. 
1997).
Contrary to popular perception the adolescent peak of MD actually occurs in those 
younger than university age, with peak age 16-17 years in girls and 17-18 years in
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boys (Jones and Mallard 1993). The highest mortality rates are in fact in teenagers 
aged 15-17 years of age (Harrison et al. 2001).
In endemic situations serogroup B is most common in infants, serogroup C in 
adolescents, and serogroups B or Y in older adults (Stephens et al. 2007b).
Molecular subtyping techniques, such as pulsed-field gel electrophoresis is one of the 
most widely adopted epidemiological tools for cluster designation, disease outbreak 
investigation, and tracking the global spread of meningococcal clones (Mayer et al. 
2002; Mothershed et al. 2001). This technique has identified hyper-invasive lineages 
of N. meningitidis such as the electrophorectic type ET-37 clonal complex, whose 
origin can be traced back to 1917. This particular clone has caused widespread disease 
throughout the world for example, in the US, Brazil and China (Caugant 1998). The 
complex often expresses as serogroup C, but also may express as serogroup B, W-135 
and Y. Some clones are genetically linked for example, serogroup W-135 was 
responsible for a global outbreak of MD in 2000 which was related to the Hajj 
pilgrimage in Saudi Arabia (Lingappa et al. 2003). It was found that the strain W-135 
was derived from clonal expansion within the ET-37 complex and not from a new 
clone (Mayer et al. 2002).
In the last three years, no major changes in the prevalence of clonal complexes across 
Europe have been identified (EU-MenNet 2007).
Strains of the ET-5 complex represented mainly by serogroup B have spread globally 
and were responsible for the major epidemics in Europe in the 1970s and 1980s and in 
the United Kingdom, where the circulation of at least 3 subpopulation of this complex 
was reported (Bygraves et al. 1999).
In contrast to serogroup A or C epidemics, which usually resolve in 1 to 3 years, 
serogroup B causes substantial morbidity and mortality. It is associated with 
prolonged outbreaks (Stephens et al. 2007b) and may persist for 5 to 10 years or 
longer, as seen in Norway (Bjune et al. 1991) and areas of Chile (Boslego et al. 1995) 
and New Zealand (Martin et al. 1998).
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In Europe, North America, Latin America and Australia/New Zealand the majority of 
sporadic cases are caused by serogroup B strains that are predominantly isolated in 
young children (Jones 1995). However, serogroup C has accounted for a higher 
proportion of cases of invasive MD in adolescents and young adults in recent years 
(Harrison et al. 2001). In the 1990s and early 2000s, outbreaks caused by virulent 
serogroup C clones were observed in Europe and North America, with a high 
proportion of fulminant septicemia cases occurring in adolescents and young adults, 
and case-fatality rates between 10% and 14% (De Wals 2006). As the only main 
serogroup for which still no general vaccine exists, the danger of a Men B in the 
developed world is still a serious threat.
1.9.2 Africa
The highest burden of MD is attributable to serogroup A disease, which since World 
War 11 has been a rare cause of disease in most industrialised countries (Rosenstein et 
al. 2001). However, serogroup A still causes recurrent epidemics in countries within 
the African “meningitis belt” and has been a significant public health problem for at 
least 100 years although it is believed to have been endemic for centuries in the West 
Coast of Sudan (Greenwood et al. 1985). Meningitis was first reported on the African 
continent as far back as 1909, by G William.
The “meningitis belt” was initially identified by Lapeyssonnie (Lapeyssonnie 1963).
It extends across 15 countries (see Figure 1.12) with an estimated total population of 
approximately 300 million from Ethiopia in the east to Senegal and The Gambia in 
the west (Stephens et al. 2007b).
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Figure 1.12 -  African meningitis belt
Source: Centers for Disease Control and Prevention
http://wuAvn.cdc.gov/travei'veilowBookCh4-Menin.aspx. Accessed 30th Aug 2007
In this area of Africa, epidemics of meningococcal meningitis occur almost every year 
in one or more countries in the region which may infect over 200,000 people at any 
one time with over 90% of cases presenting with meningitis alone (World Health 
Organization 2002).
1.9.3 Asia and Middle East
Asia has also been the focus of some major epidemics of MD over the last 30 years 
for example, China 1979 and 1980, Vietnam 1977, Mongolia 1973-74 and 1994-95, 
Saudi-Arabia 1987, and Yemen 1988 (van Deuren et a l 2000).
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Epidemic disease has been associated with the annual Hajj pilgrimage to Mecca in 
Saudi Arabia for example, resulting in the spread of serogroup A meningococci 
during the late 1980s and the spread of W 135 meningococci from 2000 onwards 
(Popovic et al. 2000). Pilgrims to Mecca became infected through close contact with 
large numbers of other pilgrims who then carried the bacteria back to their home 
countries resulting in importations into a number of countries around the world, 
including the UK. Two national outbreaks occurred in the UK due to W135 strains 
following the Hajj pilgrimages in 2000 and 2001 (Hahne et al. 2002). The 
quadrivalent (A,C,Y,W135) vaccine (introduced in 2005) is now required for entry 
into Saudi Arabia and as a result the number of W 135 cases have returned to very low 
levels in the UK.
1.9.4 Europe
Outbreaks of MD occurring in Europe are much lower compared to the explosive 
outbreaks that occur in the Meningitis Belt (Rosenstein et al. 2001;World Health 
Organisation 2002a). Notwithstanding, there is considerable variability in the 
incidence of MD throughout Europe. For example, in 2004 incident rates ranged from 
0.30 in Poland, 0.52 Italy to 3.42 Iceland and 4.35 Ireland (EU-IBIS Network 2006), 
see Figure 1.13.
The overall European incidence in 2004 was 1.13 per 100,000 population. Iceland and 
Ireland experienced very high rates of disease in 1999 (7.58 and 11.89 per 100,000 
population respectively), however, these had decreased dramatically by 2004, though 
still considerably higher than those of most other European countries. The proportion 
of cases of serogroup C disease has dropped in those countries using MenC vaccine, 
including Belgium, Netherlands and the UK, but no decrease has been seen in 
Denmark and Norway, which have not introduced the vaccine into their immunisation 
programmes (as of writing September 2007).
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Figure 1.13 -  Incidence (per 100,000 population) of laboratory-diagnosed 
confirmed and probable invasive MD in the European Union 
countries, 2003-2004
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Source; European Union Invasive Bacterial Infection Surveillance Networic(EU-IBIS Networic 2006)
Serogroups B and C are the two main causes of invasive disease in Europe, 
contributing to approximately 90% of cases. An exception to this is Sweden, which 
has a relatively high proportion of serogroup W135 and Y isolates, although total 
numbers are fairly small (EU-IBIS Network 2006), see Figure 1.14.
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Figure 1.14 -  Percentage distribution of serogroups causing laboratory-
diagnosed confirmed and probable MD in European countries, 
2004
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1.9.5 United Kingdom
Historically, large epidemics of MD in the UK were caused by serogroup A, however 
these have declined since World War II (see Figure 1.15 ) (Jones 1995). In recent 
years approximately 97% of cases of MD have been sporadic (Hastings et al. 
1997;Ramsay et al. 1997) with less than 5% of cases occurring in clusters (Health 
Protection Agency 2007b). Invasive MD occurs throughout the year, however, the 
incidence of cases peaks mostly in the winter months, usually from November 
onwards, but can occur in the summer months to a much lesser degree. The reason 
why the incidence of MD is more common in winter than summer is not fully 
understood.
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Figure 1.15 -  Notifications o f M D, England and W ales 1912-2002
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Since the end of World War II the most recent upsurge of invasive MD in the UK was 
seen in the 1990s and has been particularly associated with serogroup C strains of ET- 
37 clonal complex (Miller et ai 2001). During this time there was a shift in the age 
distribution of the disease towards teenagers and young adults (aged 15-19 years) 
(Connolly and Noah 1999), among whom case fatality rates were particularly high as 
they were more likely to have the septicaemic form of MD (Connolly and Noah 1999; 
Harrison et al. 2001).
As the rate of meningococcal serogroup C infections continued to rise in the UK, the 
development of the new vaccines progressed rapidly and in November 1999, the new 
MenC conjugate vaccine was introduced into the UK routine immunisation 
programme.
1.9.5.1 Current UK situation
Serogroup B disease continues to account for most [80%] of the reported cases of 
invasive MD in England and Wales today - a trend that is reflected across the UK 
(Health Protection Agency 2007b), see Figure 1.16.
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Figure 1.16
Invasive Meningococcal Infections in England and Wales by 
SeroGroups B and C, and Age: 1999 - 2004
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The average annual incidence of MD across the UK in 2004 was 2.46 / 100,000 
population, which showed a marked decrease from 5.24 in 1999. Although the highest 
incidence was in children < 5 years, adolescents aged 15-19 years continued to have 
the second highest incidence of 3.7 /100,000, in 2004 (EU-IBIS Network 2006). This 
trend was consistent with overall patterns of the disease around Europe.
The proportional distribution of invasive MD by age groups and year is shown in 
Figure 1.17. In total 1,134 cases of MD were reported in England and Wales in 2004 
(Health Protection Agency 2007a).
Figure 1.17
Invasive Meningococcal Infections in England and Wales 
by Age 1999 - 2004
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However, despite the success of the MenC campaign, as discussed above, the 
Meningococcal Reference Unit (MRU) reported an increase of 11% of cases in the 
UK for 2005 compared to the previous year (Meningococcal Reference Unit 2005), 
with a rising trend of Group B MD. This trend has continued into 2006 (European 
Centre for Disease Prevention and Control 2007). In 2006 the total number of 
statutory notifications of MD made to Health protection Agency (HP A) in England 
and Wales was 1284 with 174 cases reported in young people aged 15 to 24 years, 
representing 14% of the total reported (Health Protection Agency 2007b). The reasons 
for this increase in 2005 / 2006 remain unclear.
Mortality in patients with invasive MD depends on the age of the patient, the clinical 
manifestation, clonal complex of the organism, and case management (Cartwright 
1995b). Overall mortality in MD cases remains around 10% in the UK (Goldacre et 
al. 2003;Ramsay et al 1997) but is higher in cases with septicaemia than in those with 
meningitis alone (Davison et al. 2002). See Figure 1.18 for the case fatality rates in 
England and Wales by syndrome from 1999 to June 2003.
Figure 1.18 -  Case fatality rates of MD by syndrome in England & Wales, 1999 - 
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In contrast to the incidence of MD, the Case Fatality Rates (CFRs) increase with age 
(as shown in Figure 1.19) (Goldacre et al. 2003;Ramsay et al. 1997) and in those 
infected with strains with certain typing patterns (Trotter et al. 2004).
Most deaths occur in adolescents and young adults. The CFRs increased in the 15-24 
and 25+ age groups in 2002-03 compared to the previous year; however, the CFRs for 
the 1-4 and 5-14 age groups decreased when compared to year before.
Figure 1.19 -  Case fatality rates for England, Wales and Northern Ireland in 
confirmed cases of MD by age group: 2001-02 and 2002-03
Source: Enhanced Surveillance of MD National Annual Report: July 2002 - June 2003 
bttp-7/www.hpa.org.uk/infections/topics_az/meningo/ESMD_annual_report_0203 .pdf Accessed 27.08.07
Despite the recent success of the MenC vaccine, MD remains a major cause of 
morbidity and mortality, particularly in adolescents and young adults. Therefore, 
outcome studies such as described in this thesis are important in order to gain an 
understanding of the sequelae caused by MD, the effects of and long-term 
implications of the disease to, adolescents and young people, in an attempt to develop 
appropriate interventions, which will improve such persons’ lives post-MD in the 
future.
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CHAPTER 2 -  LITERATURE REVIEW: OUTCOMES OF 
MENINGOCOCCAL DISEASE
2.1 Introduction
Much is known about the pathophysiology and management of meningococcal 
disease (MD) in its acute stages. However, little is known of the long-term effects of 
MD and more specifically the effects of MD in adolescence. The little research that 
has been done in young people has shown that the proportion of individuals suffering 
significant long-term sequelae can be as high as 20% (Erickson et al. 2001). Few 
studies have focused on the septicaemic form of MD which is more prevalent in 
adolescents (Harrison et al. 2001).
Studies which have examined the outcomes of MD, have mostly focused on physical 
sequelae, particularly hearing loss, and have been conducted across all ages, with few 
studies including small numbers of adolescents. In addition, there are a number of 
studies, which have examined the outcomes of all causes of bacterial meningitis, and 
have included small samples of MD survivors. Once again, these studies have focused 
primarily on major physical sequelae in younger children. Consequently, the effects of 
MD in adolescence, particularly the possibility of damage to cerebral matter during a 
psychosocially vulnerable stage of life, are poorly studied.
What follows is a review of the literature that focuses primarily on reports that relate 
to outcomes caused by Neisseria meningitidis. In addition, studies that have 
concentrated on bacterial meningitis of all aetiologies are only reviewed here to the 
extent that specific findings related to MD had been reported. Findings from the 
studies on outcomes of MD specifically, are reviewed critically, as methodology and 
study samples vary considerably. The findings are considered under three separate 
headings: physical, neuropsychological and psychosocial outcomes.
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Included in the review is a brief discussion on the possible effects of admission to an 
Intensive Care Unit (ICU), which may itself have an effect on the psychological 
outcomes in MD.
Search method of relevant publications
An extensive literature search for all scientific articles pertaining to the sequelae of 
MD and all causes of bacterial meningitis was conducted. A number of electronic 
databases were thoroughly searched for example, Medline and Psych Info. Searches 
were performed repeatedly throughout the course of my PhD studies. Medical Subject 
Heading Terms (MeSH) and/or relevant keywords were applied to searches.
Reference lists from identified articles were also utilised to identify any additional 
studies and in addition, hand searches were conducted.
2.2 Design of outcome studies
Thirteen observational outcome investigations caused by the infection of 
N.meningitidis were identified for review (see Table 2.1).
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Table 2.1 Table summarising the methodology of 13 MD 
outcome studies reviewed
Author Y ear Country Type of Study Case
ascertainment
Follow-up
evaluation
Recruitment 
of cases
Controls
how
recruited
Time since .MD
Fellick et al 2001 UK Case-Control Retrospective Prospective Hospital
series
GP 
matched 
(age & sex) 
controls
9-10 years
Drake et al 2000 New
Zealand
Cohort Retrospective Retrospective Hospital
series
N/A 6-12 weeks
Moss PD 1982 UK Case-Control Retrospective 
recruitment from 
hospital
Prospective Hospital
series
(outbreak
study)
Gender, 
grade and 
age 
matched 
controls 
from school 
roll
5-9 years
Harrison et 
al
2001 USA Population
based
surveillance
Retrospective Retrospective Population
series
. N/A Not available
Edwards et 
al
1981 USA Cohort Retrospective Prospective Hospital
series
N/A Not available
Erickson & 
De Wals
1998 Canada Cohort Retrospective
(provincial
register)
Partly 
retrospective 
and partly 
prospective
Population
series
N/A 9-72 months 
(mean 38)
Judge et al. 2002 UK Cohort Retrospective Prospective Hospital
series
N/A 3-12 months
Naess et al. 1994 Norway Cohort Retrospective Prospective Hospital
series
N/A Approx 1 year 
after 
hospitalisation
Erickson et 
al.
2001 USA Cohort Retrospective Partly 
retrospective 
and prospective
Population
series
N/A Not available
Sander et al. 1984 Norway Case-control Retrospective Prospective Hospital 
series treating 
military 
patients
Age 
matched 
unaffected 
soldiers 
from same 
units as the 
cases
3-15 years 
(mean 8 years)
Djupesland 
et al
1982 Norway Prospective
series
Case 
ascertainment 
from hospital
Prospective Hospital
series
Patients
with
meningitis
by
organisms 
other than 
NM were 
considered 
as controls
6 weeks
Dawson et 
al
1990 UK Cohort Retrospective Retrospective Population
series
N/A Not available
Wang et al 2001 USA Cohort Retrospective Retrospective Population
series
N/A Not available
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The studies were conducted in industrialised countries, and published in the English 
language. Few of the investigations included adolescent MD survivors. Four of the 
studies were conducted in the UK, 3 in Norway, 4 in the USA and one each in New 
Zealand and Canada. Methods used to investigate sequelae of MD were varied and 
therefore studies are critically reviewed and the following aspects discussed 
separately: study design encompassing the structural aspects of the study -  notably, 
how participants were selected, study size, and timing of evaluations, the choice of 
outcome measures, and follow-up rate. Also discussed are exclusion criteria and the 
relevant findings.
2.2.1 Study type
The approach undertaken in studies to determine the outcome of any condition is 
crucial. In all 13 studies, cases were ascertained retrospectively. However, 7 studies 
evaluated participants prospectively. Studies that evaluated participants prospectively 
included: 3 case-controls studies (Fellick et al. 2001;Moss 1982;Sander et al. 1984) 
and 4 cohort studies (Djupesland and Gedde-Dahl 1983; Edwards and Baker 1981; 
Judge et al. 2002; Naess et al. 1994).
Two cohort studies (Dawson and Wardle 1990;Drake et al. 2000) and two population- 
based surveillance studies (Harrison et al. 2001; Wang et al. 2001) evaluated 
participants retrospectively.
The remaining two cohort studies evaluated participants both retrospectively (by 
examining medical records) and prospectively (by administering questionnaires and 
conducting telephone interview) (Erickson and De Wals 1998;Erickson et al. 2001).
Prospective studies have been shown to minimise selection bias (Sica 2006), and 
based on pre-determined criteria for case ascertainment, are likely to provide the most 
valid findings. The advantage of a prospective approach is that standardised clinical 
and laboratory investigations can be carried out, rather than having to rely on possibly 
incomplete historical case notes. However, with a retrospective approach, errors due 
to confounding and bias are more common than in prospective studies, particularly
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selection bias because both disease outcome and exposure have already been 
ascertained at the time of participant selection (Hennekens and Buring 1987).
There are also difficulties in assessing outcomes based on non-standardised records in 
retrospective case ascertainment and follow-up evaluation as case notes must contain 
sufficient information for a specific diagnosis and evaluation to be made.
Four studies under review ascertained cases retrospectively and evaluated 
retrospectively. For example, Harrison et al, in a population-based surveillance study 
of MD in adolescents and young adults used case reports completed by a hospital 
infection control professional; microbiology laboratory reports; and a standardised 
chart abstraction form, when reviewing medical and health department records 
(Harrison et al. 2001). The method of using a standardised data collection tool to 
abstract data from medical records of MD cases was also used in another population- 
based surveillance study of 194 children aged <18 years from 4 paediatric centres in 
Boston, USA over a 16 year period (Wang et al. 2001).
In another study which assessed hearing in children after meningococcal meningitis 
6 weeks post-discharge, cases were identified by searching medical records using 
International Classification of Diseases codes, microbiology reports, with outcomes 
determined by review of the medical, microbiology and audiological records (Drake 
et al. 2000). In the remaining study, which retrospectively evaluated hearing loss in a 
cohort of 50 children following MD with serogroup B, the medical records were again 
used to obtain information on cases. However, the authors do not provide sufficient 
detail on how data were abstracted from the records and whether a standardised 
method was employed (Dawson and Wardle 1990).
Exclusion criteria: Only three papers provide details of exclusion criteria for follow- 
up evaluation. It is important to identify such criteria as they may confound the 
findings. Fellick et al followed-up 115 children aged 1 month to 15 years at MD, 9-10 
years later with age and sex matched controls in order to examine 
neurodevelopmental outcomes (Fellick et al. 2001). Subsequently, cases with major 
neurodevelopmental disability and controls that had previous meningococcal infection 
were excluded. Wang et al in a study of 194 child survivors of MD in Boston, USA
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excluded children who did not have microbiologically confirmed MD (Wang et al. 
2001).
The other study that stipulated exclusion criteria at follow-up evaluation assessed 
hearing in 65 children 6-12 weeks, post meningococcal meningitis. Understandably, 
cases with pre-existing neurological or sensorineural hearing deficit were excluded as 
well as survivors of meningococcal septicaemia. The study also excluded cases 
outside the geographical area of the study centre, which may limit the generalisability 
of the findings (Drake et al. 2000).
The remaining 10 studies did not provide any details on their exclusion criteria or the 
pre-existing health status of participants.
All studies however provided details on confirmation of diagnosis of MD which in all 
cases was based either upon growth of N  meningitidis from blood or cerebrospinal 
fluid specimens and /or clinical presentation. Details on serogroups were provided by 
only 8 studies and clinical presentation of MD [meningitis only, septicaemia only or 
mixed disease] by 12 studies.
2.2.2 Study size
It is well known that small studies tend to be under powered and are unable therefore 
to detect an important difference in effect even if one is present (Pocock 1983). 
Unfortunately, no studies in this review reported power calculations. Therefore, 
findings from the smallest studies may underestimate the adverse effects of MD. Any 
selection process, regardless of sample size would need to ensure a sample that was 
representative in terms of factors such as age, sex and severity of illness to ensure that 
conclusions are generalisable.
Studies varied in their sample size with the number of participants at follow-up 
ranging from 25 (Erickson et al. 2001) to 420 (Erickson and De Wals 1998).
For example, the smallest study examined outcomes of MD in 25 US college students 
and found that 20% [n=5] reported permanent physical sequelae. However, age at MD
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and time to follow-up were not stated and in the absence of such important details, 
coupled with the small size of the study, it is impossible to drawn any meaningful 
conclusions (Erickson et al. 2001).
Of the 13 studies under discussion, only 5 had samples of >100 participants 
(Djupesland and Gedde-Dahl 1983; Erickson and De Wals 1998; Fellick et al. 
2001;Harrison et al. 2001; Wang et al. 2001). 4 studies had <50 participants, (Dawson 
and Wardle 1990;Drake et al. 2000;Erickson et al. 2001 ; Judge et al. 2002). The 
remaining four studies had samples ranging from 50-99 (Edwards and Baker 1981; 
Moss 1982;Naess et al. 1994; Sander et al. 1984).
2.2.3 Time interval to follow-up
Follow-up evaluations occurred at widely varying intervals ranging from 6 weeks to 
15 years post-MD. All studies evaluated participants at a single time point.
A number of studies were interested in the longer-term outcomes of MD. For 
example, a Norwegian case-control study, followed-up 71 young male MD, survivors 
3-15 years later. Age matched controls from the same military units were also 
recruited. No differences were found between cases and controls in the incidence of 
hearing loss, but neuropsychological disturbances and complaints about health were 
found in survivors (Sander et al. 1984).
Other studies have been more focused on outcomes in the short-term. For example, in 
a retrospective study of 65 infants and children (aged 6 weeks to 15 years at MD) 
hearing was assessed in 49 children (75%) 6-12 weeks post-meningococcal 
meningitis, and found a low rate (4.2%) of sensorineural hearing loss in those tested 
(Drake et al. 2000).
If the follow-up period is too long it can have a negative impact on the follow-up rate 
of the study, which in turn can affect the validity of the findings.
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2.2.4 Loss to follow-up
Attrition can be problematic in most follow-up studies and can often lead to bias when 
subjects who are lost differ from those who remain in the study (Sica 2006). If the 
proportion of cases with sequelae in those lost to follow-up was substantially greater 
than in those studied, it would result in an under-estimation of sequelae and 
compromise the internal validity of the study. The more rare the condition is the more 
significant is the effect (Mann 2003).
In the studies reviewed, loss to follow-up was not specifically discussed but deduced 
from the original sample reported and the sample at follow-up. Rates of follow-up in 
10 studies were within the generally accepted rate of 80%. Loss to follow-up rates 
ranged from 6% (Edwards and Baker 1981 ; Naess et al. 1994) to 17% (Fellick et al. 
2001).
Three exceptions were noted: Loss to follow-up was high in two studies [25%] (Drake 
et al. 2000) and [27%] (Moss 1982). In another study, which examined outcomes in 
102 survivors and 61 controls, the original sample of cases was not stated in the paper 
and therefore rates could not be assessed (Djupesland and Gedde-Dahl 1983).
2.2.5 Comparison groups
Selection of appropriate controls to avoid bias is a significant challenge for most 
researchers. Few, if any, succeed in identifying inter-alia two groups of subjects equal 
in age, gender, socioeconomic status, presence of coexisting illness, with the single 
difference being their exposure to the agent being studied (Greenhalgh 1997). 
Nevertheless, the control group needs to be as similar as possible to the affected group 
in order to allow a meaningful assessment of the outcomes. At the very least, cases 
should be matched in respect of potentially confounding variables, such as age and 
gender.
A comparison group were used in four of the studies under review and were recruited 
from a number of different sources. Sander et al, studied 71 young military recruits 
with a comparison group (n=64) recruited from the same units (Sander et al. 1984). A
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study examining the neurodevelopmental outcomes of MD in 115 MD survivors aged 
1 month to 15 years at disease and evaluated 9-10 year later, obtained the controls 
through the GP of the index case (Fellick et a l 2001). In drawing controls from the 
same geographic area as the case it is possible to reduce the bias of factors such as 
socioeconomic status (Wacholder et al 1992c).
The third investigation which enrolled a comparison group to assess the outcome of 
meningococcal B meningitis in 60 children aged 1 month to nearly 8 years at disease, 
recruited age and sex matched controls who were classmates of the index case (Moss 
1982). However, the number of controls recruited was not stated. In addition, both 
cases and controls were drawn from social classes IV and V, which question the 
generalisability of the findings to other social groups.
2.2.6 Methods of assessing outcomes
The most valid results arise from using test instruments that are standardised and 
validated with standard data collection procedures (Grimes and Schulz 2002a). Such 
an approach to data collection minimises interviewer bias and increases the reliability 
of the findings.
In the studies included in this review, the methods of assessment of outcomes varied 
considerably. A total of 8 investigations relied entirely on standardised tools in their 
evaluation of outcomes (Drake et a l 2000;Erickson et a l 2001 ;Fellick et al 
2001 ;Harrison et a l 2001 ; Judge et a l 2002;Moss 1982;Naess et a l 1994b; Wang et 
al 2001).
Other studies were less clear in their description of assessment instruments. For 
example, in a study assessing the prevalence of hearing loss in a cohort of 50 children 
aged 2 months to 17 years at MD who were hospitalised with serogroup B 
meningococcal infection Dawson et al, did not define the type of hearing tests that had 
been conducted on participants (Dawson and Wardle 1990).
Furthermore, in a study conducted by Erickson et al, which examined outcomes in 
MD survivors of all ages, an un validated questionnaire was sent to participants who
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were followed-up by telephone. Exactly how many survivors of group C or B disease 
responded to the questionnaires was not reported (Erickson and De Wals 1998).
The remaining three investigations used a combination of medical tests and/or 
examinations and unvalidated questionnaires (Djupesland and Gedde-Dahl 1983; 
Edwards and Baker 1981; Sander et a l 1984).
Ideally, assessors should be blinded to the status of the participant (case or control) as 
prior knowledge can consciously or subconsciously bias the assessor, which may 
result in an over-or-under estimation of the true measurement. If blinding is not 
feasible it is recommended that standardised, uniform data collection procedures are 
used in all subjects (Kopec and Esdaile 1990).
Only two studies discuss this issue. Sander et al, stated that they '^’believed' the 
examiners were ‘^ignorant as to whether the individual had experienced 
meningococcal disease or n o f\  How this was ascertained was not discussed (Sander 
et a l 1984). In contrast, Fellick et al, are clear and report that one researcher 
organised recruitment and therefore was not blind to the status of subjects (Fellick et 
al 2001).
2.2.7 Definition of outcome
The definition of outcomes as well as the definitions of severity varies between 
studies. A particular adverse effect may be described and/or measured in different 
ways. In studies which have focused on a single outcome such as hearing loss 
(Dawson and Wardle 1990;Drake et a l 2000) or psychiatric adjustment (Judge et al 
2002), reporting of findings is fairly uncomplicated. However, when the emphasis is 
on multiple sequelae, researchers have assessed the overall severity of disability 
resulting from the outcomes. In such studies substantial detail regarding the method of 
classifying outcome is provided (Djupesland and Gedde-Dahl 1983; Fellick et al 
2001 ; Naess et a l 1994; Sander et a l 1984). For example, Edwards et al, classified 
significant outcomes in a cohort of 79 MD survivors aged <16 years at disease, as 
allergic or non-allergic with 27% of cases experiencing one or more problems falling 
into these two categories (Edwards and Baker 1981). Accordingly, a standardised
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approach to the ascertainment of the severity of sequelae in outcome studies is 
suggested.
2.3 Risk factors for poor outcome
Identifying risk factors for poor outcome of MD survivors is essential to enable 
clinicians to prognosticate which groups of survivors who may in the long-term 
require support. In the studies under review, the risk factors for poor outcome were 
not studied systematically although a number of risk factors were identified. Seven 
studies in total discussed risk factors associated with poorer outcome.
Clinical factors
Edwards et al, reported in a cohort of MD survivors aged <16 years at disease that 
several clinical or laboratory features were predictive for the development of arthritis 
or cutaneous vasculitis (Edwards and Baker 1981). These included shock or purpura 
at admission, leukocytosis (20,000 WBC/mm3), or leukopenia (< 5,000/mm3) at 
admission and persistence of fever >than 38.3 C for longer than 5 days. Shock or 
purpura and leukocytosis (20,000 WBC/mm3) was also predictive of a poor 
prognosis. In addition, hearing loss was significantly associated with peripheral 
leukocytosis or leucopoenia at admission and a CSF fluid WBC of > 10, 000 mm3. 
Other studies have also found that clinical symptoms and laboratory factors, pre and 
during hospitalisation increased the likelihood of poorer outcomes. For example, 
Sander et al, reported that survivors (aged 18-24 years at MD), with a fever for more 
than 8 days on admission, and who had < 2.5 mmol/glucose and high WBC in their 
CSF, as well as cerebral symptoms were more likely to have a high rates of late 
sequelae (Sander et al. 1984).
Age and gender
An American population-surveillance investigation reported on a sample of 255 MD 
survivors, and found that young people aged 15-24 years were more likely to have the 
septicaemic form of the disease without meningitis, with infection caused by 
serogroup C and they were more likely to be male (Harrison et al. 2001). In addition, 
they found that cigarette smoking was reported as a risk factor for nearly half of the
72
young people in this age group and that nearly a quarter of meningococcal infections 
in 15 to 24 year olds were fatal. The authors suggest this is due to the high frequency 
of meningococcaemia in this age group. Meningococcal infection in survivors aged 
more than 25 years was associated with chronic conditions. However, since the 
survivors were not followed up prospectively after discharge fi*om hospital but rather 
data on cases was obtained from medical and health department records, using a 
standardised chart abstraction form they may underestimate the frequency of certain 
sequelae.
Erickson et al, also found in a Canadian retrospective outcome study of MD on 
survivors of all ages n=420, which included a large sample of 10-19 year olds 
[n=231], that serogroup C disease produced high rates of complications in adolescents 
and young adults. Serogroup C also had a higher fatality rate than for group B (14% 
vs. 7%) respectively. Most complications found were caused by the septicaemic form 
of infection (Erickson and De Wals 1998).
In another study, Naess et al examined sequelae one year after MD in 93 children and 
adults and reported that sequelae were more common in adults than children (40% vs. 
15%). They also found that neurological sequelae were more common in females than 
in males and audiological sequelae more common in males (Naess et al. 1994). This is 
consistent with the findings from another study which also reported a higher incidence 
of sequelae in females compared to males (Djupesland and Gedde-Dahl 1983).
2.4 Main findings on meningococcal disease from outcome studies
Findings from the studies thus far reviewed are discussed in this section with sequelae 
of MD and are considered under three headings: physical, neuropsychological and 
psychosocial outcomes.
2.4.1 Physical sequelae
Studies examining physical outcomes following MD have resulted in different rates of 
complications due to methodological variations as previously discussed, such as time
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interval to follow up, outcome measures used, diagnostic tests used, differences in 
populations and age groups. Such differences render comparability across studies 
difficult.
Physical sequelae of MD may be neurological related to meningococcal meningitis or 
sequelae relating to meningococcal septicaemia, namely scarring, amputations, 
arthritis or vasculitis and renal failure. Indeed, most physical sequelae of MD result 
from the septicaemic form of infection (Erickson and De Wals 1998).
The risk of major physical sequelae in MD has been reported to be as high as 29% 
(Djupesland and Gedde-Dahl 1983; Naess et al. 1994). Most physical sequelae have 
been reported when septicaemia is present which has generally been shown to 
increase the risk of sequelae such as multiple organ damage, renal failure, scarring, 
amputations and arthritis. One of the most comprehensive studies reviewed examined 
physical sequelae following MD and was undertaken in Quebec, Canada (Erickson 
and De Wals 1998). It was the first study to examine the impact of MD on survivors 
using an objective physical injury scale (The Annotated Scale of Bodily Injuries 
Regulation, ASBIR). The scale enabled the researchers to calculate an overall score of 
permanent mental and physical impairment. The differing effects of serogroup B and 
C were also recorded. Over 400 cases of MD were evaluated of all ages (<1 year to > 
60) which included survivors of seroGroup B (n=167, average age 13.5 years) and C 
(n=304, average age 17.6 years) who were followed up approximately 38 months 
post-MD. The largest age group of group C survivors was 10-19 year olds (n=I01) 
and of group B survivors aged <1 year (n=72). The physical impairment score 
obtained from the ASBIR took into account anatomic and physiologic deficits, 
disfigurement and suffering resulting from the deficit or disfigurement.
Most complications were of septicaemia. High rates of physical sequelae were found 
such as scarring, amputations, hearing loss, and renal problems with 3% of serogroup 
B survivors and 15% of serogroup C survivors affected. 11.5% of group C survivors 
had scarring and 4.6% had amputations. These were the most common physical 
sequelae. Among those with sequelae, the average physical impairment score was 
39% for group B and 55% for group C disease. The study noted particularly high rates 
of complications in adolescents and young adults who had MD caused by serogroup
74
c . The fatality rate of 7% was observed for serogroup B and 14% for serogroup C 
disease. For serogroup C cases, the maximum mortality and morbidity was seen in the 
20-59 year age group and for serogroup B at the upper and lower extremes of the age 
scale.
Although the study was comprehensive, its main weaknesses are that it was 
uncontrolled and retrospective with data collected from the medical records of 
survivors from 91 different hospitals. Nevertheless, the findings are useful and 
provide indications of physical sequelae in adolescents and young adults post MD.
Higher proportions with physical sequelae in survivors with seroGroup C disease 
were also noted in a more recent retrospective study of MD amongst US college 
students (n=25) using the ASBIR. This study found that 20% of survivors had 
permanent physical sequelae due to seroGroup C, mainly due to complications of 
septicaemia. No physical sequelae were noted in those with serogroup B disease 
(Erickson 2001).
In contrast, an American population-surveillance investigation reporting on a sample 
of 255 MD survivors (Harrison et al. 2001) found that very few survivors aged 15-24 
years, experienced long-term physical sequelae, only one survivor with bilateral 
below-the-knee amputation was reported and one with hearing loss. This was also 
reflected in survivors aged <15 years and those aged >25 years. This was surprising as 
the study found that this age group was more likely to have the septicaemic form of 
the disease, with infection caused by serogroup C and higher case fatality rates 
compared to younger survivors. However, as discussed previously, survivors were not 
followed-up prospectively after discharge from hospital but rather data on cases was 
abstracted from medical records, which may therefore underestimate the frequency of 
the sequelae.
Significant physical sequelae are found to be less common in younger children. A 
study of 194 child survivors of MD (aged <18 years) conducted in the US, reported 
that only 5 (2.6%) had amputation or scarring (Wang et at. 2001). This is consistent 
with an earlier case-control study of meningococcal meningitis survivors from 1982 
(Moss 1982) where 60 children (aged between 1 month and 7 years 10 months at
75
disease) were followed-up 5-9 years later. The author reported that there was no 
significantly higher incidence of physical disability compared with controls.
In contrast, a prospective study undertaken in the US evaluating 79 children <16 years 
of age, found that 27% experienced one or more significant complication including 
Myocarditis, and suppurative arthritis (Edwards and Baker 1981). A further 10.1% of 
survivors developed late-onset arthritis or vasculitis. The study also observed that 
older age groups tended to be more prone to these complications than younger 
children were. Time since MD was not reported in this paper.
A Norwegian controlled study of 71 young male military recruits (aged 18 and 24 
years of age at MD) and followed-up 3-15 years post-disease (Sander et al. 1984) 
noted that survivors anecdotally reported more general health complaints, including 
fatigue, than controls. It found that 13% had “relevant” complaints about their health 
deemed to be related to MD, whilst only 2% of controls had similar complaints. Such 
complaints included tinnitus, dizziness, visual disturbance, headache, irritability, and 
sleeplessness. The proportion of patients treated in ICU was not stated. Among the 71 
survivors, 57 had had meningitis with or without septicaemia and 14 had septicaemia. 
The authors also reported other physical sequelae; arthritis (13%), muscle pain 7%) 
and chronic skin disease (4%).
Neurological sequelae have also been reported, for example, in an uncontrolled study 
that prospectively evaluated 93 survivors of all ages, one year after meningococcal 
septicaemia and meningitis. Seven out of 52 adults and 1 out of 41 children exhibited 
abnormalities in the neurological examination such as asymmetry of reflexes, 
diplopia, and unsteady gait (Naess et al. 1994). No other physical sequelae were 
assessed.
Fellick et al followed-up 115 children aged 1 month to 15 years at MD, 9-10 years 
later with age and sex matched controls (Fellick et al. 2001). They found that the 
majority of survivors did not have gross neurological deficits. However, when 
objective measures assessing motor and coordination skills were administered it was 
found that 16.5% of cases compared to controls had significant problems.
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Hearing loss is found in MD survivors only when survivors have had meningitis with 
or without septicaemia -  see Table 2.1.
Table 2.2 MD outcome studies reporting the prevalence of hearing loss in 
surv ivors of all ages
Study Case 
sam ple at 
follow-up
Age at 
MD
Age at 
follow-up
Follow-up
time
No of cases 
assessed 
for 
hearing 
problem s
Rate of 
hearing loss |
%
Fellick et al, 
2001
115 1 month to 
15 years 3 
months
8 years 9 
months to 
25 years
9-10 years 109 4.3
Drake et al, 
2000
65 6 weeks to 
15 years
Not stated 6-12 weeks 49 4.2
Moss, 1982 60 1 month to 
7 years 10 
months
Not stated 5-9 years 60 10
Harrison,
2001
255 <15 years 
to >25 
years
<15 years to 
>25 years
Not stated Not stated 5
Edwards 
et al, 1981
79 Not stated <16 years Not stated Not stated 9
Erickson et 
al, 1998
420 <1 to >60 
years
Mean 13.5 
(exact range 
not stated)
9-72
months
420 1.9
serogroup C 
& 1.9
serogroup B
* Naess et al, 
1994
93 <2 months 
to >50 
years
Not stated 1 year 78 16.7
Erickson et 
1 al, 2001
25 Not stated Not stated Not stated 25 4
Sander et al, 
1984
71 18-24
years
Not stated 3-15 years 71 7
Djupesland et 
al, 1983
102 Not stated Not stated 6 weeks 102 5.4
Dawson et al, 
1990
35 2 months 
to 17 years
Not stated Not stated 35 8.6
As Table 2.2 shows, extreme variability in the incidence of hearing loss following 
MD is reported in the literature reviewed. The degree of hearing loss varied from 
1.9% (Erickson and De Wals 1998) to 16.7% (Naess et al. 1994). The variations in 
levels of hearing loss across studies may be in part be due to the differences in the 
timing of the hearing assessments following the acute stage of MD, the methods of 
evaluation [in some cases self-report questionnaires], age at MD, the severity of 
disease, follow up rates, and the size of the study sample.
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2.4.2 Psychosocial outcomes
This area has been poorly studied with only three of studies reviewed exploring 
psychosocial outcomes in MD survivors.
Sander et al, prospectively followed-up 71 male MD survivors aged 18-24 years at 
disease, 3-15 years after the disease (Sander et a l 1984). Survivors were aged 18-24 
years at disease. Sixty-four controls were recruited for comparability. The study found 
29% of the young men believed their vocational choices and educational success had 
been affected post-MD. Unfortunately, an unvalidated questionnaire was used to 
collect this information, with reliance placed on the subjective experience of 
participants.
Other studies have focused on quality of life (QOL) post-MD. For example, in the 
retrospective Canadian study of over 400 MD survivors (Erickson and De Wals 
1998), apart from the physical sequelae of MD which was its main focus, also 
examined quality of life (QOL). The study noted that 23% of 231 survivors who 
completed a questionnaire reported poorer QOL since MD. It found that a number of 
different psychosocial factors compromised QOL, including reduced energy, 
increased anxiety, and a reduction in leisure activities and the ability to work. An 
overall impairment score was calculated providing an estimate of the magnitude of 
reduction of QOL. Again, an unvalidated postal questionnaire that included 12 general 
statements concerning different aspects of QOL was used and was not specifically 
related to MD.
In a further uncontrolled retrospective study in the US the same authors administered 
the EuroQOL EQ5D quality of life questionnaire (EuroQol Group. 1990) to 25 
college students and found that 20% of survivors reported a reduction in QOL post- 
MD, primarily in those survivors who had physical sequelae (Erickson et a l 2001).
2.4.3 Neuropsychological sequelae
There have been few studies on the neuropsychological sequelae following MD, and 
even less in relation to adolescents. In general, relatively inconsistent findings have 
been observed across the few studies identified for review. Methodological variations
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are likely to be responsible as discussed previously. Consequently, it is difficult to 
draw meaningful conclusions or compare existing findings to adolescents. While 
major physical sequelae are simple to detect clinically, subtle neuropsychological 
abnormalities require a carefully selected control group for adequate comparison. 
Moreover, the neuropsychological sequelae of septicaemic MD has not been 
examined or related to possible social and functional effects. Prospective studies and 
adequate sex and age matched control groups are necessary for the study of subtle 
neuropsycho logical outcomes. A more complete understanding of how brain insults 
affects adolescents requires prospective research.
Several of the studies conducted have found minimal or no evidence of cognitive 
dysfunction post-MD. For example, in a matched case-control study. Moss 
prospectively evaluated 60 children aged one month to just under 8 years at MD 
(Moss 1982). Survivors were assessed 5-9 years post-disease. All survivors had a 
diagnosis of meningococcal meningitis. The Wechsler Intelligence Scale for children 
(revised) (WISC-R) and the Burt reading Test were administered by educational 
psychologists. Only a “tendency” towards lower performance and lower IQ was found 
in cases compared to comtois which failed to reach statistical significance.
Similarly, Naess et al, prospectively assessed children and adults, including teenagers 
one year post-MD (n=93, [52 adults and 41 children]) (Naess et al. 1994). This was a 
controlled study with only nine participants assessed using the Halstead test battery. 
Only two patients were reported to have deficits (mild to severe), one of whom was a 
young girl of 17 years with deficits found in attention and concentration. However, 
the study sample is far too small for meaningful conclusions to be drawn.
In contrast, Fellick et al, in a well-conducted case-control study, examined the long­
term neurodevelopmental outcomes of 115 children, aged one month to 15 years at 
disease, and followed prospectively for evaluation 8-10 years post-MD (Fellick et al. 
2001). Age and sex matched controls were also recruited. Age at assessment ranged 
from 8 years 9 months to 25 years. Objective measures of cognitive ability were 
administered which included The Wechsler Intelligence Scale for Children, 3^*^ 
edition, UK (WISC-III) and the Visual Motor Integration Test to evaluate the ability 
to copy a sequence of geometric forms. The study found that cases obtained
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significantly lower scores on psychometric tests, achieving on average 6.4 points 
lower in total IQ compared to controls. In addition, teachers and parents reported 
behavioural problems and 38 cases had special educational needs compared to 17 
controls.
Only one Norwegian case-control study assessed young adults although it did not 
report specifically on the nature of neuropsychological disturbances. Seventy-one 
male survivors aged 18-24 years at MD were followed-up 3-15 years post-disease. 
Survivors reported problems with memory (15%), and concentration (17%), with 
controls reporting no such problems (Sander et al. 1984). However, standardised 
neuropsychological tests were not administered affecting the validity of the findings.
Thus far, no systematic prospective study investigating neuropsychological outcomes 
in adolescents has been conducted.
2.5 Findings from outcome studies on bacterial meningitis of all aetiologies
The outcomes of meningococcal meningitis have also been assessed by studies that 
have examined all aetiologies of bacterial meningitis. As the majority of cases of MD 
present as meningitis, these studies are important sources of information. However, 
few studies have included adequate numbers of survivors of meningococcal 
meningitis to form any firm conclusions or indeed compare to adolescents. Most 
outcome studies have concentrated on major physical and neurological impairments in 
children diagnosed at young ages, with the main pathogen Haemophilus influenzae as 
the primary focus (Feigin et al. 1976;Feldman and Michaels 1988;Grimwood et al. 
1995;Grimwood e /ûf/. 1996;Sell üt/. 1972;Sproles e /ût/. 1969;Tejani er a/. 1982).
What follows is a brief review of the main studies and again it is possible to present 
the findings on outcomes under three separate headings: physical, psychosocial and 
neuropsychological.
2.5.1 Physical sequelae
In 1993 a meta-analysis was published which examined 45 outcome reports of 
bacterial meningitis of all aetiologies involving 4920 children up to 19 years of age
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(Baraff et al. 1993). The review included 19 reports of prospectively enrolled cohorts 
from developed countries (n=1602). Two-hundred and twenty-seven children with 
meningococcal meningitis were included in the analysis with 7.5% having one or 
more physical outcome such as deafness, mental retardation (defined as IQ less than 
70), spascity or paresis and seizures. The commonest sequela was deafness with 6.4% 
of meningococcal meningitis suffering from some form of hearing impairment (see 
Table 2.3).
Generally, physical sequelae following meningococcal meningitis were reported to be 
less than for meningitis caused by Haemophilus influenzae and Streptococcus 
pneumoniae. The highest mortality rate was associated with Streptococcus 
pneumoniae (15.3%), and Haemophilus influenzae was associated with the lowest rate 
(3.8%). The mortality rate for Neisseria meningitidis was 7.5%.
Overall, detectable sequelae were not found in 83.6% of survivors of all causes of 
bacterial meningitis. Deafness was found in 10.5%, bilateral severe or profound 
deafness in 5.1%; mental retardation in 4.2%; spascity and /or paresis in 3.5% and 
seizure disorder in 4.2%.
The meta-analysis was a comprehensive review of the existing literature on all causes 
of bacterial meningitis. However, it is important to note that most studies focused 
specifically on bacterial meningitis caused by Haemophilus influenzae, with a large 
number of the studies designed to evaluate newer antibiotics. Therefore, cases may 
have been excluded if they presented in shock or with a high probability of death.
This can be the case for patients with MD in which septicaemia may be present, and 
may account for the low numbers of sequelae in MD survivors.
Other works including survivors of meningococcal meningitis have indicated varying 
rates of sequelae with neurological abnormalities found in 4.7% of survivors 
(Grimwood e/a/. 2000;Taylor a/. 1996).
Although a single study found that a small group of children surviving meningococcal 
infection had no physical sequelae (Jadavji et al. 1986), most studies reported a risk 
between 8.5% (Grimwood et al. 1995) and 14% for major physical sequelae following
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meningococcal infection (Jadavji et al. 1986;Pomeroy et al. 1990). The timing of 
assessment may be important as Pomeroy identified 37% with abnormalities at one 
month post illness, while at one year only 14% remained so (Pomeroy et al. 1990). 
Several studies have mean length of follow-up over 5 years (Grimwood et al. 
1995;Pomeroy et al. 1990).
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Table 2,3 Outcomes o f bacterial meningitis by causative agent: meta-analysis o f prospective cohort studies from developed countries 
(Baraff et al, 1993)
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2.5.2 Psychosocial
Behavioural and social problems have been reported to be more common after 
meningitis in early childhood (Grimwood et al. 1996).
Very little research has focused on psychosocial outcomes of all causes of bacterial 
meningitis and that have included survivors of meningococcal meningitis. Only one 
study reports on this. In a prospective cohort study using age and sex matched 
controls Grimwood et al evaluated 158 survivors of all causes of bacterial meningitis 
(n=7 MD) with Hib as the major pathogen (Grimwood et al. 1995). Children aged 
between 3 months and 14 years (average 8 years) at disease were followed up 5 and 
10 years later. A standardised scale was used (Teacher Report Form) which assesses 
social and school adjustment and a good response was achieved. Parents whose 
children had meningitis completed a Child Behaviour Checklist questionnaire and 
indicated more behaviour problems although the scores only approached significance. 
Teachers also rated child survivors as having more behaviour problems and reduced 
adaptive ftmctioning. However, little is known about the effects of 
neuropsychological sequelae of meningitis on behaviour and social adjustment.
2.5.3 Neuropsychological sequelae
Previous studies of neuropsychological outcome of bacterial meningitis of all 
aetiologies, which have included meningococcal meningitis survivors, have 
predominately focused on children diagnosed at young ages. Commonly the focus of 
these studies has been on Haemophilus influenzae with Neisseria meningitidis 
included in far smaller number. However, more recently studies are emerging which 
have focused on adults (Hoogman et al. 2007).
A prospective case-control study of children under 14 years (mean age 17 months at 
meningitis, predominantly HiB) using standardised measures found that survivors 7 
years post-disease had significantly lower IQ scores and poorer reading ability, visuo- 
motor co-ordination, learning, memory and executive skills than controls (Grimwood 
et al. 1995). Overall, 18.5% of the cohort had minor neurological or psychological 
sequelae (Grimwood et al. 1996). Neuropsychological assessment was performed 
again on 109 survivors from the original cohort, 12 years post-disease. The study 
found that cognitive deficits at 7 years following infection had persisted with
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continuing problems in intellectual, academic and high level cognitive function. 
Compared to controls, survivors showed significantly lower IQ scores and poorer 
academic abilities on tasks requiring high level skills, including complex linguistic 
ability, new learning, and executive functions such as organisation, problem solving 
and mental flexibility (Grimwood et al. 2000).
Studies among adults after bacterial meningitis have described cognitive slowness, 
and impairment of psychomotor performance. For example, a recent Dutch study was 
conducted to assess cognitive outcome in 155 adults (79 after pneumococcal 
meningitis and 76 after meningococcal meningitis) and 72 controls (Hoogman et al. 
2007). Survivors were aged >16 years (mean age 38.9 years) with good recovery. 
Controls were not randomly recruited but were mainly partners, relatives or close 
friends of the survivors. However, standardised measures were used to assess 
cognitive ability. Survivors were drawn from three prospective long-term follow-up 
studies and assessed post-disease. Months between disease and assessment for 
pneumococcal survivors were mean 54.7 ± 44.0 months and for meningococcal 
meningitis survivors, mean 68.8 ± 49.4. Cognitive impairment was found in 32% of 
survivors, which was similar for survivors of pneumococcal and meningococcal 
meningitis. The authors found significant differences between cases and controls. The 
prevalence of cognitive impairment between survivors after pneumococcal and 
meningococcal meningitis was similar. The study found that pneumococcal survivors 
had more impaired test results in memory than survivors of meningococcal 
meningitis.
In another study 22 adult survivors of bacterial meningitis of all causes (none with 
MD) were cognitively assessed (mean age 52.5 ±17.1 years) 30 ± 11 months after 
disease. Psychometric tests were used and 17 controls were recruited for 
comparability. Cognitive speed and psychomotor performance and concentration as 
well as visuo-constructive capacity and memory functions were significantly impaired 
compared to controls. Survivors of pneumococcal meningitis had lower test results 
than survivors of other causes of bacterial meningitis (Merkelbach et al. 2000).
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2.6 Possible effects o f  Intensive Care admission
Due to the severity and life-threatening nature of MD, ICU admission is often routine 
in the early stages to treat coma, shock and purpura fulminans. However, regardless of 
disease aetiology, studies that have examined patients admitted to ICU, have shown 
that long-term morbidity (physical, psychological or psychosocial) can continue post­
discharge.
Only one British study has examined the effect of ICU admission on MD survivors 
(Judge et a l 2002). Twenty-nine children, aged 2-15 years at MD were followed-up 
from a Paediatric Intensive Care Unit (PICU) and assessed 3-12 months post 
discharge. An overall risk was found for child psychiatric disorder in 20% of 
survivors with symptoms of post-traumatic stress disorder present in 62% of children. 
In addition, 10% demonstrated features of a stress disorder. However, the study 
sample was small and a comparison group was not used. It is difficult therefore to 
discern whether post-traumatic symptoms resulted from MD or were simply the 
consequence of a severe illness or PICU admission.
Estimates of Post Traumatic Stress Disorder prevalence in critically ill adults are 
reported to be as high as 63% (Schelling et al 2001). It may be that critical illness is 
uniquely stressful due to factors associated with the experience of ICU such as 
awareness during painful procedures, a sense of helplessness, loss of control, and an 
imminent threat of death (Jackson et al 2007).
Brooks et al examined the physical and psychosocial outcomes of ICU admission in 
238 adult patients with a variety of diagnoses 12 months post-discharge. Controls 
were selected randomly from the local community (Brooks et a l 1997). Patients were 
all over the age of 18 years (with an ICU stay greater than 24 hours). Only three 
patients with sepsis were recorded and these were excluded from analysis, as the 
sample size was deemed too small. Compared to controls, patients reported poor 
health perception, poor quality of life, more health problems and depression with 
reduced sexual activity and greater dependency on others. Response rates achieved 
were however disappointingly low and a higher than expected rate of chronic ill
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health was seen amongst the control group due to possible response bias. However, 
these findings are consistent with other studies.
Another study examined 60 patients a year after discharge from ICU and found that 
nearly half were suffering some degree of anxiety, socialised less than before 
admission, and took part in fewer activities. Unfortunately, age groups or type of 
illnesses were not specified (Jones et al. 1994). However, these findings are consistent 
with those found in other studies in patients post-discharge from ICU (Cuthbertson et 
al. 2004;Patrick et al. 1988;Scragg et al. 2001 ;Skirrow et al. 2001). In contrast to the 
above studies, an investigation of a varied case mix of ICU patients at 3 month 
follow-up found a low prevalence of psychological distress (Eddleston et al. 2000).
Longer-term outcomes have also been examined. For example, a 3-year follow-up 
study of 182 patients with multiple aetiologies, reported that 23% had died within a 
year of discharge, and that “not a single patient was found without some particular 
disturbance”. Sixty-percent were described as having “become a different person”. 
Interestingly, 43% were not working 12 months after discharge. Unfortunately, no 
control group was used for comparison purposes, which has often been the case with 
studies in this area. Although the paper did not specify the age group studied, patients 
came from adult intensive care units (Benzer et al. 1983). A Norwegian report on 
patients 12 years after ICU reported a global reduction in quality of life in patients 
(Flaatten and Kvale 2001).
Neuropsychological sequelae in ICU patients post-discharge are starting to emerge. 
The ICU can be a stressful and noisy environment with little differentiation between 
night and day (Biley 1994). Patients are often sedated with psychoactive drugs during 
at least part of their stay, the long-term effects of which are uncertain (Broomhead and 
Brett 2002). Hopkins and colleagues reported that 100% of patients who had Acute 
Respiratory Distress Syndrome experienced cognitive impairment at hospital 
discharge, including problems of memory, attention and concentration. Although, they 
demonstrated improvements at 1 year follow-up, 30% of patients were still globally 
impaired and 78% were impaired in one or all of the domains assessed. The authors 
associated the deficits with hypoxemic episodes in the ICU (Hopkins et al. 1999).
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It is important to remember that the majority of ICU admissions are to adult units and 
consist of mature adults, a significant proportion of whom may have underlying 
chronic physical disease. As a result, the majority of research into the outcomes of 
ICU admission has been conducted predominately in adults. Although the findings 
from this research are very useful in providing insight into the possible outcomes, 
they may not be generalisable to teenagers. Furthermore, the majority of outcome 
studies of ICU admission reviewed have not used a control group of patients who 
have not been admitted to ICU against which to compare outcomes. Therefore, 
underlying disease factors are potentially major confounders in outcome studies of 
ICU.
In summary, although these studies are important, apart from the study conducted in 
young MD survivors post-discharge from PICU, the majority were conducted with 
adults and therefore it is difficult to extrapolate findings to an adolescent population 
with low incidence of background ill health. Research on ICU admission is clearly 
needed on adolescent MD survivors.
2.7 Chapter summary
The research that has been conducted to date has shown that meningococcal disease 
leaves a proportion of survivors with some degree of physical sequelae. However, an 
overall assessment of the results of the outcome of MD has been hampered by the 
diversity of both the methods used and the populations studied with a number of 
studies varying widely in their methodological rigour. This was particularly true 
among some of the older studies where different assessment instruments were used, 
lengths of follow-up time, varied sample sizes, and age groups and sampling 
procedures were sometimes unspecified. In some studies, an appropriate control group 
was seldom included with conclusions being based more on clinical impressions 
rather than objective data. Research on MD survivors would benefit from a 
standardised approach sufficiently defined by standards accepted throughout the field.
Until this is accomplished, it will be difficult to compare outcomes across most 
studies. Some of the studies used small sample sizes which questions their validity 
and generalisability. Consequently, it is difficult to draw meaningful conclusions or to
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compare existing findings to outcomes of MD in adolescents. Establishing reliable 
estimates of outcomes of MD requires follow-up of larger samples over a longer 
period. Nevertheless, these investigations have generated important insights into the 
outcomes of MD across different populations.
In particular, social, neuropsychological and psychological outcomes have not been 
explored in all age groups and more specifically in adolescents and we lack data on 
young people’s qualitative experience of life after MD. The subtle emotional and 
psychological effects of impairments have not been explored in any age group.
Furthermore, little attention has been paid to the impact of physical and 
neuropsychological sequelae of MD on later social, education and vocational 
functioning. Existing published studies have not specifically addressed these deficits, 
which may affect social and employment outcomes for adolescents and young people 
following MD. Subtle neurological and psychological abnormalities may be missed 
after meningitis or septicaemia, but may significantly affect later educational and 
employment success and quality of life. The effects of MD on quality of life and 
relationships have not been fully addressed. Notably, the effects of hearing loss, both 
socially and psychosocially, have not been explored and more specifically the effect 
that this would have on the adolescent’s vocational and educational aspirations. For 
example hearing loss in adolescence has been found to lower self-esteem, cause 
anxiety (English 2002), depression (Marschark 2007), social isolation (Spencer et al. 
2000) and impact on academic achievement (Lang 2002).
Neuropsychological assessment requires a comprehensive assessment of cortical 
integrity such as visual and verbal processing abilities, memory, attention and 
concentration, which are more appropriate in adolescents and young people post-MD. 
Tertiary-based studies are more likely to show deficits than population-based studies, 
age at diagnosis, length of follow-up and age at assessment are also likely to produce 
differing results, making it difficult to compare results across studies as well as within 
studies between different age groups. As reduced IQ and severe deficits are more 
likely in young ages and memory/attentional problems more likely in older ages, it is 
difficult to draw meaningful conclusions from the existing literature and relate the 
findings to adolescents.
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SECTION B
CHAPTER 3 -  METHODS
3.1 Aims and objectives
The main aims of this study were to:
• Explore the later outcome of MD in late adolescence and more specifically, to 
determine prevalence of educational and employment disadvantage, social 
isolation, stress and depression and reduced quality of life after MD;
• Investigate the prevalence of neuropsychological deficits in IQ, multiple aspects 
of memory, attention, verbal and visual recognition ability and executive function 
after MD in late adolescence;
• Examine the physical sequelae of MD in adolescence and impact on functioning;
• Explore the significance of neuropsychological deficits resulting from MD by 
examining their association with educational and psychological outcomes; and
• Provide the initial part of a longer-term follow-up of the outcome of MD during 
late adolescence.
3.2 Study design
The main purpose of the follow-up study was to investigate educational, employment, 
social, psychological and physical outcomes after MD in adolescence at 18-36 months 
after the acute episode, in comparison to normal control adolescents.
In view of the nature of the investigation, the most appropriate study design was a 
matched cohort study. There are a number of advantages of the cohort design. It is 
useful in the study of rare diseases (Grimes and Schulz 2002b), considered to be 
ethically safe, participants can be matched, eligibility criteria and outcome 
assessments can be standardised, and it is possible to examine multiple outcome 
variables (Oxford Centre for Evidence-Based Medicine 2007). However, outcomes
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must be defined in advance; they should be clear, specific and measurable and 
comparable in every way for the exposed and unexposed to avoid information bias 
(Grimes and Schulz 2002b).
A cohort study measures exposures in a sample of individuals (a cohort) and then 
follows the cohort for a period of time during which disease outcomes are monitored. 
In population-based cohort studies, the best strategy to avoid bias when obtaining data 
on outcomes is to carry out standardised data collection (Sackett 1979) as was the 
case in the current study.
The control group should be similar in all important respects to the exposed, with the 
exception of not having the exposure (Grimes and Schulz 2002b). Controls in the 
current study were age and sex matched and resided in the same geographical area as 
their matched cases.
Population-based cohort studies generally evaluate multiple hypotheses, defined a 
priori (Szklo M 1998), as was the case in this current study. Hypotheses regarding 
outcome of cases were generated following the baseline study, a case-control 
designed study.
3 3  Study population
3.3.1 Baseline study
MD cases and controls for the current follow-up study were drawn from a large 
population-based case-control study. Cases and controls were recruited from six 
contiguous regions of England (North Thames, South Thames, Anglia and Oxford, 
South West, Trent, West Midlands), representing approximately 65% of the 
population of England (hereafter referred to as the baseline study) (Tully et al. 2006).
The objectives of the baseline study were to investigate the risk and protective factors 
for the development of MD in adolescents during the adolescent peak (in 15-19 year 
olds). The baseline study was conducted between January 5th 1999 and June 9th 2000.
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Incident cases were recruited through regional Consultants in Communicable Disease 
Control, clinicians and the national meningococcal reference unit.
Eligible participants were teenagers aged between 15 and 19 years who were admitted 
to hospital with a primary clinical diagnosis of meningococcal infection (signs of 
septicaemia or meningitis in association with hemorrhagic rash, or both). Laboratory 
confirmation of disease was sought at the reference laboratory in Manchester through 
culture or detection by polymerase chain reaction (PCR) of Neisseria meningitidis 
from a normally sterile site or serodiagnosis in a patient with a clinically compatible 
illness.
Cases were excluded if they were identified after the fifth day of admission to 
hospital, the subject had died, the attending doctor declined to participate, the subject 
did not speak English, or approval from the local research ethics committee had not 
yet been obtained.
Controls were recruited from the case patient's general practitioner's list of patients. 
Each general practitioner was asked to contact the three patients on their list of the 
same sex as, and closest date of birth to, the case. This was to control selection bias by 
the doctor. Controls were recruited nearest in age to the case. If none of these 
participants consented, the doctor was requested to send invitation letters to the next 
three who were nearest in age. Of the 144 controls, 55 (38%) were the first control and 
36 (25%) were the second control approached. In 20% of cases, we recruited the 
fourth or greater control. The median age at referral for controls was 17.7.
One hundred and forty-four case control pairs (age and sex matched) were recruited 
for the baseline. Seventy-four cases were male (51%); median age 17.6.
3.3.2 Follow-up study
Cases and controls who consented at baseline to being contacted for follow-up 
(approximately 95%) were considered eligible for inclusion in the follow-up study.
The follow-up study was conducted from September 2000 until July 2002, at 
University College London Hospitals, 18 to 36 months after disease.
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3.3.2.1 Sample size estimation for follow-up
Determination of the appropriate sample size is a crucial part of study design. Power 
calculations were conducted to estimate the sample size required at follow-up in order 
to examine the three hypotheses in this study to detect clinically important differences 
between cases and controls.
Power analysis demonstrated that 88 matched case-control pairs would be required to 
provide 80% power at 5% significance level for the outcomes shown in Table 3.1, 
thus avoiding a type I error (rejecting the null hypothesis incorrectly), or a type II 
error, (accepting the null hypothesis incorrectly) (Jones et al. 2003).
Data were derived from StatCalc using published data from previous outcome studies 
(major physical disability (Erickson and De Wals 1998a), neuropsychological deficit 
(Grimwood et al. 1995) and for stress using unpublished data from the Risk Factor 
Study (Tully et al. 2006). Table 3.1 refers.
Table 3.1 Estimation of sample size at follow-up
V ariable Prevalence in Prevalence in N um ber of case-control
cases controls pairs  required
Major physical disability 15% <1% 71
Stress scale score greater than 4 25% 8% 69
Neuropsychological deficit
1
20% 5% 88
3.4 Recruitment at follow-up
I recruited participants to the follow-up study, approaching the first 115 case-control 
pairs on the cohort list, primarily to minimise selection bias and to correct for 
attrition.
Participants for follow-up were initially contacted via telephone and those who agreed 
to participate in the follow-up assessment were sent an appointment letter to their
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home together with an information sheet outlining the aims of the study and providing 
a detailed explanation of what their participation would involve. The invitation letter 
and telephone call assured the young person that they had no obligation to participate, 
and that prior participation in the baseline study did not obligate them to participate in 
follow-up. Appointments were made for participants at a time that best suited them.
If participants were not contactable by telephone, a letter was sent to their home 
address inviting them to participate together with an information sheet regarding the 
study. If there was no response, a final letter was sent two weeks after the first, after 
which they were considered lost to follow-up.
We did not aim to undertake a matched analysis. As much as possible we recruited 
case-control pairs together. However, if the case had agreed to participate in the 
follow-up study but the control had declined at baseline or decided at follow-up not to 
participate at the last minute, it was agreed by the research team that new controls 
would be recruited from the case patient's general practitioner's list.
As all participants were over the age of 16 years at follow-up, consent was taken in 
writing from the participants only (current NHS-E guidance) and letters and telephone 
calls were addressed to participants directly. Written consent was obtained at 
assessment.
Ethical approval was obtained by the North Thames Multicentre Research Ethics 
Committee.
3.5 Assessment procedures
A standardised assessment protocol was developed by the research team and piloted 
on the first six case-control pairs on the recruitment list. Only minor modifications 
were made to the protocol and therefore the six case-control pairs were included in the 
final sample for analysis. The assessment protocol is shown in Table 3.2.
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Participants who consented to follow-up underwent a 3 hour confidential 
assessment under standardised testing procedures. Participants were offered a short 
break 2.5 hours into the assessment.
Table 3.2 Assessment protocol of cases and controls
Tests / Q uestionnaires D uration  (m inutes)
Signing the consent form  and describing the assessment
Annotated Scale o f  Bodily Injuries (ASBIR) 10
Questionnaire for Young People 10
Rey Auditory Verbal Learning Test (RAVLT) -  Trials I-VII 15
Cambridge Neuropsychological Test Automated Battery (CANTAB) 30
RAVLT Recall trial after 30 minutes delay 10
CANTAB 65
SH O R T BREAK
Rey Osterrieth Complex Figure (ROCF) test (copy subtest) 10
National Adult Reading Test
WAIS-R -  Vocabulary subtest
Stated Hand Preference Questionnaire
A-FILE Questionnaire
Clinical Outcomes in Routine Evaluation -Outcome Measure (CORE-OM)
40
Chalder Fatigue Scale
Beck Depression Inventory (BDI-II)
Social Support Questionnaire (SSQ6)
Quality o f  Life Scale
SF-36 II Health related Quality o f  Life
Rey-Osterrieth (recall subtest and recognition) 5
WAIS-R -  Block Design subtest 15
1 conducted all assessments on participants for the follow-up study. The study was 
arranged so that each control was interviewed within one day of the case wherever 
possible.
Participants were assessed in the study centre or at home in as quiet and distraction- 
free environment as possible if unable to attend the centre, University College London 
Hospitals. Participants were reimbursed for travel costs if they travelled to the study
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centre. After completion, ali participants were given a £20 CD voucher in order to 
thank them for their participation. The full assessment was carried out in one session.
Participants completed a battery of neuropsychological tests and questionnaires. The 
supervised questionnaires measured health behaviours, educational, social and 
vocational function, depression, social support, disability, and quality of life.
3.6 Data collection
Data were collected at 2 time points.
Time 1 (Baseline)
Baseline data were taken from the Baseline study about function/events in the 2 weeks 
immediately before onset of MD (for cases) or prior to interview (for controls) and 
forms the first data point (Time 1). Data were gathered by interview from cases and 
controls within 4 weeks of onset of MD in cases.
Time 2 (Follow-up)
I collected Time 2 (follow-up data) for this doctorate. Cases and controls were 
interviewed between 18 and 36 months after interview on the Baseline study. 
Participants were again asked questions about their life and function in the 2 weeks 
prior to interview.
3.7 Outcomes measured at baseline
A. The following information was collected in the Baseline study (Time 1) and
again for Time 2 (Follow-up study). These variables were examined for differences 
between cases and controls and for changes between the premorbid (Time 1) and 
follow-up (Time 2) periods of time. Data were obtained from cases pertaining to the 
two-week period before admission to hospital, as specific, not necessarily habitual, 
behaviours were of interest.
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3.7.1 Social function - Questionnaire for young people 
The questions in the questionnaire focused on:
Cigarette, alcohol and other drug consumption in 2 weeks prior to interview
• Use of cigarettes (numbers per day)
• Alcohol (units per week)
• Illicit drug consumption (yes/no) in 2 weeks prior to interview.
Change between Time 1 and Time 2 was calculated.
Intimate social contacts in 2 weeks prior to interview:
• Whether the case/control had a partner. Change in the percentage of intimate 
relationships was assessed
• Place of residence whether dependent on parents or independent. Change in 
independence before and after MD was assessed.
Other social activities (within the previous 2 weeks)
• Hours per week of social contacts outside family
• Hours per week of attendance at dances and parties, clubs and raves
• Hours spent in other group social activities -  church and youth groups.
School, college or work activities and environment
• Type of school/college/work and location
• Socio-economic status -  vehicle and home ownership.
The following were calculated for Time 1 and Time 2
• The percentage of cases and controls in education or in employment
• Socio-economic status of controls and cases -  through vehicle and home 
ownership.
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3.7.2 Psychological measures at baseline
3.7.2.1 Personal and family life stress
The Adolescent-Family Inventory of Life Events (A-FILE) (McCubbin et a l 1982) 
was administered to cases and controls to assess stressors of family life. The A-FILE 
is a 50-item self-report scale of life-events and changes which the adolescent 
perceives his or her family to have experienced during the previous 12 months.
The A-FILE has been used extensively as a measure of stress in adolescent studies. 
For example, adolescents and self-harm (Tulloch et a l 1997), stress in adolescence 
(Araujo et al. 1999), cholesterol levels and stress in a group of adolescents (Coleman 
et a l 1998), family counselling research (Volker 1995), social support and 
adolescence (Carty 1989), family stress (Ravert and Martin 1997) and adolescents 
within at risk families (Garbarino and Schellenbach 1984).
Content
The scale is subdivided into six subscales of family life:
i) Family responsibilities: (19 items) relating to interpersonal tensions and to 
strains owing to health care and finances;
ii) Family changes: (14 items), that consists of items relating to role or status 
transitions of family members, change in role or status of a family 
member, the addition of family members, or geographical mobility of the 
family unit or a member. Transitions, also includes items such as parental 
separation, divorce, remarriage, parent becoming unemployed or starting a 
new job and child or adolescents transferring to new school.
iii) Family sexual matters: (4 items) relating to pregnancy, childbearing and 
the onset of sexual activity by a teenage member of the family.
iv) Family losses: (7 items) focuses on the death of a family member, other 
relatives or friends and to the loss of property or income.
v) Stresses at school and substance use: (4 items) relating to use of drugs or 
alcohol, conflict about substance use, and premature exit from school by a 
family member.
vi) Family legal stresses (2 items) relating to conflict with the law, the arrest 
or assault of a family member.
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Participants were asked to respond if the event had occurred within their family and to 
rate the distress of an event on a standard 10 cm visual analogue scale, with 0 
corresponding to no distress and 10 to extremely distressing. The distance of the mark 
along the line was measured as a value.
Scoring
Scores obtained: Total Stress score (range 0-50) and Total Distress score (range 
0-500). Individual subscale scores can also be obtained for the number of stressful 
events experienced [responsibilities (range 0-19), changes (range 0-14), sexual 
matters (range 0-4), losses (range 0-7), stresses at school and substance abuse (range 
0-4) and legal stresses (range 0-2)]. Higher total and subscale scores denote a higher 
number of stressful events and greater distress.
Validity and reliability
As a measure of life stressors, the A-FILE is an established psychometric instrument 
(McCubbin and Patterson 1983) with good construct validity and internal reliability 
(total scale alpha .83) (McCubbin et al. 1982). It has been controlled for symptom 
contamination, thereby eliminating confounding by health-related symptoms or by 
major illness.
Reliability coefficients for each subscale have been established: transitions (.52), 
sexual issues (.43), losses (.45), responsibilities and strain (.74), substance use issues 
(.66) and legal conflicts (.46) (McCubbin et al. 1982). Test-retest reliabilities over a 4- 
to 5-week period have been reported to range from .64 to .84 (McCubbin and 
Thompson 1991).
Variables used:
• Total Stress score (range 0-50)
• Total Distress score (range 0-500).
The change in life stress between Time 1 and Time 2 was assessed.
NB. Hospitalisation due to the acute MD event was excluded, but the hospitalisations 
subsequent to the initial MD hospitalisation were included.
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3.7.2.2 Social support
Social support in cases and controls was assessed using the short form of the Sarason 
Social Support Questionnaire (SSQ6) (Sarason et al. 1987), a widely used measure of 
perceived social support in adolescence and young adults. The SSQ6 is an abbreviated 
instrument derived from the well-known the 27 item Social Support Questionnaire 
(SSQ) (Sarason et al. 1983).
The SSQ6 is used extensively in different research areas. For example, it was used to 
assess social support in patients with pulmonary disease (Sutton et al. 1999), 
gynaecological problems (Reid et al. 2002), epidemiological studies of idiopathic 
juvenile arthritis (Packham and Hall 2002) and HIV research (Prado et al. 2002). It 
has also been used in psychological research such as social support and attachment 
(Kafetsios and Sideridis 2006) and abuse within the family (Schaeffer et al. 2005).
Content
The instrument comprises six items assessing two important parts of social support for 
every item. Each question presents a situation and requires a two-part answer:
(i) Participants were asked to identify the people to whom they could turn to and on 
whom they could rely in specified sets of circumstances. A maximum of nine persons 
can be listed as supports for each item.
(ii) Participants were then asked to rate their level of satisfaction with the available 
support listed for that item. The satisfaction rating uses a six-point Likert scale 
ranging from “very satisfied” to “very dissatisfied.”
Scoring
Scores obtained: three separate scores were calculated from the SSQ6.
i) A Total Network score derived by summing the number of people reported in each 
of the six items and dividing by 6 (the number of questions) (range 0-9).
ii) A Total Satisfaction score obtained by calculating the mean across all six- 
satisfaction ratings (range 0-6).
100
iii) A Total Support score obtained by combining the number of people reported for 
each subscale and satisfaction rating and dividing by 12 to provide a mean score 
(range 0-7.5).
Higher SSQ6 scores indicate a higher level of social support.
Validity and reliability
The SSQ6 is psychometrically sound demonstrating excellent internal consistency 
reliability coefficients .90 to .93 for both the number of supportive individuals and 
satisfaction with support and with an overall Cronbach’s alpha = .96 (Sarason et al.
1987). Test retest reliability is also good (r= .85) (Sarason c/fl/. 1987).
The dimensions of the SSQ6 correlate with other scales measuring anxiety, 
depression, loneliness, and social skills, providing evidence of construct validity 
(Sarason et al. 1987).
Variables used:
• Total Network score (range 0-9)
• A Total Satisfaction score (range, 0-6)
• A Total Support score (range 0-7.5).
The SSQ6 scores (Network, Satisfaction and Total Support score) were calculated and 
change in social support scores between Time 1 and Time 2 was examined.
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3.8 Outcomes measured at follow-up
B. The following information was collected at Time 2 only (follow-up 18-36 
months after baseline interview).
3.8.1 Physical injury and disability
Physical injury and disability was assessed in cases using an adapted version of the 
Annotated Scale of Bodily Injuries Regulation (ASBIR) (Commission de la Santé et 
de la Sécurité du Travail 1987;Erickson and De Wals 1998).
The ASBIR has been used to assess physical injury and disability in a retrospective 
study of outcomes of MD in all ages in Canada (Erickson and De Wals 1998) and also 
in a study of MD amongst college students in the United States (Erickson et al. 2001).
The ASBIR provides a quantitative score of physical injury and disability. The 
impairment score is comprehensive, taking into account anatomic and physiologic 
deficits, disfigurement and suffering or loss of enjoyment of life, resulting from the 
deficit or disfigurement. The score is expressed as a percentage of physical 
impairment, which increases with severity of permanent injury. Scores for different 
types of injuries are additive, therefore it is possible for certain individuals with 
multiple sequelae to have a percentage score greater than 100%.
The measure asked questions on:
• Amputation -  upper or lower limbs / bilateral or unilateral, and questions on 
prosthesis.
Hearing loss and degree of loss 
Vertigo 
Scarring
Impairment in walking or standing 
Impairments in upper limbs 
Symptoms consistent with Raynaud’s Disease 
Epilepsy 
Speech problems
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• Loss of other function.
3.8.2 Neuropsychological measures
A comprehensive battery of neuropsychological tests was administered to assess 
general intellectual ability, executive function, psychomotor speed, visuospatial 
functioning, attention and memory in both the verbal and visual domains. The 
neuropsychological tests administered to cases and controls are shown in Table 3.
Tests were administered in a fixed order according to the assessment protocol. 
Pen-and-paper tasks were administered according to standardised instructions (Lezak
1995) and computerised tests from the Cambridge Neuropsychological Test 
Automated Battery (CANTAB) according to CANTAB manual protocols, on a 
portable PC fitted with a colour touch-sensitive screen monitor. These tests are 
described below.
Tests were scored according to published standardised instructions. Approximately 
ten percent of pen-and-paper tasks were re-scored by a second trained observer to 
ensure reliability. All scores were correct and no changes were required.
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Table 3.3 Neuropsychological measures
♦Cambridge Neuropsychological Test Automated Battery (CANTAB) 
(Fraye/a/. 1997)
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3.8.2.1 Intellectual ability
Intellectual ability was measured in the current study to ensure that any possible group 
differences between cases and controls could not be attributed to differences in 
intellectual ability.
Full scale Intelligence Quotient (IQ) estimates were obtained from both the National 
Adult Reading Test (NART) (Nelson and Willison 1991) and the Wechsler Adult 
Intelligence Scale-Revised (WAIS-R) Short Form (Wechsler 1981). Raw scores from 
both the WAIS and NART were converted into a scaled score with an average full- 
scale IQ of 100, with a standard deviation of 15 (above and below the mean). These 
two tests were administered not only to estimate current IQ vs. premorbid IQ but also 
to track possible decline over time for future follow-up.
National Adult Reading Test (NART)
Assessment of pre-morbid intellectual functioning was obtained using the NART 
(Nelson and Willison 1991). Reading ability is considered relatively stable following 
brain injury (Crawford 1992;Kaufman 1990;O'Carroll 1995).
The NART is an oral reading test that measures vocabulary and reading ability. 
Participants read aloud 50 phonetically irregular words. Here the reader has to ‘know’ 
the word, rather than relying on phonology to read it correctly (e.g. ‘cellist’, ‘gauche’ 
and ‘topiary’). Knowledge of rules facilitating correct pronunciation of phonetically 
irregular words must have been acquired prior to any disease onset.
Estimates of premorbid IQ are derived from the number of errors. The words are 
ordered in increasing difficulty and the ability to pronounce these words in the right 
way is considered a robust indicator for premorbid functioning.
The NART has been found to be highly correlated with overall intelligence, with 
WAIS-R, r =.85 (Mockler et al. 1996;Willshire et al. 1991). It also possesses high 
internal consistency (alpha .90) (Crawford et al. 1988; Crawford 1989;Nelson and 
Willison 1991), high test-retest reliability (alpha .98) (Crawford 1989) and inter-rater 
reliability coefficients between .96 and .98 (O'Carroll 1987) and is capable of
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predicting a substantial proportion of variance in the IQ of a normal population (Moss 
and Dowd 1991).
However, NART has a number of limitations. It fails to discriminate between levels in 
the very superior range of intelligence (Crawford et al. 1988), and that it does not 
stretch very far below the average range (Morris et al. 2000). There is also the 
assumption of English as a first language and that it is unsuitable for those who have 
dyslexia and articulation problems (Watt and O'Carroll 1999).
Nevertheless, the NART has become widely used as a retrospective estimator of 
premorbid level of intellectual functioning in neuropsychological practice and 
research concerning a wide range of conditions (Taylor 1999), for example, closed 
head injury (Moss and Dowd 1991;Watt and O'Carroll 1999), genetic influences on 
cognitive function (Singer et al. 2006), and HIV-related deficits (Damos and Parker
1994). The NART has also been employed in numerous studies into adult neural 
processing capacity, in particular, cognitive reserve (Stem et al. 2003).
Wechsler Adult Intelligence Scale Revised (WAIS-R) Short Form 
Current intellectual ability was estimated using two subtests (Vocabulary and Block 
Design) WAIS-R Short Form (Brooker et al. 1986; Sattler et al. 1988; Silverstein et 
al. 1982;Wechsler 1981). These two subtests are frequently used for an IQ estimate, 
because their estimate of IQ correlates with Full-Scale IQ (alpha .90) based on all of 
the subtests of the WAIS-R (Hoffman et al. 1988;Missar et al. 1994;Sattler et al.
1988).
The Vocabulary subtest is a test of verbal knowledge and is comprised of 42 items. 
Participants were asked to verbally define their understanding of increasingly difficult 
words to assess verbal intelligence.
The Block Design is a construction test assessing visuo-constructive ability and non­
verbal reasoning. Participants were shown a series of geometric designs, and were 
asked to construct replicas of the designs one at a time using a set of red and white 
blocks. Each block has two white and two red sides, and two half-red and half-white
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sides with the colours divided along the diagonal. The subject’s time to complete each 
design was recorded.
A number of studies have used the WAIS-R (short-form) for clinical research 
purposes (Gooding et al. 1999;Harris et al. 1996;Kremen et al. 1995;Seidman et al. 
1998).
3.S.2.2 Stated Handed Preference (SHF) Questionnaire to assess laterality
Laterality (in which certain functions such as language comprehension are localised 
on one side of the brain in preference to the other) has been shown to affect cognitive 
abilities (McManus et al. 1983;McManus et al. 1993). One example is handedness 
(the tendency to use one hand or the other to perform activities). Typically defined as 
the hand that one most often prefers to use when performing uni-manual tasks (Cavill 
and Bryden 2003). Assessing laterality is important when conducting group 
comparisons to ascertain whether there are differences, as a tendency for right­
handers to perform better than left-handers on visuospatial tasks has been consistently 
found in previous studies (Bradshaw 1989; Levy 1972).
In this study hand preference was quantified on the basis of a questionnaire (adapted 
from (Crovitz and Zener 1962). It has been shown repeatedly that approximately 90% 
of the population shows a preference for the right hand with the other 10% preferring 
the left hand (Annett 1985).
Participants were asked to indicate which hand they normally used to perform each of 
18 common actions, some of which are bimanual. For each action, the subject was 
also asked to rate the fi*equency of use of the two hands on a five-point scale, with a 
rating of one being the normal response of a strongly right-handed subject, and a 
rating of five, the response of a strongly left-handed subject. Total scores ranged 
from 18 to 90. In line with other studies utihsing this measure (Isaacs et al. 
1996;Milner 1975;Vargha-Khadem 1985) a score of less than 30 was considered to be 
indicative of strong right-handedness, and one over 55 of strong left-handedness.
107
3.8.2.3 Cambridge Neuropsychological Test Automated Battery (CANTAB)
The CANTAB assesses visual and spatial recognition memory, (Owen et al. 
1990;Owen et al. 1995;Sahakian et al. 1988), spatial memory span (Milner 1971) 
spatial working memory and strategy (Owen et al. 1992) and attentional set-shifting 
(including rule learning and cognitive flexibility (Downes et al. 1989;Owen et al. 
1992). All tests are based on classical experimental paradigms (Fray et al. 1997).
Subtests on the CANTAB are graded in difficulty, minimizing floor and ceiling 
effects and allowing use with a wide variety of ages and diagnoses (Fray et al. 
1997;Luciana and Melson 1998;Robbins a/. 1994;Robbins er a/. 1998).
The tests have proved sensitive to mild cognitive abnormalities in psychiatric and 
neurological disorders (Dolan and Park 2002;Elliott et al. 1995a;Elliott et al. 
1996;Kempton 1999;Veale ef a/. 1996).
CANTAB tasks have been extensively validated in brain injury studies (Fray et al.
1996) and have high test-retest reliability with studies demonstrating correlations for 
individual test items between .56 and .86 (Lowe & Rabbitt, 1998).
The battery includes training and screening tasks designed to assess motor skill, the 
ability to follow instructions, psychomotor speed and accuracy, and gross perceptual 
skills. These are all fundamental abilities that can influence performance on the 
cognitive tasks.
Previous research has found that performance on the CANTAB tests is highly 
correlated within the specific domains (executive, memory, and attention) (Pantelis et 
al. 1997).
The battery acknowledges that cognitive functions are both diverse and modular in the 
sense that they are supported by overlapping yet distinct sets of neural structures that 
may be differentially affected by different forms of Central Nervous System 
pathology.
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Previous studies using CANTAB
Although this is the first report on the application of CANTAB cognitive tests in 
adolescents following MD, the battery has been used in a wide variety of clinical 
populations for example:
Epilepsy (Moore et al. 2002)
Schizophrenia (EWiott et al. 1995;Pantelis e/a/. 1997)
Depression (Elliott et al. 1996;Grant et al. 2001 ;Sweeney et al. 2000).
ADHD (l^Qmpion et al. 1999)
Antisocial personality disorder (Dolan and Park 2002)
Obsessive compulsive disorder (Nielen and Boer 2003)
Chronic Fatigue Syndrome (Capuron et al. 2006)
Parkinson’s Disease (Owen et al. 1992)
Healthy older adults (De Luca et al. 2003)
Older adults with hypertension (Louis et al. 1999)
Alzheimer's disease (Dorion et al. 2002)
Dementia (Owen et al. 1991;Sahakian et al. 1988)
Substance abuse problems (Sclafani et al. 2002),
Bipolar disorder (Sweeney et al. 2000)
Test administration: The tests are administered with the aid of a high-resolution touch 
screen monitor and data is instantly recorded with scores automatically calculated and 
stored on the computer. I ensured that the young person was comfortably seated when 
starting the CANTAB testing, at the right height and that he / she was approximately 
0.5 m from the monitor as recommended by the developers. Participants were asked to 
respond to instructions by touching the screen with the index finger of their dominant 
hand. After an initial explanation and completing a simple “motor screening task” 
successfully (touching the centre point of flashing crosses on the screen). I controlled 
the computer and gave verbal instructions to the participants for each task. I presented 
each test in accordance with the instructions detailed in the user manual.
Auditory and visual feedback is provided by the CANTAB tasks and in addition, 
some tasks use the press-pad. Responses were made either by touching a particular
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stimulus displayed on the screen or by operating a response pad, depending on the 
test. Descriptions of the tasks follow.
Memory
The following tests assess visual and spatial aspects of memory:
Delayed Matchins to Sample (DMS) is a test of short-term visual recognition memory 
based on the delayed matching to sample paradigm used extensively in primate 
research (Owen et al. 1995;Sahakian et al. 1988 ;Sahakian and Owen 1992). The test 
takes approximately 14 minutes and is sensitive to temporal and parietal lobe 
dysfunction (Sweeney et al. 2000).
Participants are presented with a complex visual pattern in a box (the sample) and 
after variable periods of delay (0, 4 or 12 seconds delay) the subject is instructed to 
choose the pattern that had previously appeared from an array of four similar patterns. 
The subject must touch the pattern that exactly matches the sample. Performance was 
assessed according to the percentage of correct responses participants selected for all 
delays and response latency for all delays (msec).
Pattern & Spatial Recognition Memory (SRM & PRM): these two tasks assess 
encoding, retrieval and recognition ability of pattern and spatial memory. They were 
designed by Sahakian and colleagues (Sahakian et al. 1988) and are sensitive to 
working memory impairment and therefore to frontal lobe function (Owen et al.
1995). The tests each take approximately 5 minutes to complete.
In the spatial recognition test, five squares are shown in different locations on the 
screen. Following a delay of 5 seconds, the squares are re-presented in different 
locations on the screen and the participants are asked to touch the location at which 
they had seen a square appear (the recognition stage) one of which is in a place 
previously seen in the presentation phase. Locations are tested in the reverse of the 
presentation order. This procedure is repeated a further three times each time with five 
new locations.
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In the pattern recognition task, participants were presented with a series of 12 abstract 
coloured patterns appearing one after the other, and were asked to remember them. 
These patterns are designed so that they cannot easily be given verbal labels. 
Following a delay of 5 seconds, the 12 patterns were re-presented in reverse order, 
paired with a new pattern, and participants were asked to touch the pattern they had 
seen previously. This cycle was repeated with another set of 12 patterns followed by a 
recognition phase.
Performance on both tests was assessed according to the percentage of correct 
responses.
Paired Associate Learnins (PAL): assesses visual memory and new learning (ability 
to form visuo-spatial associations). The test was designed by Sahakian and colleagues 
(Sahakian et al 1988) and is sensitive to temporal and parietal lobe dysfunction 
(Jakala et a l 1999; Sweeney et a l 2000). The test takes approximately 11 minutes to 
complete.
The task consists of correctly locating the number of patterns presented on the screen 
after their first appearances. Boxes appear on the screen and each opens in 
randomised order. One or more of them will contain a pattern. The patterns are then 
displayed in the middle of the screen, one at a time. The subject is then required to 
remember the patterns associated with different locations on the screen and touching 
the box where the pattern was originally located. If the subject makes an error, the 
patterns are re-presented to remind the subject of their locations. The difficulty level 
increases throughout the test with the number of patterns increasing from one to eight. 
Performance was assessed by the percentage of all stages completed successfully and 
the total number of errors made (when the subject selects a box that does not contain 
target stimulus) summed across the eight stages (adjusted for the number of stages 
completed).
Attention
The following tests measure different aspects of attention and reaction time:
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Rapid Visual Processing (RVP): test assesses visual sustained attention, although it 
also requires both selective attention and working memory for its successful execution 
(Sahakian et al. 1988). The test is sensitive to dysfunction in the parietal and frontal 
lobe areas of the brain (Coull et al. 1996) and takes approximately 7 minutes to 
complete.
RVP uses the press pad exclusively as an input device. A white box was presented in 
the centre of the computer screen inside which digits from 2 to 9 appeared in a 
random order at a rate of 100 digits per min. Participants were asked to detect three 
sequences of digits (i.e., 2-4-6,3-5-7, and 4-6-8) and to register responses using the 
press pad. These three digit strings were shown continuously at the right of the screen 
to help remind participants of these target sequences. Participants responded by 
pressing the pad when the last digit of a target sequence was displayed. During the 
test, a target sequence was presented 27 times.
Afterwards, 2 sensitivity measures ‘A’ and ‘B’ were calculated using Signal 
Detection Theory (Green and Swets 1966;Swets 1964). The sensitivity to target 
sequences is reflected by ‘A’ and ‘B’ is the tendency to respond regardless of the 
presence of a target sequence. Both measures are based on the proportion of hits 
(correct responses) and the proportion of false alarms (responses made when no target 
sequence was presented) of the responses made during the test.
Performance was assessed by how good the subject was at detecting target sequences 
(RVP A) and whether there was a tendency to respond regardless of whether the 
target sequence was present (RVP B) and latency to respond to correct detections (in 
msec).
Simultaneous Matching to Sample (MTS): assesses the ability to recognise complex 
visual designs. This is a matching test, with a speed/accuracy trade-off. It was 
designed by Downes and colleagues (Downes et al. 1989) and is sensitive to temporal 
and parietal lobe dysfunction (Sweeney et al. 2000). The duration of the test is 
approximately 9 minutes.
The participant is shown a complex visual pattern (the sample) in the middle of the 
screen, and then, after a brief delay, a varying number of similar patterns are shown in
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a circle of boxes around the periphery of the screen, that have elements in common 
with the target. Only one of these boxes matches the pattern in the centre of the 
screen, and the subject must indicate which it is by touching it.
In addition to touching the sensitive screen, participants also used a press-pad, which 
they were asked to hold down and when ready to make a response, to release the pad 
and touch the correct pattern. Performance was assessed according to the percentage 
of correct selections and the latency time from releasing the press pad to choosing the 
correct pattern on the screen.
Executive function
These tests address executive function, working memory, and planning; all associated 
with the frontal area of the brain.
Intra-Extra Dimensional Set Shift (JED): This is a test of rule acquisition and reversal 
(attentional set-shifting ability), examining the subject’s ability to attend to the 
specific attributes of compound stimuli, and to shift that attention to a novel visual 
stimuli. The test was designed by Downes and colleagues (Downes et al. 1989) and is 
comparable to the Wisconsin Card Sorting Task (Berg 1948). The test is sensitive to 
frontostriatal dysfunction (Sweeney et al. 2000) and lasts approximately 7 minutes.
The task involved nine stages, with participants proceeding to the next stage when a 
criterion of six consecutive correct responses had been attained. The subject starts by 
seeing two simple colour-filled shapes, and must learn which one is correct by 
touching it. Feedback teaches the subject which stimulus is correct, and after six 
correct responses, the stimuli and/or rules are changed. These shifts are initially intra- 
dimensional (e.g. colour filled shapes remain the only relevant dimension), then later 
extra-dimensional (white lines become the only relevant dimension). Simple stimuli 
are made up of just one of these dimensions, whereas compound stimuli are made up 
of both, namely white lines overlying colour-filled shapes.
Participants progress through the test by satisfying a set criterion of learning at each 
stage (6 consecutive correct responses). If at any stage the subject fails to reach this 
criterion after 50 trials, the test terminates.
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Performance was examined according to the total number of stages completed 
successfully, the total numbers of errors made in completing those stages (adjusted to 
account for participants who did not successfully complete the task) and the total 
number of trials to complete the task. In addition, the number of errors made prior and 
during the extra-dimensional shift stage (important attentional shift stage) of the task 
were assessed.
Spatial Working Memory (SWM): This test is a self-ordered searching task assessing 
the subject's ability to retain spatial information and to manipulate remembered items 
in working memory. The test was designed by Owen and colleagues (Owen et al.
1990) and is sensitive to frontostriatal dysfunction (Sweeney et al. 2000). The test 
requires approximately 8 minutes to complete.
In this task, participants are required to search through a spatial array of coloured 
boxes presented on the screen by touching each one in order to find blue tokens, 
which are hidden inside. In each trial, only a single blue token is hidden inside one of 
the boxes. The subject must touch each box in turn using a process of elimination 
until one opens with the token (a search). Once found, the next token is hidden and a 
new search begins. The main aim is that once a token is found within a particular box, 
that box would not be used again to hide a token. In the conduct of this test are four 
trials with each number of boxes gradually increasing until it is necessary to search a 
total of eight boxes. The colour and position of the boxes are changed from trial to 
trial to discourage the use of stereotyped search strategies. On each trial, the subject is 
required to try to locate all the hidden tokens and transfer them to the right side of the 
screen without opening a box that has been previously selected. Returning to an 
empty box already sampled on a search is an error (“between” search-errors).
Performance was measured by the number of between search errors calculated for 
trials of four or more tokens only. In addition, the subject’s ability to adopt a 
systematic searching approach {strategy score) was measured by counting the number 
of times the subject begins a new search with the same box. An efficient strategy for 
completing the task is to follow a predetermined sequence by beginning with a 
specific box and then, once a token has been found, to return to that box to start the 
new search sequence (Owen et al. 1995), such a strategy results in a low strategy 
score.
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Stockiri2s o f Cambridge (SOC): This test assesses the subject’s ability to engage in 
spatial problem solving and reasoning. This is a computerised version of the ‘Tower 
of London’ test devised by (Shallice 1982) and adapted by Owen and colleagues 
(Owen et al. 1990). It makes substantial demands on executive function and therefore 
is sensitive to frontostriatal dysfunction (Sweeney et al. 2000). The duration of this 
test is approximately 8 minutes.
The subject is shown two displays containing three coloured balls. The displays are 
presented in such a way that they can easily be perceived as stacks of coloured balls 
held in socks suspended from a beam. The subject must use the balls in the bottom 
half of the screen to match the arrangement on the top of the screen. The balls may be 
moved one at a time by touching the required ball, then touching the position to which 
it should be moved. The time taken to complete the pattern and the number of moves 
required are taken as measures of the subject’s planning ability. The main feature of 
this task is that it is possible for the subject to solve the problem in advance of making 
a response.
Performance was assessed on the number of problems solved correctly within the 
minimum number of moves (perfect solutions). In addition, initial and subsequent 
thinking latencies (time taken to initiate the first move, select the subsequent ball and 
to complete the problem for each test trial) for five moves (the most difficult level) 
during the trials were recorded providing estimates of cognitive speed.
Spatial Span Test (SSP): This test assesses working memory capacity. It is a 
computerized version of Corsi Block Tapping test (Milner 1971), and was adapted by 
Owen and colleagues (Owen et al. 1990). The test is sensitive to temporal and parietal 
lobe dysfunction (Sweeney et al. 2000) and takes approximately 8 minutes to 
complete.
A series of white boxes are shown on the screen. Some of the squares change in 
colour, one by one, in a variable sequence. At the end of each sequence, a tone 
indicates that the subject should touch each of the boxes coloured by the computer in 
the same order as they were originally presented. The number of squares range from 2 
to 9 squares.
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Performance was assessed by the span length, denoted by the longest sequence of 
boxes successfully recalled.
Psychomotor speed
The Five Stage Reaction Time task (RT): The task assesses psychomotor speed and 
coordination. The reaction time (simple or choice, unpredictable) to a visual target is 
measured (Bagger et al. 1991). This test is sensitive to frontostriatal dysfunction 
(Chari et at. 1996) and takes approximately 5 minutes to complete.
The task is divided into five components, the first three components are for practice 
purposes only, and tasks 4 and 5 are test trials. The test requires that the subject must 
sometimes respond by using the press-pad, sometimes by touching the screen, and 
sometimes both. Participants were required to lift their dominant hand from a 
response pad and touch a yellow spot immediately after it appears in the centre of the 
screen as quickly as possible. The Five choice reaction time test showed the subject 
five circles and the yellow spot appearing in any one of the circles. The response time 
to a yellow spot appearing in one of the five circles was measured.
Performance was assessed by the latency of responses consisting of two measures, the 
time taken to lift the dominant hand from the response pad for 5 choices (reaction 
time) and the time taken to move the hand from the response pad to the computer 
screen for 5 choices (movement time) in milliseconds.
3.8.2.4 Other neuropsychological tests administered at Time 2
Rey-Osterrieth Complex Figure Test
The Rey-Osterrieth Complex Figure Test (ROCF) is a measure of visuospatial 
constructional ability and complex long-term visual memory. The test was originally 
developed by (Osterrieth 1944;Rey 1941) and translated into English by (Taylor 
1959) and is commonly used by clinical neuropsychologists with populations of all 
ages. High inter-rater reliability has been demonstrated on the ROCF (alpha .95-.98) 
(Bennett-Levy 1984a;Berry et al. 1991). Test-retest reliability was found to be in the 
.60 to .76 range (Berry et al. 1991 ;Delaney et al. 1988).
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A number of studies have utilised the ROCF to examine the impact of severe and mild 
brain injury on cortical and sub-cortical integrity (Benayoun et al. 1969; Bennett- 
Levy 1984b;Brooks 1972;Leininger et al. 1991). The ROCF has been found to be 
sensitive to laterality of cerebral lesion especially when the right hemisphere is 
affected (Loring et al. 1988).
The ROCF is composed of two parts, the first requires the participant to carefully 
copy a complex geometric figure with a pencil on paper (this assesses visuospatial 
constructional ability), while the second asks him / her to reproduce the figure from 
memory, without forewarning. The recall part of the test assesses the participant’s 
capacity to encode complex visuospatial information into memory and retrieval 
ability. In the current study, participants were asked to recall the figure, after a 40- 
minute delay. Instructions to participants in this current study were standardised.
In this study the most commonly used scoring procedure was used and developed by 
(Osterrieth 1944) and modified by (Taylor 1959). The figure contains 18 elements 
including crosses, squares, triangles and a circle arranged around a central rectangle.
For scoring purposes, the diagram is divided up into 18 scoring units (0.5 -2.0 points 
are awarded for each element) based on the accuracy of the reproduction {copy score). 
Points are based on placement and presence of distortion for each of the 18 elements 
of the figure. A maximum score of 2 points, one for accuracy and one for placement, 
is allocated to each scoring unit so that the highest possible number of points is 36. 
The absolute size of the drawing is not important, but the relative proportion of 
elements to the overall figure must be maintained. The Osterrieth scoring system 
treats all 18 units equally, be they isolated details or organising structures. A time 
limit is not imposed for the copy or recall trial although time to complete the task was 
recorded.
After recalling the figure the Recognition memory subtest was administered (Meyers 
and Lange 1994) to each subject. Participants were presented with internal details 
from the ROCF comprising of 12 parts of the two dimensional line drawing presented 
in their proper size, shape and orientation, mixed randomly with 12 distracters. These 
24 figures were then randomly placed on 4 pages in roughly 2 columns per page.
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depending on the shape and size of the figures. Participants were asked to encircle 
each figure that belongs to the “whole design” just drawn.
Performance was assessed using the following scores: Copy score, Recall score and 
the Recognition subtest score.
Rey Auditory Verbal Learning Test
The Rey Auditory Verbal Learning Test (RAVLT) was developed by André Rey in 
France (Rey 1941;Rey 1964) and translated into English by (Taylor 1959). The 
RAVLT provides measures of immediate memory, efficiency of verbal learning, 
effects of interference, and recall following short and long delay periods (Rey 
1964;Spreen and Strauss 1998). The scores obtained from the RAVLT are frequently 
used in the literature to reflect different aspects of episodic memory (Blachstein
1997).
The RAVLT has consistently been ranked as one of the most popular measures 
utilised in neuropsychological assessment because it is brief, straightforward, easy to 
understand, and shown to be sensitive to brain injury (Lezak 1995). The learning 
measures have been found to correlate significantly, mostly in the .50 to .65 range 
with other learning measures (Macartney-Filgate and Vriezen 1988). Test-retest 
reliability correlation coefficients have been found to be .38 -.70 (Snow et al. 1988).
The RAVLT is appropriate for use in children, adolescents, and adults and as such has 
been utilised in a variety of clinical samples representing different medical and 
psychiatric conditions. For example, some of the more recent studies utilising the 
RAVLT include children with diabetes (Northam et al. 2001), genetic disorders 
(Jarrold et al. 2004), schizophrenia (Torres et al. 2001;Torres et al. 2004), epilepsy 
(Andelman et al. 2006), and traumatic brain injury (Masanic et al. 2001).
The RAVLT takes approximately 10 to 15 minutes to administer and consists of eight 
trials.
The standard format starts with a list of 15 common nouns (List A), which is read 
aloud at the rate of one word per second. The subject’s task is to repeat all the words 
he or she can remember, in any order. This first trial (I) is a measure of immediate
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memory span. This procedure is carried out five times. These first five trials (I to V) 
are termed the learning trials.
After Trial V, a second list of words (List B -  Trial VI) a distractor list is presented, 
allowing the subject only one attempt at recall. The degree to which old learning can 
interfere with new learning is assessed in this trial (proactive interference). 
Immediately following this (Trial VII) the individual is asked to remember as many 
words as possible from the first list (List A). The degree to which new learning 
interferes with the recall of old information is assessed by performance in this trial 
(retroactive interference).
After a 30-minute delay (which were not filled with other verbal memory tests) Trial 
VIII was administered and the participants were asked to recall the first list of words 
(List A) again.
The following measures were obtained:
• Trial I: Immediate memory recall
• Trials I-V level of learning ability (sum of words recalled over 5 trials)
• Trial VI a measure of interference / proactive interference -  discrepancy between 
Trial I & Trial VI reflects the detrimental influence of the other four learning trials 
and the vulnerability to interference.
• Trial VIII delay recall
3.8.3 Psychological measures at Time 2
5.8.3.1 Fatigue scale
Daily fatigue and energy levels in cases and controls were assessed using the Fatigue 
Scale (Chalder et al. 1993), an 11 item self-report scale covering the physical and 
mental aspects of fatigue, with higher scores denoting greater level of fatigue. This 
scale was originally used in a hospital-based case control study (Wessely and Powell
1998) and in a study designed to measure response to treatment (Butler et al. 1991). 
Since then it has been used in numerous epidemiological studies to assess fatigue 
levels in different populations (De Vries et al. 2003; Hotopf et al. 1996; Hotopf et al.
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2003; Loge et al. 1998; Pawlikowska et al. 1994; Taylor et al. 2002; Wallman et al. 
2004).
Content
Participants were asked to rate the extent to which fatigue has caused problems for 
them in relation to exemplar statements. Physical fatigue questions ask about 
problems with tiredness, need to rest, problems with starting things, lack of energy, 
decreased strength in muscles, feeling sleepy, and feeling weak. Mental fatigue 
questions asked about problems in thinking clearly, poorer memory, making more 
slips-of-the-tongue and difficulty in concentrating. There are 4 possible answers to 
each of the 11 questions with response options ranging from better than usual to much 
worse than usual on a Likert format.
Scoring
The scale was scored according to the continuous scoring procedure, with codes 
ranging from 0 to 3 and total score ranging from 0 to 33 (with higher scores signifying 
greater fatigue).
Scores obtained:
Total fatigue score (sum of all 11 items)
Mental fatigue score describing cognitive difficulties (sum of items 1-7)
Physical fatigue score (sum of items 8-11)
Higher scores indicate greater fatigue 
Validity and reliability
The scale has been found to be reliable (Cronbach’s alpha for all items 0.88- 0.90) and 
valid (sensitivity 75.5 and specificity 74.5) with good face validity and discriminant 
validity (area under the ROC curve =0.85) (Chalder et al. 1993), and has shown 
sensitivity to treatment changes (Deale et al. 1997).
3.8.3.2 Beck Depression Inventory (BDI-II)
The Beck Depression Inventory (BDI) was developed in the 1960s (Beck et al. 1961), 
and revised in 1996 to comply with the DSM-IV criteria for depression (Beck et al.
1996) as the Beck Depression Inventory-Second Edition (BDI-Il). It has become the
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gold-standard instrument designed to assess the intensity of depression in older 
adolescents and young adults and is used primarily as a screening tool in clinical and 
non-clinical populations (Beck 1987;Bennett et al. 1997). Items of the scale were 
derived from clinical observations of depressed patients including their typical 
attitudes and symptoms.
The strengths of the BDI-II is that it is brief, easy to administer, and applicable to a 
wide range of populations. It is the most widely used measure of depression in clinical 
practice and in research projects (Beck et al. 1988). It is not meant to serve as an 
instrument of diagnosis, but rather to identify the presence and severity of symptoms 
consistent with the criteria of the DSM-IV.
There are two main reasons why this instrument was administered in the current 
study. Firstly, major life events such as MD and its possible sequelae are a significant 
risk factor for subsequent depression and secondly, depressive symptoms have 
consistently been found to affect cognitive functioning (Cassens et al. 1990;Veiel
1997). Even in neurologically intact younger persons, depressive symptomatology 
may interfere with the normal expression of their cognitive abilities (Walsh 1985).
The BDI takes approximately 10-15 minutes to complete. Participants are asked to 
consider each statement as it relates to the way they have felt for the past two weeks.
Content
The BDI-II is a self-administered measure, consisting of 21 symptom-attitude 
categories or items assessing the cognitive, behavioural, affective and somatic 
components of depression (mood, pessimism, sense of failure, lack of satisfaction, 
guilt feelings, sense of punishment, self-dislike, self-accusation, suicidal wishes, 
crying, irritability, social withdrawal, indecisiveness, distortion of body image, work 
inhibition, sleep disturbance, fatigability, loss of appetite, weight loss, somatic 
preoccupation, and loss of libido).
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Scoring
Each item has one numerical answer ranging from 0 (low depression) to 3 (maximum 
depression) to show increasing depressive symptomatology. A total score was 
obtained by summing the rating for items ranging from 0-63.
Cut-off score guidelines for the BDI-II are given with the recommendation that 
thresholds be adjusted based on the characteristics of the sample, and the purpose for 
use of the BDI-II.
Scores range from low (denoting minimal depression) to high (denoting severe 
depression). A score of 0-13 is considered in the minimal range, 14-19 is mild, 20-28 
is moderate, and 29-63 is severe. Scores of >13 indicate depressive symptomatology 
within the clinical range.
Validity and reliability
The BDI-II has good psychometric properties and has been shown to be a valid 
measure for detecting depression among adolescents (Bennett et al. 1997).
There are many studies supporting the validity of the BDI. The items of the BDI-II 
are clinically derived and have undergone extensive reliability and validation studies 
(Beck et al. 1996;Whisman et al. 2000). It has excellent construct validity. In fact, 
researchers evaluate the validity of new scales based on the BDI. Correlations of 
between 0.66 and 0,75 were achieved against other depression and personality scales 
(Beck 1970).
Internal consistency assessments of reliability have been high (>.90) in most 
evaluations. Beck and colleagues measured the psychometric properties of the BDI-II 
with samples from four different psychiatric outpatient clinics (« = 500) and one 
college student group {n = 120). Alpha reliability was .92 for the outpatients and .93 
for the college students (Beck et al. 1996). Reported alpha coefficients with different 
undergraduate samples include .89 (Steer and Clark 1997), .90 (Osman et al. 1997), 
.91 (Dozoh et al. 1998), .92 (Steer gr a/. 1997), .92 (Steer e/a/. 1998).
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3.8.3.3 General psychological functioning
The Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) 
(Barkham et a l 1998;Barkham et a l 2001;Evans et al. 2002) is an acceptable, 
standardised outcome measure designed to measure emotional disturbance and 
general psychological functioning. The measure is primarily used in service settings 
across multiple disciplines that offer psychological interventions in primary and 
secondary care (Barkham et al. 2005;Evans et a l 2002).
Content
The CORE-OM is a standardised assessment measure consisting of 34 simply worded 
questions all answered on the same five-point scale. The questions refer to the 
subject’s state of mind over the preceding week. It contains 3 domains: subjective 
well-being, symptoms, and functioning. In addition, a measure of self-risk or harm is 
included. Half of the items focus on low-intensity problems (e.g. ‘I feel 
anxious/nervous’) and half focus on high-intensity problems (e.g. I feel panic/terror’).
The CORE-OM taps the domains of subjective well-being (4 items), symptoms (12 
items), functioning (12 items) and risk (6 items; 4 ‘risk to self items and 2 ‘risk to 
others’ items). Within the symptom domain ‘item clusters’ address anxiety (4 items), 
depression (4 items), physical problems (2 items) and trauma (2 items). The 
functioning domain ‘item clusters’ address general functioning (4 items), close 
relationships (4 items) and social relationships (4 items).
Scoring
Each item is scored on a 5-point scale ranging from 0 (not at all) to 4 (most or all of 
the time). The minimum score that can be achieved is 0 and the maximum 136. A 
total score is calculated by adding the response values of all 34 items. The measure is 
problem scored, that is, the higher the score the more problems the individual is 
reporting and/or the more distressed they are. The final result usually presented is an 
average per item (0-4). The score can be subdivided into those for well-being, 
functioning, risk and other problems.
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Validity and reliability
The CORE-OM provides good internal reliability, with alphas ranging from 0.70 and 
0.97 in studies with large samples (non-clinical and clinical samples) from primary 
and secondary care-based psychological therapy services (Barkham et al. 2005;Evans 
et al. 2002).
Convergent validation against a battery of existing measures such as the BDI-II has 
also shown to be good (Evans et al. 2002).
3.8.3.4 Health related quality o f life
Health related quality of life was assessed using 2 self-report questionnaires that 
assessed different aspects of participants’ personal and social function and quality of 
life. No adequate scales cover the age range 15 to 19 years, so one validated adult- 
oriented scale was used and a simple adolescent-oriented set of questions were 
formulated.
3.5.3.5 SF36-II
The Short Form 36 Health Survey was originally developed in the USA in the early 
1990s (Ware and Sherboume 1992) and modified to make it acceptable in the British 
context (Brazier et al. 1992).
The UK SF36 Version II (Jenkinson et al. 1999) was used in this current study to 
measure health related quality of life (HRQOL). It is an extensively researched, self- 
report measure and the most commonly used health status measure in the world today 
(Staquet et al. 1998). It has been studied in a wide variety of populations by Ware 
and colleagues (Ware and Sherboume 1992) and generates a profile of HRQoL 
outcomes.
Content
The SF-36 consists of 36 items, which measure eight dimensions of health: physical 
functioning (10), social functioning (2), and role limitations due to physical problems 
(4) role limitations due to emotional problems (3), mental health (5), energy/vitality
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(4), pain (2) and general health perception (5). There is a further single unsealed item 
asking respondents about their perceptions of health changes over the past year.
Scoring
The UK SF36-II scoring system (Jenkinson et al. 1996) was used to calculate a score 
within a dimension which had a possible range from 0 (worst possible health state) to 
100 (best possible health state). The subscales are not summed together to produce an 
overall score, instead the scores for each of the eight domains are reported.
Two summary measures were also calculated (Ware et al 1994;Ware et al. 1995); the 
Physical Component Summary Score (PCS) and the Mental Component Summary 
Score (MCS) according to algorithms specified by the developers (Ware et al 
1994; Ware et al. 1995). This has the advantage of enabling a reduction in the number 
of statistical comparisons conducted. The component scores were obtained by 
aggregating the scores across the eight SF-36 subscales, and then transforming them 
to z-scores and multiplying by their respective factor score coefficients. The scores 
were then standardized as t scores with a mean of 50 and a standard deviation (SD) of 
10.
Validity and reliability
The SF36-II is a reliable and valid generic measure for use among both disease and 
general populations. Good construct validity has been found in terms of 
distinguishing between groups with expected health differences (Brazier et al. 1992). 
Strong correlations were reported between the mental-health subscale and other 
psychological subscales (the range was r=0.51 to r=0.82) (Ware et al. 1993).
In the UK considerable evidence was found for the reliability of the SF-36 
(Cronbach's alpha greater than 0.85, reliability coefficient greater than 0.75 for all 
dimensions (except social functioning) (Brazier et al. 1992).
3.8.4 Global quality of life
A set of simple global questions were developed about QOL. Participants were asked 
to rate their current global quality of life (QOL) compared to their peers, and whether 
they thought, their QOL had changed since the time of the baseline study. Participants
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were asked to place a mark anywhere along a line between two extremes at either end 
(Likert Scale). The distance of the mark along the line was measured as a numeric 
value. Scores range from -5 to +5 with higher scores indicating better QOL.
Cases were also asked which of areas of their life (home, friendships, academic and 
vocational achievements, leisure activities, and physical ability) had been most 
affected by MD. Choices of response ranged from ‘Not at all’ to ‘A great deal’.
3.8.5 Social and vocational domains at Time 2
Variables used:
• Educational /  employment attendance. The number of days missed from 
education or work in the 3-month period before interview was noted.
• Educational achievement level. Those participants in education were asked to
rate their level of achievement during the school or college year after MD on a
simple scale of high, average or low achievement. Participants were also asked 
regarding the results of most recent exams.
• Educational Outcomes: participants reported the number of exam passes 
obtained at GCSE (General Certificates of Secondary Education) level and A 
(Advanced) Level, and whether they had failed any exams in the year before 
interview.
3.8.5.1 Disease variables from Time 1
The following information was gathered from Time 1 and was used in the analysis in 
this study to examine the association of disease and demographic characteristics at 
baseline (Time 1) with outcomes at follow-up (Time 2)
•  Severity of illness -  indicated by admission to an intensive care unit (ICU) and
length of stay in ICU
• Meningococcal serotype (B, C) or other (Y, W135, or ungroupable)
•  Clinical definition of type o f MD - (meningitis only, septicaemia only, or mixed 
disease). This was defined at baseline in cases with a clinical diagnosis of 
meningococcal infection (signs of septicaemia or meningitis in association with 
haemorrhagic rash, or both). Laboratory confirmation of disease was also sought
126
through culture or detection by polymerase chain reaction of Neisseria 
meningitidis from a normally sterile site or a serodiagnosis in a patient with a 
clinically compatible illness.
3.8.6 Follow-up of cases
Cases were asked at interview whether they had been seen by any health professional 
after discharge from hospital since MD.
3.9 Data analysis
The aim of the follow-up study was to determine the outcomes in a cohort of 
adolescents who had MD between 15 and 19 years of age by making comparisons 
with a group of adolescents of the same age and sex who did not have MD.
Data from this study were used to test the hypotheses that educational, vocational, 
social and psychological function, quality of life and cognitive function were poorer 
in survivors of adolescent MD than in controls.
As many of the outcomes under study are significantly influenced by age and gender, 
differences between cases and controls were assessed using linear regression 
controlling for age, gender and time since baseline.
3.9.1 Cross-sectional analyses
3.9.1.1 Group comparisons
Descriptive statistics were computed for cases and controls to compare results of 
measures and to identify specific variables that would serve as predictors of poor 
outcome at follow-up in regression models.
All quantitative variables were initially assessed for approximate normal distribution. 
Variables following a normal distribution are summarised by mean and SD.
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Independent t-tests were used to compare the difference in mean values between cases 
and controls to examine differences between the two groups for continuous variables.
Quantitative variables having non-normal distribution were summarised by median 
and range. The Wilcoxon-Mann-Whitney test was used to compare the difference in 
median values for cases and controls.
Fisher’s exact test was used to compare proportions and distributions between the two 
groups for categorical variables.
All analyses were two tailed, and statistical significance was defined at the 0.05 level.
3.9.1.2 Cases only
A series of analyses were conducted in cases only.
Neuropsychological variables:
i) To examine the effect o f age at baseline and gender on neuropsychological scores: 
Analyses of covariance (ANCOVA) were performed to examine the effect of gender 
and age at baseline (independent variables) on scores of neuropsychological measures 
(dependent variables) in cases only. The variable of gender by age at baseline (that is, 
the interaction term), was also added to the models.
ii) To assess i f  male andfemale MD survivors were differentially affected by the age 
at which they contract MD -  Regression analyses were computed to confirm the 
results from the ANCOVA and to take full advantage of all the variance in the age at 
baseline and gender variables. Each regression model included scores from the 
neuropsychological measures as dependent variables with gender and age at baseline 
again used as independent variables. In addition, the interaction term (gender and age 
at baseline) was included in linear regression models.
iii) To explore the association o f mental health functioning with performance on 
cognitive tests. This was examined using linear regression. Cognitive test scores for 
cases were converted to z-scores using the mean and standard deviation of the control
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group for each individual test to explore the contribution of mental health functioning 
to neuropsychological test performance. Scores for the Beck Depression Inventory 
and the SF36 Mental Health Summary score were regressed against each of the 
cognitive domain z-scores in linear regression, adjusting for age at testing and gender.
iv) The association o f premorbid IQ (NART score) with cognitive deficit and 
educational achievement was examined using linear regression, adjusting for age at 
testing and sex. NART scores were categorised into cases that achieved <100 (below 
average) vs. >=100 (average and above) and further sub-divided to <115 vs. >=115 
and regressed against a cognitive summary score (CSS) and educational variables 
(number of passes at GCSE and A level). The rationale for the CSS is described in 
the cross-sectional results section of this thesis.
Identified deficits on functioning
i) The association o f identified deficits on functioning: The ASBIR score and the 
cognitive summary score(CSS) were entered into multiple linear regression models as 
independent variables with educational achievement (number of passes at GCSE and 
A level), mental health functioning (BDl-11 and SF36 MCS), QOL, fatigue (Total 
Fatigue Score) and social support (SSQ6 Total score) as the dependent variables, 
adjusting for age at follow-up and gender.
ii) The relationship o f mental health function and social support: Regression analyses 
were conducted with mental health scores (BDl-11 and SF36 Mental Component 
Score) with the SSQ6 total social support score, adjusting for age at testing and 
gender.
iii) To examine the association o f MD with depression a series of logistic regression 
analyses of depressive symptoms (BDl score >13) were regressed onto variables 
known to be risk factors for depression, including life stress, female gender and age, 
and socioeconomic status (SES). Initially, the regression model was unadjusted for 
age at follow-up, then partially adjusted, then in an “all in” multivariate model. Life 
stress is a major determinant of depression (Brown and Harris 1978).
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3.9.2 Longitudinal analyses
These were undertaken in cases only to assess:
i) The association o f disease and demographic characteristics at baseline with 
physical disability, mental health, fatigue, and cognitive deficit were examined using 
linear regression adjusted for age at disease and gender. Disease-related factors 
examined included MD seroGroup (C compared with B), type of MD (septicaemia or 
mixed septicaemia / meningitis compared with meningitis alone), severity of disease 
(number of days spent in Intensive Care Unit), age at MD and gender. Predictors 
(disease-related variables) were chosen based on findings from previous studies on 
outcomes of MD known to be associated with poor outcome in survivors (Erickson 
and De Wals 1998; Erickson et al. 2001).
ii) The association o f follow-up after MD with disease severity (ICU admission), 
physical disability, social support, quality of life and mental health functioning using 
linear regression of follow-up post-MD on physical disability, social support, quality 
of life and mental health functioning.
iii) To assess i f  cases and controls changed differently at follow-up in terms o f stress, 
social support and health behaviours from baseline a series of linear regression 
analyses were performed. Status, gender and age at follow-up with social support and 
stress scores at follow-up were entered into the model, adjusting for scores of social 
support and stress at baseline.
Stata 8 statistical software was used for data analysis.
All computer data were stored under the terms of the Data Protection Act.
3.10 The researcher s role within the follow-up study
The follow-up study was a collaborative study between 3 clinicians, one a professor 
of paediatric epidemiology, one a consultant of adolescent medicine, and one a 
consultant clinical psychologist, together with a statistician.
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It is important to clarify my role within the study.
The design of the follow-up study, writing of the grant application for support to carry 
out the study, and obtaining ethical approval were complete before I was appointed to 
undertake the study. Therefore, I had no input into these areas.
As the sole study researcher, I was involved in designing the assessment protocol and 
questionnaires, sourcing measures used to assess outcomes, tracing and recruiting 
young people, and conducting all participants’ assessments. I was also responsible for 
the day-to-day administration of the study, including contacting GPs and as well as 
designing databases, coding and data entry. I undertook all analysis of the data with 
guidance from a statistician.
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SECTION C
CHAPTER 4 -  RESULTS: CROSS-SECTIONAL ANALYSES
4.1 Introduction
This chapter presents cross-sectional findings from the follow-up study including 
demographic information on both cases and controls and clinical information (cases 
only). The main body of this chapter encompasses description of the quantitative data 
collected from participants by questionnaires and cognitive tests in physical, 
psychological, social and neuropsychological domains.
Results of linear regression to investigate disease factors associated with poor 
outcome in cases are also presented in this chapter. Longitudinal analyses of 
measures given to participants at the baseline study and then again at follow-up 
(A-File and Social Support Questionnaire) are shown in Chapter 5.
4.2 Study population
4.2.1 Recruitment - See Figure 4.1 for recruitment breakdown.
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Figure 4.1 Flow chart showing number of cases and controls identified, contacted and recruited
^  r
Controls Controls approached  
for recruitment at 
follow up
n=115 controls
Cases
Controls interviewed
n=107
Cases interviewed
n=105
New controls recruited 
via GP o f case n=4
Six controls interviewed 
but unable to recruit 
matching case
Four cases interviewed 
but unable to recruit 
matching control
115 case -  control 
pairs approached  
at follow-up
' Not approached at 
follow-up
n=29 case -  control 
pairs
Final sample 
analysed at follow up
101 case-control pairs 
(aged 16-22 years)
Baseline Studv
144 case-controls pairs 
recruited in Baseline Study
Cases approached for 
recruitment at follow  
up
n=l 15 cases
Refused / non- 
contactable / other
Refused n=l 
Non-contactable n=7 
Work commitments n=2
Refused / non- 
contactable / other
Refused n=2 
Non-contactable n=8 
Work commitments n=l 
Living abroad n=l
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Of the 144 case-control pairs available from the baseline study, 100 case-control pairs 
provided sufficient power to examine the three hypotheses in this study (see Chapter 3 
-  Methods).
In order to allow for attrition and minimise selection bias the first 115 case-control 
pairs (n=230) on the recruitment list of 144 case-control pairs from the baseline study 
were approached for follow-up. 105 (91%) cases and 107 (93%) controls (inclusive of 
4 new controls recruited from the GP list of the case) agreed to participate and were 
interviewed.
Of the 230 young people approached, 10 cases and 12 controls did not participate. 
Only one case and two controls refused to participate whilst seven cases and eight 
controls could not be contacted as they had moved address. One control was living 
overseas, and two cases and one control were unable to take time off work.
From the 105 cases interviewed, four were not included in the final sample for 
analyses, as the corresponding controls were not recruited. Similarly, from the 107 
controls interviewed, six who were interviewed were not used in analyses, as 
corresponding cases were not recruited. The final sample therefore for analyses 
comprised 101 age and sex matched case-control pairs.
4.2.2 Population followed-up
Data from study participants (101 cases and 101 controls) at follow up on 
demographic and baseline clinical characteristics are presented in Table 4.1.
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Table 4.1 Demographic and clinical details on cases and controls
AU N  are 101 for cases and controls except where specified
Category Cases
n(%)
C ontrols
n (% )
Age (years) 16-18 40 (40) 39 (39)
19-22 61(60) 62 (61)
Mean (SD) 19.3(1.5) 19.4(1.5)
Ethnicity
White 91 (90) 93 (92) 1
Black Caribbean/African 4 (4 ) 3(3)
Indian Asian 3(3) 2(2)
Others 3(3) 3(3) 1
Em ploym ent status i
Employed or self-employed 46(45) 42 (41)
Unemployed or home duties 9(9) 10(10)
School student 16(16) 15(15)
University student 30 (30) 34 (34)
Socio-economic status (ownership o f  house and/or car)
Not house or car 5(5) 6 (6 )
Own house, no car 4 (4 ) 4 (4 )
Not house, >/=l car 13(13) 10(10)
Own house, >/=l car 78 (77) 78 (77)
Information not available at baseline 1(1) 3(3)
Type of MD
Meningitis Alone 33 (32)
Meningitis & Septicaemia 40 (40)
Septicaemia Alone 27 ( 27)
Information was not available on clinical presentation 1(1)
SeroG roup
SeroGroup B 47(46)
SeroGroup C 33(33)
SeroGroup Y 1(1)
Ungroupable 3(3)
Clinical diagnosis o f MD only 17(17)
Adm itted to ICU [n=97] 52 (54)
Median No o f nights in intensive care (range) 2(1-28) I
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Cases and controls did not differ in age, ethnic minority status, employment status or 
socioeconomic status. Forty-seven pairs (46%) were male. Median time from baseline 
study interview to follow-up interview was 583 days (range 359-1225 days) for cases 
and 574 days (range 355-1211 days) for controls (not significantly different).
Case confirmation (seroGroup): Seventeen cases had only a clinical diagnosis of 
MD. Eighty-four cases had microbiologically confirmed MD seroGroup (see Chapter 
3 -  Methods for case definition).
Type o f MD: Of the 101 cases, 40 had both meningitis and septicaemia, 33 had 
meningitis alone and 27 septicaemia alone. Information was not available on clinical 
presentation for 1 case.
Severity o f disease (ICU admission): ICU admission and number of nights spent were 
used as measures of the severity of disease. Data were available on Intensive Care 
Unit (ICU) admission in 97 cases; 52 (54%) were admitted to ICU (median admission 
length 2 nights; range 1 to 28).
Venue for interview: 45 cases and 38 controls were interviewed at the test centre 
whereas 55 cases and 62 controls were interviewed at home.
4.2.3 Non-participating subjects from baseline study
Table 4.2 shows characteristics of non-participating subjects: (i) 10 cases and 12 
controls from baseline study approached at follow-up but not recruited; and (ii) 29 
cases and 29 controls not approached at follow-up for recruitment.
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Table 4.2 Baseline demographic and clinical characteristics of non­
participating subjects at follow up
Approached not recruited Not approached
Category Cases lost C ontrols lost Cases lost Controls
(n=10) (n=12) (n=29) lost (n=29)
n (% ) n (% ) n (% ) n (% )
Age (years) 15-17 6(60) 7(58) 14(48) 15 (52)
18-19 4(40) 5(42) 15(52) 14(48)
Ethnicity
White 7 (70) 10(83) 28 (96.5) 27 (93)
Black Caribbean/African 1(10)
Indian Asian 1(10) 1(3)
Pakistani 1(10)
Others 2 (17) 1 (3.5) 1(3)
Employm ent status
Employed or self-employed 3 (30) 5(42) 7(24) 11(38)
Unemployed or home duties 1(10) 0 3 (10) 2 (7 )
School student 4 (40) 4(33) 9 (31) 10(34)
University student 2 (20) 3(25) 10(35) 6 (21)
Socio-economic status (ownership o f )
Not house or car 3 (30) 3(25) 3 (10) 1(3)
Own house, no car 1(8) 3(10) 1(3) 1
Not house, >/=l car 1 (10) 7(24) 5 (18)
Own house, >/= 1 car 6 (60) 8(67) 16 (56) 22 (76)
Type of MD
Meningitis Alone 3 (30) 8 (28)
Meningitis & Septicaemia 4(40) 7 ((24)
Septicaemia Alone 2 (20) 7(24)
Information was not available on I
clinical presentation 1 (10) 7(24)
SeroG roup ‘
SeroGroup B 5 (50) 13 (44)
SeroGroup C 3 (30) 8(28)
SeroGroup Y
SeroGroup W135 1(10)
Clinical diagnosis o f  MD only 1 (10) 8(28)
Adm itted to ICU 4(40) 6(21)
Median No o f nights in intensive care 4(2-17) 3 (2-5)
(range)
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Efforts to recruit included first contact by telephone. If not contactable by phone, 
subjects were sent a short letter requesting confirmation of telephone number and 
participation. Potential participants were considered lost to follow-up in the case of 
failure to respond or where a reply was received reporting the young person had 
moved.
Those approached but not recruited were similar to recruited subjects in terms of age, 
sex, ethnicity and occupation disease types, serogroups, ICU admission or number of 
nights spent on ICU. Because of small numbers, these associations were not tested 
statistically. There was proportionally less home and car ownership (socioeconomic 
status) in cases approached but not recruited (10%) compared to cases recruited 
(30%).
4.2.4 Baseline subjects not approached at follow-up
Details of baseline subjects not approached at follow up are shown in Table 4.2. 
Those not approached were similar to recruited subjects in terms of age, sex, 
ethnicity, socio-economic status and occupation, disease types and serogroups. 
Because of small numbers, these associations were not tested statistically. However, 
proportionally, cases recruited were more likely to have been admitted to ICU (54%) 
than cases not approached (21%).
4.3 Outcomes from cross-sectional analyses
The following describes the outcomes from quantitative data collected from 
participants by questionnaires and tests in social, psychological, neuropsychological 
and physical domains. Whether a subject was interviewed in the study centre (cases 
n=45 [45%], controls n=38 [38%]) or at home (cases n=55 [55%], controls n=62 
[62%]) was not associated with any measured outcomes.
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4.3.1 Social behaviour and health risk behaviours
Data regarding social and sport activities, days off work, school or college, living 
arrangements and health behaviours in cases and controls at follow up are shown in 
Table 4.3. Analyses were conducted using Fisher’s exact test.
There were no significant group differences between cases and controls on any 
measures of social activity or leisure. There were also no significant differences in 
reported health risk behaviours including smoking, drinking alcohol or drug use in the 
2 weeks before interview. However, there was a trend (p=0.08) for more controls 
(70%) than cases (57%) to have attended a party or nightclub in the 2 weeks prior to 
interview.
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Table 4.3 Social and health behaviours in cases and controls at follow-up
M easure Variables Cases 
N=101 
n (% )
C ontrols
N=101
n (% )
P value
Social Activities
A ttendance a t Social activities
In 2 weeks preceding interview 
Pub / bar
Disco / Nightclub / Party 
Youth Club 
Group Activities 
Religious ceremonies
90 (89) 
58 (57) 
0
70 (69) 
8 (8 )
86 (85)
71 (70) 
4 (4 ) 
74 (73) 
15(15)
0.5
0.08
0.12
0.5
0.18
Sporting activities
Participated in sport activities
In 2 weeks preceding interview 41 (41) 39 (39) 0.9
Living arrangements
i
Living with family 
Living Independently
By self or with partner 
With friend
83 (82)
6 (6 )
12(12)
76 (75)
8 (8 )
17(17)
0.5
0.5
0.5
School or work absences
M issed days from w ork/ school / college
In 3 months preceding interview 
Total sample responding yes (%) 31(31) 30 (30) 1
Health Behaviours
C onsider self to be a sm oker 45 (45) 41 (41) 0.7
R egular use of recreational drugs 14(14) 19(19) 0.5
D rank alcohol
In 2 weeks preceding interview 84 (83) 86 (85) 0.9
4.3.1.1 Social support
Mean and SD scores for cases and controls on social support variables are presented 
in Table 4.4. Analyses were conducted using Independent Mests. Statistically 
significant p-values are in boldface.
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Subscale scores of the Social Support Questionnaire 6 (SSQ6) (Sarason et al. 1987) 
assess the number of ‘available others’ the subject feels he or she can turn to in times 
of need in different situations. The questionnaire also assesses perceived satisfaction 
with available support.
A total Satisfaction subscale score was obtained by calculating the mean across all six 
satisfaction ratings (a maximum mean score of 6). The total Network score was 
obtained by summing the number of people reported in each of the six subscales and 
dividing by six, which is the number of subscales on the SSQ6. The Total Support 
Score was obtained by combining the number of people reported for each subscale 
and satisfaction rating and dividing by 12 to provide a mean score (see Chapter 3 -  
Methods).
Table 4.4 Mean ± SD Subject scores on SSQ6 
Higher score indicates greater support
M easure Subscales Possible
Range
Cases 
N=101 
M ean (SD)
C ontro ls 
N=101 
M ean (SD)
P value
M ean (SD) Satisfaction score 0-6 5.2 (0.9) 5.5 (0.7) 0.06
Fem ales 5.4 (0.8) 5.6 (0.8) 0.3
M ales 5.0 (1.0) 5.3 (0.6) 0.12
A verage num ber of sup p o rts 0-9 3.2 (1.4) 3.6 (1.3) 0.03
Fem ales 3.3 (1.3) 3.6 (1.2) 0.18
M ales 3.1 (1.5) 3.6 (1.4) 0.08
Total score 0-7.5 4.0 (1.1) 4.4 (0.9) 0.01
Fem ales 4.1 (1.0) 4.4 (0.82) 0.13
M ales 3.9 (1.2) 4 .3 (1 ) 0.05
Cases had significantly fewer people in their social network and lower total support 
scores. There was a trend for cases to be less satisfied with the degree of social 
support available. As gender differences are reported in the literature in levels of 
social support (Colarossi and Eccles 2000;Geckova et al 2003; Piko 1998), group
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differences by sex was examined. A trend was found for male cases to report a lower 
network (p=0.08) and total score (p=0.05) compared to male controls.
4.3.2 Psychological outcomes
Data were available on 3 psychological outcome measures, Beck Depression 
Inventory (BDI-II) (Beck et al. 1996); the Mental Health Dimensions and Mental 
Component Summary score of the SF36 (Jenkinson et al 1996); and the Clinical 
Outcome Research Evaluation (CORE) questionnaire (Core System Group 1998).
4.3.2.1 Beck Depression Inventory -II (BDI-II)
The mean (SD) BDI-II scores are presented in Table 4.5. Higher score indicates 
higher levels of depressive symptomatology. A cut-off score of greater than 13 is 
recommended as indicative of caseness (see Chapter 3 -  Methods). Scores can be 
categorised as falling within mild depression (14-19), moderate depression (20-28), or 
severe depression (29-63). Analyses were conducted using Independent /-tests and 
Fisher’s exact tests for proportions. Statistically significant p-values are in boldface.
Table 4.5 Subject scores on Beck Depression Inventory
M easure V ariables Test 
score range
Cases
N=101
Controls
N=10I
P value
All Mean (SD) 0-63 8.04 (7) 6.9(6) 0.2
(Subjects Number (%) rating >13 20(20) 12(12) 0.18
Number o f females rating >13 N (%) 14 (26) 8(15) 0.16
Number o f males rating >13 N (%) 6(13) 4 (9 ) 0.5
Mean BDI scores did not differ significantly between cases and controls. However, 
nearly twice as many cases as controls (20% vs. 12%) reported depressive symptoms 
that were in the clinical range, although this failed to reach significance. As marked 
gender differences in the prevalence of depressive symptoms are well known (Baron 
and Perron 1986;Rutter 1985; Rutter I986;Teri 1982) group differences by gender 
was examined. No significant differences were found.
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43.2.2 Associations between MD and depressive symptoms adjusted fo r  other
risk factors
The association of MD with depression was further examined after adjustment for 
other factors known to be strong risk factors for depression.
Table 4.6 shows a series of logistic regression analyses of depressive symptoms (BDI 
score >13) regressed onto variables known to be risk factors for depression, including 
life stress (Brown and Harris 1978), female gender and age (Baron and Perron 1986; 
Lewinsohn et al. 1998), and socioeconomic status (SES). These are initially 
unadjusted for age at follow-up, then partially adjusted, then in an “all-in” 
multivariate model. Data shown are Odds Ratios (OR) and 95% (Cl). Statistically 
significant p-values are in bold.
Table 4.6 Associations between MD, stress and depressive symptoms
i U nivariate associations O R  adjusted for age and M ulti-variable model: O R
gender adjusted for all o the r
factors
OR (95% Cl) P OR (95% Cl) P OR (95% Cl) P
Meningococcal
disease 1.9 (0.9, 4.1) 0.1 1.9 (0.9, 4.2) 0.10 2.6 (1.1, 6.2) 0.03
Female sex 2.0 (0.9,4.4)
1
0.08 2.0 (0.9, 4.4) 0.10 2.8 (1.1, 7.2) 0.04
High
socioeconomic 
status (SES)
I 2 .3(0 .3 ,18.8) 0.4 2.3 (0.3, 18.9) 0.4 4.1 (0.6, 4.2) 0.2
Age at follow-up 0.89 (0.70, 1.16) 0.4 0.95 (0.74, 1.23)
1
0.7 0.97 (0.73, 
1.32)
0.9
Stress 1I
Stress total score 
follow-up
1 ! 
i  1.16(1.07, 1.27) 11 <0.001 1.19(1.09,1.30)
!
<0.001
:
1.25(1.13, 1.38) 1 <0.001
The table shows that MD increases the risk of depression in cases when adjusted for 
gender, age, SES and stress. MD and stress each independently increase risk of 
depression and therefore, stress has confounded the association of MD with 
depression.
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The SF-36 mental health dimensions and Mental Component Summary score (MCS):
Data on the mental health dimensions of the SF36 and the Mental Health Component 
Summary score are presented in Table 4.7. Analyses were conducted using 
Independent Mests. Statistically significant p-values are in boldface.
The SF36 rates mental and physical well-being along eight dimensions of health.
The eight dimension scores can be further aggregated into a component summary 
score: the physical component summary score and the mental health component 
summary score (Ware et al. 1994) derived by principal components analysis. The 
aggregated summary scores are then transformed to a mean of 50 and a standard 
deviation of 10. This process is aimed at producing the two summary scales while 
losing a minimum of information (see Chapter 3 -  Methods).
Table 4.7 Mean ± SD subject scores on the SF36 Mental Health Dimensions 
and Mental Component Summary (MCS)
Higher score indicates better health status
M easure V ariables Test 
score range
Cases 
N=101 
Mean (SD)
Controls 
N=101 
M ean (SD)
P value
SF36 Dimension Score 0-100
Social functioning 88.2(15) 90.0(14) 0.3
Mental health functioning 71.0(16) 74.3(15) 0.1
Role limitation due to emotional problems 83.5 (33) 79.5 (33) 0.3
Energy and vitality 58.9(19) 60.7(16) 0.4
: 1M ental Com ponent Sum m ary
1Total Sample 46.6 (30) 53.5 (24) 0.07
Females 41.2 (33) 51.7 (24) 0.05
Males 1
1
52.9 (20) 55.7 (24) 0.5
There were no significant differences in the scores on the four mental health 
dimensions of the SF36 which includes mental health (feelings of nervousness and 
depression); role limitation with work or other daily activities due to emotional 
problems, social function (interference with normal social activities due to physical or 
emotional problems) and vitality (feeling tired and worn down). However, on the 
MCS score which is the aggregate summary of scores for the four dimensions there
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was trend for cases to have a lower score than controls denoting more problems in 
these areas and poorer mental health. As gender differences in mental health are well 
described (Baron and Perron 1986;Rutter 1985; Rutter 1986;Teri 1982), group 
differences by sex were examined, revealing female cases to have a lower MCS score 
than female controls (p=0.05).
Clinical Outcome Research Evaluation Outcome Measure (CORE-OM):
Data from the CORE-OM are presented in Table 4.8. Analyses were conducted using 
Independent Mests. Wilcoxon-Mann-Whitney tests were performed on data not 
normally distributed.
The CORE-OM is a 34-item self-report measure assessing general psychological 
functioning in four domains: subjective well-being, problems or symptoms, 
functioning, and risk to self and others. It has been widely used to measure emotional 
disturbance in service settings delivering psychological interventions in primary and 
secondary care (Barkham et a l  1998;Barkham et al. 2001 ;Evans et a l  2002) (see 
Chapter 3 -  Methods).
Table 4.8 Mean ± SD subject scores on CORE-OM
Higher score indicates more problems and distress
V ariable Test
score
range
Cases 
N=101 
M ean (SD)
C ontrols 
N=101 
M ean (SD)
P value
jDomains
Subjective well-being 0-4 1.0 (0.7) 0.9 (0.6) 0.17
problem s or Symptoms 0-4 0.8 (0.6) 0.7 (0.6) 0.2
Life Functioning 0-4 0.8 (0.5) 0.7 (0.5) 0.4
Risk / harm (suicidal ideation and harm to se lf  and others) 0-4 0.1 (0.2) 0.1 (0.3) 1
T o ta l Score 0-4
Total Sample 0.7 (0.4) 0.6 (0.4) 0.2
Females 0.8 (0.5) 0.7 (0.4) 0.16
Males 0.6 (0.4) 0.6 (0.4) 1
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No significant group differences were noted on the four dimensions of the CORE-OM 
psychological scale. As sex differences in domain scores have been reported on the 
CORE-OM (Evans et al. 2002), group differences by sex were examined and no 
significant differences found.
Personal and Family Life Stress:
Data for the Adolescent Family Inventory of Life Events (A-FILE) (McCubbin et al. 
1982) are presented in Table 4.9. Data shown are mean ± SD scores on the A-FILE 
with total scores on stress and distress for events in the family in the year preceding 
interview. Analyses were conducted using Independent Mests. Wilcoxon-Mann- 
Whitney tests were performed on data not normally distributed.
The A-FILE assesses the number of stressful events and the distress they elicit in six 
domains of family life (see Methods section). A total stress score reflects an accrual 
of life events and changes occurring in the family: transitions of family members, 
sexuality, losses, responsibilities and strains, substance use and legal conflict.
Table 4.9 Mean ± SD subject scores on A FILE
Higher scores indicate more stressful events and distress
M easure Subscales Score Cases ; Controls P value
Range N=101 N=101
Stress
Family transitions 0-4 1.5 (1.4) 1.8 (1.5) 0.15
Family sexual matters 0-4 0.2 (0.5) 0.2 (0.5) 1
Family losses 0-7 0.6 (0.1) 0.7 (0.1) 0.3
Family responsibilities 0-19 3.1 (3) 3.8(3) 0.08
Stresses at school and substance abuse 0-4 0.5 (0.8) 0.5 (0.8) 0.8
Family legal stresses ! 0-2 0.1 (0.4) 0.2 (0.4) 0.2 1
T otal stress Total sample 1 0-50 6.0 (4) 1I  7.1 (5) 0.05 !
score !1
Females 5 .7(4) 6.8 (4) 0.11 ;
Males I 6.3 (4) 7.4(5) 0.2
Total distress Total Sample 0-500 24.0(23) 1 30.4(29) 0.08
score*
Females 26.8(22) 30.4(26) 0.4 ,
Males 20.8(23) 30.5 (32) 0.10 :
*Each event [50 in total] rated on a scale o f  0-10  - high score indicates greater distress
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Cases had lower levels of life stress than controls, although this narrowly missed 
significance (P=0.05).
To investigate this finding further exploratory analysis was undertaken. The 
possibility that cases were exposed to fewer controllable life events was explored (see 
Table 4.10). Data shown are mean ± SD scores on the A-FILE for the number of 
stressful events (controllable and uncontrollable) in the family in the year preceding 
interview. Analyses were conducted using Independent /-tests.
The events of the A-FILE were therefore divided into controllable life events (i.e. 
starting a new school, parent going to college or starting new job) and uncontrollable 
life events outside the family (i.e. deaths, legal trouble, family illness). The results 
demonstrate that cases reported fewer controllable events in the year preceding 
interview than controls, which approached significance (p=0.05) with a trend towards 
experiencing fewer uncontrollable events (p=0.07). The Total Stress score (for both 
controllable and uncontrollable events combined) was lower in cases compared to 
controls (p=0.05). It is not possible to determine the possible underlying reasons.
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Table 4.10 Mean ± SD subject scores on Stressful Events within the Family on 
the A-FILE
M easure V ariables N um ber of 
Events
Cases
N=101
C ontrols
N=I01
P value
A-FILE Controllable events 30
Stressful
Events
Family transitions 11 1.2 (1.2) 1.4 (1.2) 0.2
Family sexual matters 2 0.14(0.35) 0.14(0.37) 1
Family losses ' - - f  — 0.02 (0.14) 0.05 (0.22) 0.2 j
Family responsibilities 12 1.7(2) Z 2 ^ : J ) 0.08 1
Stresses at school and substance abuse 4 0.44 (0.75) 0.51 (0.87) 0.5
Total 30 3.5 (2.6) 4.2(3.1) 0.05
Uncontrollable events 20
Family transitions 3 0.32 (0.51) 0.40 (0.60) 0.3 1
jpamily sexual matters 2 0.1 (0.29) 0.1 (0.29) 1
Family losses 6 0.53 (0.74) 0.61 (0.77) 0.4
Family responsibilities 7 1.2 (1.3) 1.5 (1.4) 0.2
Family legal stresses 2 0.1 (0.36) 0.17(0.43) 0.2
Total 20 2.5 (1.7) 2.9 (2.2) 0.07
Total S tress score 50 6.0 (4) 7.1 (5) 0.05
4.3.3 Quality of life
Quality of life data are presented in Table 4.11. Data shown are median scores or 
mean ± SD where appropriate for quality of life (QOL) compared with baseline and 
compared with peers. Analyses were conducted using Independent Mests. Wilcoxon- 
Mann-Whitney tests were performed on data not normally distributed. Statistically 
significant p-values are in boldface.
Subjects were asked to rate their current global QOL on a Likert scale compared to 
their peers and whether their QOL had changed since the time of the baseline study 
(see Chapter 3 -  Methods).
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T a b le  4.11 S u b jec t sco res on Q u ality  o f  L ife  (Q O L )
Higher score indicates better QOL
[Measure Subscales Test Score 
Range
Cases
N=101
C ontrols
N=101
P value
Median
(range)
Q O L  com pared with
baseline (for cases, before
M D)
jFemales
M ales
1 -5 to +5 1
! !
1
i  1 
1 1
-0.1 (-5 to 3)
-1 (-4 ,3 )
-0.90 (-5,3)
I  0.96 (-3 to 3) :
0.8 (-3, 3) 
j  0 4 7 L ^ 2 )  j
<0.0001
0.001
0.01
Mean (SD) |QOL com pared w ith you r 
peers (for cases, those 
^without MD)
I -5 to +5
1 I
-0 .80(1.37) 1 -0.31 (1.26) ; <0.001
jFemales
M ales
1 i
i
-0.90(1.43) 
-0.68 (1.29)
-0.42(1.30) : 
-0 .19(1.22) ;
0.07
0.06
Cases reported that overall quality of life was significantly worse than peers and 
unlike controls, had not improved since the baseline study. This was true for both 
male and female cases.
When stratified for gender, both male and female cases felt their quality of life was 
significantly poorer than baseline compared to controls. There was a trend for male 
(p=0.06) and female (p=0.07) cases to report lower QOL compared to peers.
As QOL is complex and composed of multiple dimensions, MD survivors were asked 
additional descriptive questions: \^hether home life, friendships, academic 
achievements, leisure activities, vocational achievements, and physical ability had 
been affected since having MD. Forty-nine percent of cases said home life has been 
affected since MD; 41% friendships; 53% leisure activities; 41% vocational 
achievements; 54% physical ability; and 49% academic achievements (see Table 
4.12). Data shown are numbers and percentages for areas of life affected or unaffected 
since MD.
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Table 4.12 Subject scores on self-reported areas o f life affected since MD
Domains Not at all Only a little Q uite a lot A G rea t deal
N (% ) N (% ) N (% ) N (% )
Home life 52 (51) 36 (36) 7(7) 6 (0
Friendships 60 (59) 24 (24) 12(12) 5 (0
Academic achievements 52 (51) 30 (30) 14(14) 50)
Leisure activities 48 (47) 35(35) 14(14) 4 (4 )
Vocational achievements 60 (59) 28(28) 6 ^ 0 7 (7 )
Physical ability 47 (46) 36 (36) 10(10) 80)
4.3.4 Educational outcomes
Data for educational outcomes are shown in Table 4.13. Data shown are mean ± SD 
and percentages. Analyses were conducted using Independent /-test, and Fisher’s 
exact test for proportions. Wilcoxon-Mann-Whitney tests were performed on data not 
normally distributed. Statistically significant p-values are in boldface.
Table 4.13 Educational outcomes of cases and controls
M easure Subscales Cases Controls P value
N=101 N=101
Educational Outcom es
Number o f passes achieved at GCSE 
level (range 0-13)
mean (SD) 8 0 ) 9 (3 ) 0.02
“ Ô .Ô 7 'Percent o f subjects post secondary 
education without A-Levels
64 50
Percent who failed exams in the 
previous year
19 8 0.04
Self rating o f 
education 
subsequent to 
MD
Average N (%) 
Below average N (%) 
Above average N (%)
i
1
70 (69)
1 5 0 )
26 (26)
59 (58)
4 ( 4  I
38 (38) ^.18
Cases achieved significantly fewer passes at GCSE level and were more likely to have 
failed an exam in the previous 12 months. Of those who had completed their
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secondary education after the baseline study, 64% of cases compared to 50% controls 
did not attain any A levels.
Cases and controls were asked to rate their academic achievement post-MD. No 
differences were found between cases and controls in this regard.
4.3.5 Physical outcomes
Data were available on physical health outcomes from three sources: the Annotated 
Scale of Bodily Injuries Regulation (ASBIR) (Erickson and De Wals 1998); the 
Physical Component Summary (PCS) score from the SF36 (Jenkinson et al. 1996); 
and the Chalder Fatigue Scale (Chalder et al. 1993).
4.3.5.1 Annotated Scale o f Physical Injuries Regulation
ASBIR data are shown in Table 4.14. The data shown are percentages of cases who 
reported physical injuries. The percentage increases with severity of permanent 
injury. Cases may report >1 deficit.
The ASBIR is an evaluation system developed by the Quebec Occupational Health 
and Safety Commission for assessing work-related injuries and used in outcome 
studies of MD to assess physical injury (Erickson and De Wals 1998; Erickson et al. 
2001). The ASBIR provided a quantitative estimate of physical injury and disability 
(in cases), including anatomic and physiologic deficits, disfigurement and suffering or 
loss of enjoyment of life.
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Table 4.14 Subject scores on the ASBIR
A nnotated Scale of Bodily In ju r) (ASBIR) Cases 
N (% )
Cases reporting physical sequelae N  = 58
Symptoms consistent with Raynaud’s disease (colour or temperature 
change or pain in hands or feet in response to cold)
28 (48.3)
Skin scarring 18(31)
Vertigo symptoms 17 (29.3)
Mobility problems 13 (22.4)
Speech problems 13 (22.4)
Hearing problems 12(20.7)
Amputations 3 0 ! 2 )
Epileptic episodes 2 Q ^ )
Impairment in upper limb function 4 (7 )
Fifty-seven percent of survivors (n=58) had physical sequelae as reported on the 
ASBIR. Cases reported a range of injuries from minor scarring to bilateral 
amputations. A number of cases reported multiple physical symptoms (see Table 
4.15).
Table 4.15 Number of reported sequelae in eases (n=58)
Cases N (% ) N um ber of reported Total num ber of reported
symptoms symptoms
3 (5 ) 5 15
3 (5 ) 4 12
4 (7) 3 12
23 (40) 2 46
25 (43) 1 25
58(100) 110
The most frequently reported physical injuries were symptoms consistent with 
Raynaud’s disease, followed by skin scarring (on their face, scalp/skull, neck, arms, 
shoulder and elbows, forearms and wrists, hands, trunk and lower limbs). In addition, 
cases reported mobility problems, speech problems, impairment in upper limb
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function, hearing problems and symptoms of vertigo. The least reported sequelae 
being epileptic episodes and amputation (bi-lateral amputations of the lower leg).
4.3.5.2 SF36 Physical Domain scores and Physical Component Summary
(PCS) score
Data on the physical domains of the SF36 and the Physical Component Summary 
score are presented in Table 4.16. Data shown are mean ± SD. Analyses were 
conducted using Independent t-tests. Statistically significant p-values are in boldface. 
A Higher score for each domain indicates better health status from 0 (worst possible 
health state) to 100 (best possible health state).
The SF36 rates mental and physical well-being along eight dimensions of health. The 
eight dimension scores can be further aggregated into a component summary score: 
the physical component summary score and the mental health component summary 
score (Ware et a l  1994) derived by principal components analysis. The aggregated 
summary scores are then transformed to a mean of 50 and a standard deviation of 10. 
This process is aimed at producing the two summary scales while losing a minimum 
of information (see Chapter 3 -  Methods).
Table 4.16 Mean ± SD subject scores on the SF-36 Physical Domain and 
Physical Component Summary
M easure Subscales Score
Range
Cases
N=101
Controls
N=101
P value
SF36 1 0-100
PCS Domain scores {General health perception i 62.2 (20.4) 70.3(18.8) <0.01
Physical functioning | 91 (13.7) 92(14.7) 0.6
Bodily pain j 78.8(21.6) 81.5(17.2) 0.3 1
Role limitations due to physical | 
functioning |
85.6 (27.7) 87.9 (27.3) 0.5
Physical C om ponentTotal |
Sum m ary (PCS) I
1 I
48.4 (29.8) 51.8 (26) 0.4
PCS by gender
i
[Females 1 
•Males j
42.6 (34) 
55.2 (22.5)
49.7 (27.2) 
54.2 (24.6)
0.2
0.8
153
No significant group differences were noted in the physical domain scores except 
general health perception which was significantly poorer in cases compared to 
controls (p=<0.01). The summary score (PCS) for the four dimensions was not 
significantly different between cases and controls and no differences were found when 
stratified by gender.
4.3.5.2.1 Change in health status in previous year
A  single item of the SF36 related to change in subjects’ health over the past year.
This item is scored separately and is not included in the PCS or MCS scores. Forty- 
four percent of cases compared to 23% of controls reported that overall their health 
status had improved in the year preceding interview (p = <0.001, Fisher’s exact test).
4.3.5.3 Fatigue
Mean ± SD scores on daily fatigue and energy levels in cases and controls are 
presented in Table 4.17. Analyses were conducted using Independent Mests.
Wilcoxon Mann-Whitney tests were performed on data not normally distributed. 
Statistically significant p-values are in boldface.
The Chalder Fatigue Scale (Chalder et at. 1993) is a self-report instrument in which 
subjects are asked to rate the extent to which fatigue has caused problems for them in 
relation to exemplar statements as a measure of physical and mental fatigue. The 
Fatigue Scale produces a total score, a score reflecting mental and physical fatigue as 
well as separate sub-scale scores for mental fatigue and physical fatigue. The 
questionnaire comprises 11 items, each of them being quantified on a scale of 0 to 3 
(scored in a Likert format with response options ranging from better than usual to 
much worse than usual). Thus, the maximum score is 33 (see Chapter 3 Methods).
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Table 4.17 Mean ± SD subject scores on the Fatigue Scale 
Higher scores denote greater fatigue
Measure Subscales Test Score 
Range
Cases 
N=101 
M ean (SD)
C ontrols 
N=101 
M ean (SD)
P
value*
Physical fatigue iProblems with tiredness | 0 - 3
score Need to rest |
Problems starting things |
Lacking in energy
Less strength in muscles |
i !
jFeeling sleepy j
jpeeling weak j
T ota l Physical Fatigue score 0 - 2 1
1.5 (0.6)
1.4 (0.5) 
1.2 (0 .6 ) 
1.3 (0.6) 
1.1 (0 .6)
1.5 (0.6) 
1.1 (0.5) 
9 .1(3)
1.4 (0.6)
1.3 (0.6) 
1.1 (0 .6 ) 
1.2 (0 .6)
1.0 (0.5)
1.4 (0.6)
1.0 (0 .6 ) 
8.4(3)
0.09
0.3
0.3
0.4
0.4
0.2
0.14
0.13
M ental fatigue 
score
^Problems in thinking clearly 0 - 3  j 1.2 (0.6) 1.0 (0.4) | 0.08
poorer memory j 1.0 (0.5) 0.9 (0.4) I 0.01
Making more slips o f  the tongue ; 1.2 (0.6) 1.0 (0.5) i 0.02
bifficulty concentrating j 1.2 (0.6) 1.1 (0.5) | 0.12
T otal M ental Fatigue score | 0 - 1 2  I  4.6 (1.9) 4 (1.2) 0.01
T otal fatigue scoreT otal 
(physical and 
m ental fatigue)
Males
0 - 3 3
Females
13.7(5) 
14.1 (5) 
13.0 (4)
12.3 (4) 
12.7 (4) 
12.0 (4)
0.04
0.10
0.2
Cases had a significantly higher total fatigue score compared to controls. When 
subscales were examined, cases had greater mental fatigue, were more prone to 
making slips of the tongue, and experienced poorer memory. A trend for cases to have 
problems in thinking clearly (p=0.08) was also noted. Further, there was a trend for 
cases to have more problems with physical tiredness (p=0.09).
A number of reports have shown that complaints of fatigue are greater in adolescent 
females than males (Kobayashi and Demura 2006; Monden 1990;Takakura 1997). 
Accordingly, gender differences were examined. No gender differences in total 
fatigue scores were found between cases and controls.
155
4.3.6 Neuropsychological outcomes
This section describes the quantitative data collected on cognitive tests for cases and 
controls. A comprehensive battery of neuropsychological tests was administered to 
assess intellectual ability (premorbid and current), executive function, psychomotor 
speed, visuospatial functioning, attention and memory in both the verbal and visual 
domains.
Table 4.18 summarises the neuropsychological tests administered at follow-up to 
cases and controls (see Chapter 3 -  Methods).
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Table 4.18 Neuropsychological tests administered to cases and controls
♦Cambridge Neuropsychological Test Automated Battery (CANTAB) (Fray et al. 1997)
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4.3.6.1 Laterality
Laterality (in which certain functions such as language comprehension are localised 
on one side of the brain in preference to the other) has been shown to affect cognitive 
abilities (McManus et al. 1983;McManus et al. 1993). Laterality was assessed in 
cases and controls on the basis of hand preferences quantified using a questionnaire 
(Crovitz and Zener 1962). Scores range from 18-90 (see Chapter 3 -  Methods).
No significant differences were found in handedness between cases and controls with 
80% of cases and controls being predominantly right-handed, 10 % indicating a mixed 
hand preference and 10% indicating a strong left hand preference. The expected 
proportion with a right hand preference (score <30) in the normal population is 90%. 
The median score for cases was 27 (range 18-89) and for controls 28 (range 18-82).
4.5.6.2 Intellectual ability
Premorbid intellectual ability was assessed using the National Adult Reading Test 
(NART) (Nelson and Wiilison 1991). The NART is a test of verbal ability and 
provides an accurate measure of premorbid IQ by assessing the ability to read 50 non- 
phonetic words (irregularly spelt words). An estimate of premorbid IQ is derived 
from the number of errors. Reading ability has been shown to be relatively well 
preserved in brain injury (Nelson et al. 1978).
Current intelligence ability was estimated using 2 subtests (Vocabulary and Block 
Design) from the Wechsler Adult Intelligence Scale -  Revised (WAIS-R) Short Form 
(Brooker er fit/. 1986; Sattler 1988; Silverstein er a/. 1982; Wechsler 1981).
Vocabulary is a test of verbal knowledge and Block Design a measure of perceptual 
organisation. The two subtests are frequently used for estimating IQ because the tests’ 
measure of IQ correlates (.90) with Full-Scale IQ based on all of the subtests of the 
WAIS (Hoffman er a/. 1988;Missar er a/. 1994;Sattler 1988).
Raw scores from both the NART and the WAIS were converted into a scaled score 
with an average of 100 (SD 15), (see Chapter 3 -  Methods).
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Data on the premorbid and current estimates of intellectual ability are shown in Table 
4.19. Data shown are mean ± SD. Analyses were conducted using Independent t- 
tests.
Table 4.19 Subject scores on intellectual ability
V ariable1 M easure Cases 
N=101 
M ean (SD)
C ontrols P value 
N=101 
M ean (SD)
Pre-m orbid estim ate 1 National Adult Reading Test (NART)
!
1
96.7(10.9)
i  i
: 99.2(10.9) 1 0.11
C u rren t estim ate ; Wechsler Adult Intelligence Scale - Revised 
Short Form (WAIS-R) 102.1 (11.6) i 104.3(10.2); 0.15
Data were normally distributed with no difference found between cases and controls.
4.3.6.3 Memory
Short and long-term verbal memory were assessed using the Rey Auditory Verbal 
Learning Test (RAVLT) (Rey 1941 ;Rey 1964;Taylor 1959). Short-term visual 
memory was assessed using four tests from Cambridge Neuropsychological Test 
Automated Battery (CANTAB) (Sahakian and Owen 1992). Tests included Delayed 
Matching to Sample assessing both simultaneous and short-term visual memory, 
Spatial Recognition Memory assessing recognition memory for spatial locations and 
Pattern Recognition Memory assessing recognition memory for patterns. Long-term 
visual memory was assessed using the recall and recognition subtests from the Rey- 
Osterrieth Complex Figure (ROCF) test (Osterrieth 1944;Rey 1941;Taylor 1959) and 
the Paired Associate Learning from CANTAB assessing episodic memory, (see 
Chapter 3 -  Methods).
Data on short and long-term visual and verbal memory are presented in Table 4.20. 
Data shown are means ± SD unless otherwise stated. Analyses were conducted using 
Independent r-tests, and Fisher’s exact test for proportions. Statistically significant p- 
values are in boldface.
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Table 4.20 Subject scores on cognitive tests of mem or)
Variable Measure Score Cases Controls P D irection of
Range N=101 N=101 value Difference - cases
M ean M ean com pared to
(SD) (SD) controls
VERBAL MEM ORY
1
i
i
Short-term  ' 
RAVLT
Immediate Memory Recall (T ria l!)  0-15 
Interference Trial (Trial 6 / List B) j 
Long-term  j 
Delay trial (30 minutes) |
7.4 (1.9) 
5.9 (1.8)
11.5 (2.5)
7.5(2) ! 0.7 
6.5 (1.7) 0.04
i
11.5(2.4) 1
1
1
Worse j
i
VISUAL M EM ORY 1 1
1 Short-term
CANTAB
|Delaved Matching to Samole i
jMean latency time -  all delays 
j(milliseconds) | 
Percentage o f correct responses (all delays)
3378
(971)
81.7
j
3194 ,0 .16 
(878) 1 
82.7 , 0.4
1
1
;
1 1 
!
:  1
Snatial Recognition Memory 
Percentage o f correct responses 84 85 , 0.5
Pattern Recognition Memory
percentage o f correct responses
 :
90.7 92.5 0.13
j
! 1
:  1
1  1
1
Long-term  visuospatial associative 
memory
Paired Associates Learning 
All stages completed %
Total errors (adjusted) 1
100 
6.5 (5.6)
98 0.5 
6 .3(8) 1 0.19
i
ROCF
Recall (40 minutes delay) 0-36
Recognition 0-24
1
16.6 (5.3) 
20.8(1.9)
18.6 (4.8) <0.01 
21 (1.8) 0.3
Worse
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Verbal memory:
Short-term: Cases recalled significantly fewer words on the Interference Trial of the 
RAVLT compared to controls. No differences were found between cases and controls 
on the Immediate Memory Recall Trial of the RAVLT.
Long-term: No differences were noted between cases and controls on the Delay Trial 
of the RAVLT.
Visual memory:
Short-term: No differences were found between cases and controls on tests assessing 
short-term visual memory (Delayed Matching to Sample, Spatial and Pattern 
Recognition Memory) with both groups comparable in the number correct responses 
achieved and latency times.
Long-term: Cases achieved significantly lower scores on the recall subtest of the 
Rey-Osterrieth Complex Figure test compared to controls. No differences were found 
on the recognition part of the test where participants are presented with correct and 
incorrect details of the drawing and asked to recognise if they featured in the original 
drawing. Similarly, no differences were found between cases and controls on the 
Paired Associates Learning test with both groups completing all stages of the test with 
similar overall error rates.
4.3.6.4 Attention
Attention was assessed using two tests from the CANTAB (Sahakian and Owen 
1992): Rapid Visual Information Processing assessing sustained attention; and 
Matching to Sample assessing selective attention.
Sustained attention: Three measures are reported for the Rapid Visual Information 
Processing (RVP) test. Two sensitivity measures: RVP ‘A’ which assesses the ability 
to detect target sequences and the RVP ‘B’ assessing the subject’s tendency to 
respond regardless of whether target sequence is present. Both measures are based on 
the proportion of hits and the proportion of false alarms of the responses made during 
the RVP test. The mean time taken to respond was also measured.
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Selective attention: Matching to Sample is a simultaneous visual search task. Two 
measures are reported: the percentage of correct responses and the response latency. 
Efficient performance on this task requires the ability to search among the targets and 
ignore the distractor patterns, which have elements in common with the target. As 
this task includes both speed and accuracy demands, subjects may trade-off speed of 
response in favour of accuracy, or vice versa (see Methods Section).
Data on tests of sustained and selective attention are presented in Table 4.21. Data 
shown in this table are mean ± SD unless otherwise stated. Analyses were conducted 
using Independent f-tests, and Fisher’s exact test for proportions. Wilcoxon-Mann- 
Whitney test was performed on data not normally distributed.
Table 4.21 Subject scores on CANTAB tests of attention
V ariable M easure Score Range Cases Controls P Direction of
N=101 N=101 value Difference -
(
M ean (SD) M ean (SD) cases 
com pared to 
controls
Sustained Raoid Visual Information i !
A ttention Processing fRVP) !
RVP ‘A ’ Detecting target sequences 0 to 1 0.89 (0.05) 10.90 (0.05) i 0.01 Slower
RVP ‘B ’ Tendency to respond 1
regardless o f  whether target ; 1 I
sequence is present -1.00 t o +1.00 0.93(0.1) ; 0.89 (0.2) 0.3
Mean latency to respond (time in 1
milliseconds) 1 439(92) 436(104) 0.5
Selective Matching to Sample '
attention Mean latency time (milliseconds) 1 1600 (4 7 9 )j 1460 (372) } 0.02 Slower
Percentage o f correct responses I  93.7 j 93.6 I 0.8 !
Sustained attention'. Cases detected significantly fewer targets than controls on the 
sensitivity index measure A’ on the Rapid Visual Processing task. No differences 
were found between cases and controls on the sensitivity index measure B’ or on the 
response time on this test.
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Selective attention: Cases were significantly slower than controls in touching the 
screen for correct trials on Matching to Sample task measuring selective attention, 
although no difference in accuracy was found as both groups achieved the same 
number of correct responses.
4.3.6.5 Executive function
Four tests from the CANTAB (Sahakian and Owen 1992) were administered to 
evaluate executive function: Intra-Extra Dimensional Set Shift is primarily a test of 
attentional flexibility, assessing rule acquisition and attentional set shifting;
Spatial Working Memory assesses working memory and strategy use; Stockings of 
Cambridge assesses spatial problem-solving ability and motor control; and the Spatial 
Span test assesses working memory capacity (see Chapter 3 -  Methods).
Data on executive function tests are shown in Table 4.22. Data shown in this table are 
mean ± SD on cognitive tests of executive functioning. Analyses were conducted 
using Independent t-tests. Wilcoxon-Mann-Whitney test was performed on data not 
normally distributed. Statistically significant p-values are in boldface.
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Table 4.22 Subject scores on CANTAB tests o f executive function
V ariable M easure Score Cases C ontrols P valuet D irection o f
Range N=101 N=101 D ifference -
■ M ean (SD) M ean (SD) cases com pared  
to contro ls
Rule acquisition Intra/ Extra Dimensional Shift
and  atten tional Stages completed 0-9 8.4 (1.2) 8.4 (1.3) 0.9
set shifting ability  {Total errors (adjusted) 31.4 (28.5) 28.1 (31.7) 0.06 ;
Pre-EDS errors 9 .2 (6 ) 8.4 (5.5) 0.15
EDS errors 10.7(10.8) 9.1 (9.8) 0.3
iTotal number o f trials
{Completed on all attempted 107.6 (49.3) 101.79 (56.5) 0.08 ■
stages (adjusted)
W orking m em ory Snatial Working Memory
and  strategy  use jNumber o f  between search
errors for 8 boxes 16.4(11.8) 13.9(11) 0.11
Strategy score (higher score =
poor use o f  strategy) 1-37 31.8(5.2) 32.2 (5.1) 0.6
Spatial p lanning Stockings o f  Cambridge
and  m otor Mean initial thinking time for 5
contro l moves 9758 (7634)1 11352 (7750) 0.04 Faster
Mean subsequent thinking time
for 5 moves 662 (701) 715 (796) 0.7
Problems solved in minimum .
number o f  moves 9(1 .9) 9 (2 ) 0.7
W orking memorviSpatial Span
capacity  Span length recalled 0-9 6.5 (1.5) 6.9 (1.3) 0.12
Rule acquisition and attentional set-shifting ability: There was a trend for cases to 
commit more errors than controls on the set shifting task (P=0.06), which has been 
attributed to problems in cognitive flexibility (Elliott et al. 1995). However, no 
differences were found between cases and controls on pre-extradimensional errors, or 
extradimensional shift errors.
A trend was also noted for cases to require more total trials to complete all attempted 
stages than controls (P=0.08), although no differences were found on the number of 
stages completed with both groups successfully passing all stages.
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Working memory and strategy use: No significant differences were found between 
cases and controls on the number of between-search errors committed at the most 
difficult level (8 boxes) on the Spatial Working Memory task. No differences were 
also noted on the Strategy score of the Spatial Working Memory test with cases and 
controls equally efficient in their ability to adopt a systematic searching approach.
Spatial planning and motor control: Cases were significantly faster than controls in 
initial thinking time for five move problems (the most difficult level) on the Stockings 
of Cambridge planning ability task. The speed at which they made their decisions did 
not compromise their accuracy of the problems solved in the minimum number of 
moves.
Working memory capacity: Cases did not differ from controls in the length of spatial 
memory span on the Spatial Span test.
4.3.6.6 Visuospatial ability, verbal learning, non-strategic visual learning and
memory and psychomotor speed /accuracy
The copy subtest of the Rey-Osterrieth Complex Figure Test (ROCF) (Osterrieth 
1944;Rey 1941) was administered to assess visuospatial ability and perceptual 
organisation. The Rey Auditory Verbal Learning Test (RAVLT) (Rey 1941;Rey 
1964;Taylor 1959) was administered to assess verbal learning and organisation. In 
order to assess psychomotor speed the Reaction Time task from the CANTAB 
(Sahakian and Owen 1992) was administered, measuring speed of response to a visual 
target where the stimulus is either predictable (simple reaction time) or unpredictable 
(choice reaction time). Five Choice reaction (latency to release the touch pad) and 
movement time (from release of touch pad to touch of the screen) is reported. (See 
Chapter 3 -  Methods).
Data on cognitive tests of visuospatial ability, verbal learning, and psychomotor 
speed/accuracy are presented in Table 4.23. Data shown in this table are mean ± SD. 
Analyses were conducted using Independent Mests. Wilcoxon-Mann-Whitney test 
was performed on data not normally distributed. Statistically significant p-values are 
in boldface.
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Table 4.23 Subject scores on cognitive tests for visuospatial ability, verbal 
learning, and psychoniotor speed /accuracy
V ariable M easure Score Cases C ontro ls P D irection of
Range i\=101 N=101 value D ifference - cases
M ean (SD) M ean (SD) com pared  to
contro ls
V isuospatial
Ability
RO CF
Copy 0-36 : 30.4 (3.9) | 31.4 (3.5) 0.10
V erbal L earning RAVLT
Total Level o f  Learning 
(Trials 1-5) 0-75 : 53.4 (8.9) 54.1 (8) 0.6
Psychom otor 
Speed/ A ccuracy
^A N T A B  
Reaction Time test
I  i  
’ !
Five choice movement time ; 
'in milliseconds
: 403 (113) j
i
367(101) 0.02 Slower
Five choice reaction time in 
milliseconds)
: 352(58.3) ; 343 (50) ; 0.2
Visuospatial ability: No significant differences were found between cases and controls 
in visuospatial ability.
Verbal learning: No significant differences were observed between cases and controls 
in verbal learning ability with both groups achieving comparable number of words 
learnt over five trials of the RAVLT.
Psychomotor speed: Movement time for five possible different stimuli presented (the 
most difficult level) on the Reaction Time task was significantly longer in cases 
compared to controls. No group differences were found in reaction time.
There were no significant group differences in the number of tests failed, not 
completed or aborted on the CANTAB.
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4.3.6.7 The effect o f gender and age at baseline on neuropsychological results
Analysis of covariance (ANCOVA) was performed to examine the effect of gender 
and age at baseline (independent variables) on scores of neuropsychological measures 
(dependent variables) in cases (N=101). The variables of gender by age at baseline 
(that is, the interaction term), were also added.
Data on tests assessing intellectual ability, memory, attention, executive function, 
visuospatial ability, verbal learning and psychomotor speed are shown in Tables 4.24, 
4.25 and 4.26.
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Table 4.24 Effect o f gender and age at baseline in cases (N=101) on tests
assessing intellectual abilit} and memor)
V ariable M easure Significant F value P value In terac tion  of 
effect gender by age at
baseline
IN TELLEC TU A L ABILITY
P re-m orbid  estim ate NART Age ! 5.7
1
! 0.02 NS
C u rren t estim ate W AIS-R Age ! 11.9 0.001 NS
M EM O RY
1 V erbal M em ory i
1 S hort-term RAVLT
! Immediate Memory Recall (Trial 1) ! NS NS
Interference Trial (Trial 6 / List B) Age 8.7 0.004 NS
Long-term Delay trial (30 minutes) 1 NS NS
Visual M emory
:
S hort-term CANTAB
Delayed Matching to Sample
Mean latency time -  all delays NS NS
(milliseconds)
!
' Percentage o f  correct responses NS NS
1 Spatial Recognition Memory
Percentage o f  correct responses NS NS
Pattern Recognition Memory
Percentage o f  correct responses NS NS
Long-term Paired Associates Learning
All stages completed % NS NS
I Total errors (adjusted) j NS NS
I RO CF 1
Recall i NS NS
1 Recognition G ender 4.5 0.03 F=4.4; P =0.04
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Table 4.25 Effect of gender and age at baseline in cases (N=101) on tests
assessing attention and executive function
V ariable M easure Significant F value 
effect
P value In terac tion  o f 
gender by age 
a t baseline
A TTEN TIO N
Sustained A ttention CANTAB
Raoid Visual Information Processing
!
1
RVP ‘A ’ Detecting sequences - 
RVP ‘B ’ Tendency to respond 
regardless o f whether target sequence 
is present
Mean latency to respond (time in 
milliseconds)
1
1
1
Age 22.9
NS
<0.0001
NS
NS '
;
1
1
NS
NS
Selective atten tion Matching to Sample 1 :
Mean latency time (milliseconds) 
Percentage o f  correct responses G ender i 8.8
NS
0.004
'
NS
i
F=7.5; P=0.01
EX ECU TIV E FUNCTION
Rule acquisition and Intra/ Extra Dimensional Shift '
a tten tional set 
shifting
Stages completed 
Total errors (adjusted)
NS
NS
NS
NS
W orking m em ory fSoatial Working Memory
and stra tegy  use Number o f  between search errors for 
8 boxes 
Strategy score
Age 3.9 0.05
NS
F=3.8; P=0.05
NS
Spatial p lanning and Stockings o f  Cambridge
m otor control Mean initial thinking time for 5 
moves
Mean subsequent thinking time for 5 
moves
Problems solved in minimum number 
of moves (Planning ability)
1
NS
NS
NS
NS
NS
NS
W orking m em ory 
capacity
Snatial Snan 
Span length recalled NS NS
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Table 4.26 Effect of gender and age at baseline in cases (N=101) on tests
assessing visuospatial abilit) , verbal learning and psychoniotor 
speed
1 V ariable M easure Significant F value 
effect
P value In terac tion  of 
gender by age 
a t baseline
VISU OSPATIAL RO C F 1 :
ABILITY Copy i ; NS NS
VERBAL RAVLT
LEARNING Total Level o f  Learning (Trials 1-5) ■ NS NS
PSY C H O M O TO R CANTAB ; !
S P E E D / Reaction Time test ; ;
ACCURACY fiv e  choice movement time in
piilliseconds NS NS
Five choice reaction time in
tnilliseconds) NS NS
Effect o f  age
A significant main effect of age at baseline was observed on tests estimating 
intellectual ability, short-term verbal memory, spatial working memory and sustained 
attention.
Effect o f  gender
In addition, there was a significant effect of gender on tests assessing selective 
attention and long-term visual memory.
Effect o f  age and gender (Interaction)
The interaction of age at baseline and gender on tests assessing long-term visual 
memory, selective attention and spatial working memory was significant.
To assess if male and female MD survivors are differentially affected by the age at 
which they contract MD, regression analyses were computed to confirm the results 
from the ANCOVA and to take full advantage of all the variance in the age at baseline 
and gender variables. Each model included scores from the neuropsychological 
measures as dependent variables with gender and age at baseline again used as
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independent variables. In addition, the interaction term (gender and age at baseline) 
was included in regression models.
Table 4.27 shows coefficients and 95% Cl for the regression of neuropsychological 
test scores with gender and age at baseline.
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Table 4.27 Table shows coefficients and 95% CI for the regression of neuropsychological test scores with
gender and age at baseline. Cases only N=101
Variables Prem orbid
Intellectual
ability
NART
C u rren t estim ate 
of intellectual 
ability 
W AIS-R
S hort-te rm  verbal 
m em ory 
In terference tria l 
(RAVLT)
Long-term  visual 
m em ory 
Recognition 
ROCF
Coefficient 
(95% Cl)
p value 1 Coefficient 
(95% Cl)
p value Coefficient 
(95% Cl)
p value Coefficient 
(95% Cl)
p value
G ender
Male
Female
0
7.0 (-44.7, 58.7) 0.80
1
1
: 0 
! 15.4 (-40.1, 70.9) 0.58 -2.0 (-10.7, 6.8) 0.66
0
10.1 (0.66, 19.6) 0.04
Age at baseline 2.7 (0.56,4.8) 0.01 2.4 (0.12,4.7)
1
0.04 0.32 (-0.04, 0.68) 0.08 0.54 (0.15,0.93) 0.01
Gender by age at 
baseline C -0.32 (-3.2, 2.6) 0.83 : -1.1 (-4 .2 ,2 .!) 0.51 0.09 (-0.41,0.58) 0.72 -0.57 (-1.1,-0.03) 0.04
C Interaction term gender and age at baseline
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Table 4.27 (cont.) Table shows coefficients and 95% CI for the regression of neuropsychological test
scores with gender and age at baseline. Cases only N=101
V ariables Sustained attention 
Rapid Visual Processing 
(RVP B’)
Selective attention 
M atching To Sample 
(MTS)
%  of correct responses
Executive function 
Spatial W orking M emory 
(SW M) (num ber of between 
search erro rs  for 8 boxes
1
Coefficient p value Coefficient p value Coefficient p value
(95% Cl) (95% Cl) (95% Cl)
G ender i
_
Male ; 0 0 0
Female i  0.00 (0.22, 0.22) 0.99 6.6 (2.2, 11.0) 0.004 -54.8 (-112.0,2.4) 0.06
Age at baseline : 0.02 (0.01,0.02) 0.001 0.27 (0.09, 0.45) 0.004 -3.2 (-5.6, -0.84) 0.01
Gender by age at baseline C 1 -0.00 (-0.01,0.01) 0.95 -0.34 (-0.59, -0.09) 0.01 3.2 (-0.04, 6.4) 0.05
C Interaction term gender and age at baseline
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4.3.6.8 Effect o f age and gender
The analyses revealed that at follow-up, survivors who were younger at MD, 
regardless of gender, performed worse on tests of intellectual ability (NART & 
WAIS-R) and on the test of sustained attention (RVP). In addition, male survivors 
who were younger at MD performed worse on tests assessing selective attention 
(MTS) and long-term visual memory (ROCF).
In contrast, survivors who were younger at MD committed fewer errors on the 
executive function task assessing Spatial Working Memory. There was no age or 
gender difference found in short-term verbal memory (RAVLT).
4.3.6.9 Summary o f cognitive tests
No differences were found between survivors and controls in general intellectual 
ability and handedness. Survivors did however demonstrate problems in short-term 
verbal memory skills, cognitive flexibility and storage of verbal information. The 
ability to encode verbal material and retrieve it from long-term memory was 
unaffected. Impairment was also found in long-term visual memory. Significant 
deficits were also found in sustained and selective attention tasks. There was also 
some suggestion of minimal impairment in executive functioning, where survivors 
demonstrated a trend to commit more errors in attempting the attentional set-shifting 
task. MD survivors’ also demonstrated significantly slower psychomotor speed 
compared to controls. However, survivors were not impaired in their response 
latencies on any other test in the battery. Furthermore, no impairment was observed 
on tests assessing visuospatial construction ability and visual recognition memory. 
Planning ability was also relatively well preserved. Survivors, younger at MD, 
performed worse on tests of intellectual ability and sustained attention (RVP) but 
committed fewer errors on the executive function task. Male survivors, younger at 
MD, performed worse on tests assessing selective attention and long-term visual 
memory.
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4.4 Health professional follow-up
Data for follow up of cases by geographical region are shown in Table 4.28. Values 
shown are numbers and percentages.
Table 4.28 Follow up post-MD by region in the UK (cases n=101)
Region Not followed up Followed up Total
N (% ) N (% ) N (% )
j North Thames 10(53) 9 (47) 19(100)
' South Thames
1
14(52) 13 (48) 27(100)
Anglia & Oxford 6(40) 9(60) 15(100)
South West 11 (44) 14(56) 25 (100)
Trent 2(33) 4 (67) 6(100)
West Midlands 5(56) 4(44) 9 (100)
Total 48 (48) 53 (52) 101 (100)
Of the 101 cases, 53 had contact with a health professional post illness. The remainder 
reported that they had not even been seen by their general practitioner. There were no 
significant geographical variations in the proportion followed-up between regions 
(p=0.92, based on Fisher’s exact test). Cases were not referred to a mental health 
professional at any time between the baseline study and the current study. None of the 
20% of cases who were in the clinical range for depressive symptoms had received a 
referral to a mental health professional.
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4.5 Associations o f identified deficits on functioning (cases only)
In this section, the relationship of identified deficits with functioning in cases was 
examined. The ASBIR score and a cognitive summary score (CSS) were entered into 
multiple linear regression models as the independent variables with educational 
achievement (number of passes at GCSE and A level), mental health functioning 
(BDI-II and SF36 MGS), QOL, fatigue (Total Fatigue Score) and social support 
(SSQ6 Total score) as the dependent variables. The association of mental health 
functioning with cognitive performance was also assessed.
Adjustment of analyses for time between baseline and interview was undertaken in all 
regression analyses and made no material difference to findings.
4.5.1 Analyses of identified physical sequelae on functioning
The association of identified physical deficits with outcomes was examined. 
Coefficients and 95% Cl for the regression of educational achievement, mental health 
functioning, QOL, fatigue and social support on ASBIR score are shown in Table 
4.29. Coefficients are adjusted for age at follow-up and gender.
Table 4.29 Association of physical deficits (ASBIR score) with educational, 
psychological, qualit> of life, fatigue and social support measures
ASBIR score
Adjusted coefficient p 
(95% Cl)
Number o f  passes at GCSE level -0.01 (-1.06, 1.04) 0.9
Number o f  passes at A level -0.48 (-0.98, 0.02) 0.06
BDl score 1.7 (-0.94, 4.3) 0.2
SF36 mental component score -12.8 (-24.7, -0.98) 0.03
Quality o f  life compared with peers -0.10 (-0.67, 0.45) 0.7
Fatigue score 1.5 (-0.33,3.4) 0.11
Social support 0.01 (0.00, 0.01) 0.04
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Poorer mental health functioning was associated with higher levels of physical 
sequelae. There was also a trend towards achievement of fewer A Level passes. A 
positive effect was that young people with physical sequelae had higher social 
support. Quality of life, fatigue or the number of passes at GCSE achieved were not 
associated with physical sequelae.
4.5.2 Analyses of the impact of identified cognitive deficits on functioning in cases
4.5.2.1 Cognitive Summary Score
In order to investigate potential mechanisms for poor QOL, fatigue, psychological and 
educational outcomes in survivors a Cognitive Summary Score (CSS) was derived. 
The CSS is a single variable comprised of scores for cognitive tests where cases had 
performed significantly worse than controls: short-term verbal memory (RAVLT, List 
B score), long-term visual memory (ROCF recall), sustained and selective attention 
(RVP A & MTS, mean latency) and psychomotor speed (RT, five choice movement 
time). The test raw scores were converted to z-scores using the mean and standard 
deviation of the control group for that test. The average of the five z-scores was 
calculated to create the summary score (CSS). Negative CSS scores indicate greater 
cognitive deficit compared with the controls, although the CSS was not used to 
differentiate between cases and controls. The mean for cases was -0.5 (SD 1.0). On 
tests where higher scores indicated impairment (for example timed tests), the z-score 
was inverted so that improved performance resulted in a higher CSS.
Previous investigators have used this method both in research (Brooks et al. 
2000;Holthausen et al 2001 ; Jung et al 1999;Martis et al 2003;Pugh et al 
2003;Sullivan et al 2002;Travis et a l 2002;Wilson et al 2000), and clinical settings 
(Spreen 1998). A single variable reduces the number of analyses conducted and Type 
I error.
To assess the impact of identified cognitive deficits on functioning in cases the CSS 
was entered as the independent variable into a multiple regression model and 
regressed against educational achievement (number of GCSEs and A Levels), mental
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health functioning (scores from the BDI-II and SF36 MCS), quality of life, fatigue 
total score and social support total score (see Chapter 3 -  Methods).
Associations of the CSS are shown in Table 4.30. The Table shows coefficients and 
95% Cl with coefficients adjusted for age at follow-up and gender.
Table 4.30 Associations of the cognitive suminar> score (CSS) with 
educational, psychological and quality of life measures
Cognitive Sum m ary Score (CSS)
Adjusted coefficient P 
(95% Cl)
j Number o f  passes at GCSE level 0.90 (0.4, 1.4) 0.001
Number o f  passes at A level 0.30 (0 ,0 .6) 0.05
BDI score -0.37 (-1.8, 1.1) 0.6
SF36 mental component score 2.5 (-4.2, 9.1) 0.5
Quality o f  life compared with peers 0.11 (-0.19,0.42) 0.5
Fatigue score 0.40 (-0.62,1.4) 0.5
Social support score
■
0.00 (-0.07,0.08) 0.9
Greater cognitive deficit was associated with poorer educational achievement (fewer 
passes at GCSE and A level) but not with measures of mental health, quality of life, 
fatigue or social support.
4.5.3 Association of mental health functioning with cognitive performance
In order to investigate the association between mental health functioning and 
cognitive ability, the raw scores of each test were converted to z-scores using the 
mean and standard deviation of the control group. The average of the test z-scores was 
calculated to create the domain score used in regression analyses. Data are shown in 
Table 4.31. The Table shows coefficients and 95% Cl. Coefficients are adjusted for 
age at testing and sex.
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Table 4.31 Association of mental health function (cases only) and cognitive 
ability
Cognitive dom ains
M ENTAL H EALTH FUN CTIO NIN G  
Association with Association with 
Depressive sym ptom s SF-36 M ental H ealth 
(BDI score) C om ponent score 
A djusted coefficient* P value A djusted coefficient* 
(95%  C l) (95%  C l)
P value
Memory -0.001 (-0.02,0.01) 0.85 0.002 (-0.002, 0.01) 0.34
Attention 0.01 (-0.01,0.22) 0.45 0 (-0.003, 0.04) 0.83
Executive function 0.01 (-0.01,0.02) 0.39 0.001 (-0.002, 0.004) 0.64
Visuospatial ability -0.003 (-0.04, 0.03) 0.88 -0.001 (-0.01,0.01) 0.82
Psychomotor ability 0.013 (-0.02,0.04) 0.40 -0.002 (-0.01,0.01) 0.63
Non-strategic learning and 
memory -0.01 (-0.02,0.01) 0.31 0.001 (-0.002, 0.003) 0.56
Verbal learning 0.02 (-0.02, 0.05) 0.34 -0.001 (-0.01,0.01) 0.87
Intellectual ability 0.001 (-0.03,0.31) 0.94 0.001 (-0.01,0.01) 0.75
Cognitive performance across each domain was not associated with the BDI and SF36 
mental component score.
4.5.4 Association of premorbid IQ (NART score) with educational achievement and 
the cognitive summary score (CSS)
Association of premorbid IQ (NART score) with educational achievement and the 
cognitive summary score are shown in Table 4.32. The Table shows coefficients and 
95% Cl for the regression of premorbid intellectual ability with educational outcomes 
and the cognitive summary score. Coefficients are adjusted for age at testing and sex.
Lower premorbid intellectual ability predicted fewer exam passes at GSCE and A 
Levels, and a lower cognitive summary score.
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Table 4.32 Association of premorbid intellectual ability with educational outcomes and the cognitive summary 
score (CSS)
PREM O RBID  IQ <100 vs. >=100 PREM O RBID  IQ <115 vs. >=115
Association with ! Association with 
P rem orbid  IQ  j P rem orbid  IQ 
A djusted coefficient* P value | A djusted coefficient* 
1 (95%  C l) (95%  C l)
P value
Educational Achievem ent Educational Achievem ent
N um ber of passes a t G CSE level 
Premorbid IQ <100 
Premorbid IQ >=100
0
1.16(0.13,2.18) 0.03
N um ber of passes a t GCSE level 
Premorbid IQ <115
Premorbid IQ > = 115
0
1.83 (-0.40,4.04) 0.11
N um ber o f passes at A ‘ Level
Premorbid IQ <100 
Premorbid IQ >=100
0
1.06 (0.59, 1.52) <0.0001
N um ber of passes a t A ‘ Level
Premorbid IQ <115 
Premorbid IQ >=115
0
2.16(1 .15 ,3 .16) <0.0001
Cognitive S um m arv Score fCSS) C ognitive Sum m arv Score
Premorbid IQ <100 
Premorbid IQ >=100
0
0.57 (0.23, 0.92) 0.001
Premorbid IQ <115 
Premorbid IQ >=115
0
1.03 (0.27, 1.80) 0.01
180
4.5.5 Relationship o f mental health function and social support
Association of mental health functioning and social support are shown in Table 4.33. 
The Table shows coefficients and 95% Cl for the regression of mental health scores 
(BDI and SF36 Mental Component Score) with the SSQ6 total social support score. 
Coefficients are adjusted for age at testing and sex.
Table 4.33 Relationship of mental health function and social support
1
1 BDI SF36 M ental C om ponent Score
r1 Adjusted coefficient P Adjusted coefficient P
(95% Cl) (9594 Cl)
Social Support 
Total score
-0.05 (-0.08, -0.02) ; <0.01 ; 0.01 (0.01,0.02) 1 0.0011
Poorer mental health functioning was significantly associated with lower social 
support.
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4.6 The number of cases scoring above or below the mean of controls in 
outcome domains
The number of cases scoring above and below the mean of controls in Physical 
function (Total Fatigue Score, General Health Perception); Quality of Life compared 
to before MD; Social Function (Total Social Support score); Academic achievement 
(number of GCSEs); Psychological function (Mental Component Summary score), 
and Cognitive Function (Cognitive Summary Score) is shown in Table 4.34.
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Table 4.34 Cases scoring above and below the mean of controls
Cases Scoring 
Above or 
Below M ean of 
C ontrols
PHYSICAL 1 
Total Fatigue Score
UNCTION
G eneral Health 
Perception
QUALITY OF 
LIFE
QO L com pared 
with before MD
SO( lAL 
FUNCTION
Total Social 
Support Score
ACADEMIC
ACHIEVEMENT
No. of 
GCSEs
PSYCHOLOGICAL Î 
FUNCTION
M ental 
C om ponent , 
Sum m ary Score
COGNITIVE
FUNCTION
Cognitive 
Sum m ary Score
No. of 
Cases
% No. of 
Cases
% No. 
of Cases
% No. of 
Cases
% No. of 
Cases
% No. of
Cases
% No. of 
Cases
%
< mean 51 50.5 63 62.4 74 73.3 64 63.4 49 48.5 50 49.5 74 73.3
>= mean 50 49.5 38 37.6 27 26.7 37 36.6 52 51.5 51 50.5 27 26.7
183
Approximately half the cases scored above or equal to the mean of controls on the 
total fatigue score, number of GSCEs attained and the mental heath score. However, 
approximately one-third of cases scored above or equal to the mean of controls on 
general health perception and social support. Further, just over a quarter of cases 
scored above or equal to the mean of controls in respect to QOL compared with 
before MD and cognitive function.
4.7 Cases impaired in multiple domains
The number of domains affected in cases only is shown in Figure 4.2. Domain 
scores are < mean of controls on Total Fatigue Score, General Health Perception, 
Quality of Life compared to before MD, Social Function (Total Social Support score). 
Academic achievement (number of GCSEs), Psychological function (Mental 
Component Summary score). Cognitive Function (Cognitive Summary Score). In 
addition, the total ASBIR physical disability score (cases only) was included in these 
analyses.
Figure 4.2 Number of cases impaired in multiple domains
00
■
Number of domains affected
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Figure 4.2 reports that all cases are impaired in at least one domain. Notably, only 3% 
of all cases were impaired in one domain whereas 47% of cases were impaired in five 
or six domains. One case was impaired in all eight domains.
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4.8 Chapter summary
Survivors of MD in adolescence have greater mental fatigue, less social support, 
poorer educational outcomes and reduced quality of life 18-36 months after disease, 
compared with well-matched controls. These problems are in addition to deficits in 
short and long-term memory and attention as well as slowed psychomotor speed. 
Despite marked deficits, only half the sample was followed-up medically by any 
health professional including the participants’ GP. A summary of significant cross- 
sectional findings of the data are presented in Table 4.35. Data shown in this table are 
mean ± SD unless otherwise stated on social support, quality of life, educational, 
health perception, fatigue and cognitive variables that are significant between cases 
and controls.
In addition, greater cognitive deficit was associated with poorer educational 
achievement (fewer passes at GCSE and A Level) not with measures of mental health 
or fatigue. In contrast, physical sequelae were associated both with poorer mental 
health functioning, as well as a trend towards poorer educational achievement (fewer 
A Level passes). However, physical sequelae were also associated with higher social 
support, while poorer mental health functioning was associated with lower social 
support.
Lastly, prior to adjustment for life stress, there was a trend for cases to have poorer 
mental health than controls, with lower mental health component SF36 scores being 
attained. Moreover, nearly twice as many cases as controls reporting depressive 
symptoms that were in the clinical range. After adjustment for life stress, cases were 
significantly more likely to have depressive symptoms than controls.
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Table 4.35 Summary of significant cross-sectional findings between cases and controls
M easure Variable Score Cases Controls P value
Range ! N=101 N=101
jSOCIAL SUPPORT Network score (average number o f supports) 0-9 3.2 (1.4) 3.6 (1.3) I 0.03
(SSQ6) Total score 0-6 1 4.0(1.1) 4.4 (0.9) 0.01
QUALITY OF LIFE QOL compared with baseline median (range) -5 to +5 1 -0.1 (-5 to 3) 0.96 (-3 to 3) <0.0001
j
1 QOL compared with peers mean (SD) : -0.80(1.37) -0.31 (1.26) <0.001
EDUCATIONAL Number o f passes achieved at GCSE level: mean (SD) 1 8 ( ^ 9C1) 0.02
i Percent who failed exams in the previous year 19 8 0.04
HEALTH PERCEPTION SF36-II General health perception score 0-100 ■ 62.2 (20.4) 70.3(18.8) <0.01
FATIGUE Mental fatigue score 0 - 1 2 4.6 (1.9) 4(1.2) 0.01
Fatigue Scale Poorer memory 0 - 3 1.0 (0.5) 0.9 (0.4) 0.01
Making more slips o f the tongue 1.2 (0.6) 1.0 (0.5) 0.02
Total fatigue score (mental and phvsical fatigue combined score) 0 - 3 3 13.7(5) 12.3 (4) 0.04
COGNITIVE
Short term verbal memory -RAVLT Interference Trial (Trial 6 / List B) 0-15 5.9 (1.8) 6.5 (1.7) 0.04
Long-term visual memory -CFT Recall 0-36 16.6(5.3) 18.6(4.8) <0.01
Sustained attention - CANTAB Rapid Visual Processing (detecting sequences) 0-1 0.89(0.05)  ^ 0.90 (0.05) 0.01
Selective attention Simultaneous Matching to Sample (mean latency time, milliseconds) : 1600(479) 1460(372) 0.02
Executive function Stockings o f Cambridge (mean initial thinking time for 5 moves) ! 9758 (7634) 11352(7750) 0.04
Psychomotor Speed / Accuracy Reaction Time Test (five choice movement, milliseconds) 403 (113) : 367(101) 0.02
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CHAPTER 5 -  RESULTS: LONGITUDINAL ANALYSES
5.1 Introduction
In this chapter, I examine longitudinal associations of baseline disease factors (four 
factors: seroGroup, age at MD, disease type [meningitis only, septicaemia only or 
mixed disease], and severity of MD [indicated by the number of days spent in 
intensive care]) with function at follow up. In addition, I investigate change over time 
in social support, stress and health behaviours in cases compared with controls from 
Time 1 (baseline) to Time 2 (follow-up).
5.2 Baseline disease factors
5.2.1 Physical sequelae
Sequelae were assessed on the Annotated Scale of Bodily Injuries Regulation 
(ASBIR), (Commission de la Santé et de la Sécurité du Travail 1987) a quantitative 
estimate of physical injury and disability (in cases), including anatomic and 
physiologic deficits, disfigurement and suffering or loss of enjoyment of life. Here I 
examine the distribution of individual sequelae by disease factors, as well as 
associations between disease factors and ASBIR score (see Chapter 3 -  Methods).
5.2.1.1 Reported sequelae
Type o f MD: Sequelae by type of MD are shown in Table 5.1. Of cases who reported 
physical symptoms (n=58) on the ASBIR, 16 (28%) had meningitis only; 16 (28%) 
septicaemia and 26 (45%) presented with mixed disease. A number of cases had 
multiple sequelae.
SeroGroup: The types of physical symptoms detected in seroGroups B and C are 
indicated in Table 5.2. In cases that reported physical symptoms and where data is 
available on seroGroup (n=46), 24 cases (52%) with seroGroup B had at least one
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complication compared to 22 cases (48%) with seroGroup C. A number of cases had 
multiple sequelae.
Intensive Care Unit (ICU): The types of sequelae detected in cases admitted to ICU 
are shown in Table 5.2. Data were available on ICU admission in 97 cases; 52 (54%) 
were admitted to ICU (median number of nights in ICU, 2 nights; range 1 to 28). 
From the 52 cases who were admitted to ICU, (58%) n=30 had physical sequelae. A 
number of cases had multiple sequelae
Table 5.1 Number and t\ pe of physical symptoms reported on the ASBIR in 
cases by clinical presentation
Physical sym ptom s
Clinical Presentation  (N=58) 
M eningitis Septicaem ia Mixed 
N=16 N=16 Disease N=26
No. of No. of No. of 
sym ptom s sym ptom s sym ptom s 
n o o r te d  rflBorted n s o r te d
T otal num ber 
o f reported  
Omptoms
Sym ptom s consistent with 
R aynaud s disease 6 9 13 28
I
Skin S carring 0 6 12 ; 18
Vertigo 5 3 9 17
j
M obility problem s 4 5 6 13
Speech problem s 5 2 6 13
H earing problem s 5 2 5 12
A m putation(s) 0 1 2 3
Epileptic episodes 1 1 0 2
Im pairm ent in upper limb 
function 0 1 3 4
Total num ber o f symptoms 26 30 54 110
Note: Percentages in relation to the above data are not appropriate given that a 
number of cases had multiple physical sequelae.
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T a b le  5 .2  N u m b er  and ty p e  o f  p h y sica l sy m p to m s rep o rted  on th e  A S B IR  in 
ca ses  by sero G ro u p  an d  IC U  a d m iss io n
Physical Sequelae SeroG roup  B 
N=24
No. of sym ptom s 
r^P#rted
S eroG roup  C 
N=22
No. o f sym ptom s 
rep a rted
ICU adm ission 
(N=30)
No. of sym ptom s 
rcp a rted
Sym ptom s consistent with 
R aynaud’s disease 12 8 15
Skin S carring 6 10 16
V ertigo 7 6 9
M obility problem s 6 5 8
Speech problem s 5 5 6
H earing problem s 8 1 3
A m putation(s) 0 3 3
Epileptic episodes 1 1 1
Im pairm ent in up p er limb 
function 1 3 4
T otal num ber of sym ptom s 46 42 65
N ote: Percentages in relation to the above data are not appropriate g iven  that a 
num ber o f  cases had m ultiple physical sequelae
5.2.1.2 ASBIR score
A ssocia tion s o f  d isease and dem ographic characteristics at baseline w ith physical 
disability  score (A S B IR ) w ere exam ined using linear regression . D isease-related  
factors included M D  seroGroup (C com pared w ith  B ), type o f  M D  (sep ticaem ia  or 
m ixed  septicaem ia /  m eningitis com pared with m eningitis a lone), severity  o f  d isease  
(num ber o f  days spent in Intensive Care U nit (IC U )) and age at M D  and gender.
5 .2 .2  Factors associated w ith physical d isability
A ssocia tion s o f  d isease and dem ographic characteristics at b aselin e w ith  physical 
disability , at fo llo w  up are show n in Table 5 .3. The T able sh o w s scores for physical 
injury by baseline factor, coeffic ien ts, and 95%  C l for the regression  o f  A S B IR  score  
on each o f  the baseline variables. C o effic ien ts are adjusted for age at d isease  and 
gender. S tatistically  sign ificant p -values are in boldface.
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Table 5.3 Associations of disease and demographic characteristics at baseline
with physical disability
Baseline factors Total Physical Injuries score (ASBIR)
Mean (Range) Coefficient P
ASBIR score (95% Cl)
Disease type
Meningitis alone ; 9.4 (1-76) 0
Septicaemia alone '  1 17^4 T Ü 238) ^ 10.2 H 3.873472) r 0.4^'
Mixed disease 1 22 .2 (1-293) 12.4 (-8.8,33.6) 0?2
SeroGroup ! 1
B 18.8 (1-76) 0  ^ “
C ‘  ! 487f(l-29‘3) r 2273 "(2.2742:4) o7oy
G ender Male ! 27.9 (1-293) 0
Female 30.2(1-238) -2.3 (-20.4, 15.7) 0.8
Age at disease N/A -4.2 (-10.3, 1.9) 0.2
Nights spent in intensive care N/A i 0.03 (-1.6, 1.6) 0.9
Greater physical disability w as predicted by seroGroup C compared with B disease. 
The average physical impairment score on the A SB IR  w as higher for seroGroup C 
(48% ) compared to seroGroup B (19% ). Type and severity o f  M D , gender and age at 
disease were not associated with physical sequelae.
W here data is available on seroGroup, for cases admitted to ICU and w ho reported 
physical sequelae (n=30), the average impairment score on the A SB IR  w as 20%  for 
serogroup B (n=10) and 60.4%  for serogroup C (n=17).
For cases w ho were N O T  admitted to ICU but reported physical sequelae (n= 26) and 
where data is available on seroGroup, for seroGroup B (n = I4 ) the average impairment 
score on the A SB IR  w as 18% compared to 6.4%  for seroGroup C (n=5).
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5.2.3 Factors associated with poor mental health
A ssociations o f  disease and dem ographic characteristics at baseline w ith mental 
health (B eck score (B eck 1987) at fo llow -up using linear regression are show n in 
Table 5.4. The Table show s the score for the B eck D epression Inventory (B D I-II) by 
baseline factor, coefficien ts, and 95%  C l for the regression o f  BDI score on each o f  
the baseline variables. C oefficients are show n adjusted for age at disease and gender. 
Statistically significant p-values are in boldface.
T ab le  5 .4  A ssocia tion s o f  d isease  and d em o g ra p h ic  ch a ra cter istics  a t b aselin e  
w ith d ep ressive  sym p tom s
Baseline factors Depressive symptoms
(Beck Depression Inventory score)
Mean BDI score Coefficient P
' (95% Cl)
Disease type
Meningitis alone 7.2 0 1
Septicaemia alone 9.0 ~ 0.81-2.7, 4.3) " : “ 0.7
Mixed disease 8.1 : 0.4 (-2.6, 3.5) 0.8
SeroG roup
B 7.1
C “ 7.3 '  -0 .Ï (0 .1 , 2.8) : 0.9
G ender Male 6.3 0
Female 9.6 3.2 (0.63, 5.9) 0.02
Age at disease N/A  ^ -0.02 (-0.93,0.89) 0.9
Nights spent in intensive care N/A -0.03 (-0.42,0.36) . 0.9
The BDI score was not associated with any disease factors. H ow ever, fem ales w ere  
more likely to have more depressive sym ptom s.
5.2 .4  Factors associated with fatigue
A ssociations o f  disease and dem ographic characteristics at baseline w ith the total 
fatigue score from the Chalder Fatigue Scale (Chalder et al. 1993) at fo llow -u p  using  
linear regression are shown in Table 5.5. The Table show s the total fatigue score for 
the Fatigue Scale by baseline factor, coeffic ien ts, and 95%  C l for the regression o f  the
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total fatigue on each o f  the baseline variables. C oefficien ts are show n adjusted for age 
at disease and gender. Statistically significant p-values are in boldface.
T ab le  5.5 A ssocia tion s o f  d isea se  and d em o g ra p h ic  ch a ra cter istics  at b aselin e  
w ith  total fa tigu e score
Baseline factors
Mean fatigue 
total score
Total Fatigue Score 
(C halder Fatigue Scale)
Coefficient 
(95% Cl)
P
Disease type i  1 1
Meningitis alone 1 3 J ^ 0 :
Septicaemia alone : ny~~ 1 -1.3 (-3.7, 1.2) “ 0.3 '
Mixed disease 0'.2'2 (^2.0, 2.4) ~ 7 ^
.
SeroGroup
B 13.2 0
C 13.1 -0.16 (-2.3, 2.0) Ô/9
G ender Male 13.0 0
Female 14.1 1.2 (-0.72,3.0) 1 0.2
Age at disease N/A 0.09 (-0.56,0.73) 0.8
Nights spent in intensive care N/A -0.10 (-0.34,0.22) 0.7
The total fatigue score w as not associated with any disease factors.
5.2.5 Factors associated with cognitive deficit
A ssociations o f  disease and dem ographic characteristics at baseline with the cogn itive  
summary score (C SS) at fo llow  up using linear regression are show n in Table 5.6.
The Table show s the CSS by baseline factor, coeffic ien ts, and 95%  C l for the 
regression o f  the CSS on each o f  the baseline variables. C oefficients are show n  
adjusted for age at disease and gender. Statistically significant p-values are in 
boldface.
193
Table 5.6 Associations of disease and demographic characteristics at baseline
with cognitive summary score (CSS)
Baseline factors Cognitive Sum m ary Score (CSS)
Mean CSS Coefficient 
(95% Cl) 1
P
Disease type ; !
Meningitis alone -0.6 0
Septicaemia alone -0.5 0.21 (-0.28,0.7) ! 0.4
Mixed disease -0.5 ; 0.18 (-0.25,0.6) I 0.4
SeroGroup : 1
B -0.28 0
C -0.60 , -0.24 (-0.65,0.16) !
i
0.2
G ender Male -0.29 0 I
Female -0.75 -0.36 (-0.72, 0.01) ; 0.06
Age a t disease N/A 0.18 (0.05,0.30) : <0.01
Nights spent in intensive care N/A 0.02 (-0.03, 0.08) 0.4
The CSS was not associated with any disease factors. However, greater cognitive 
deficit was associated with being female and younger age at diagnosis.
5.2.6 Follow-up and Intensive Care
Associations of follow-up after MD with disease severity (ICU admission), physical 
sequelae (ASBIR score), social support, quality of life and mental health functioning 
(Beck 1987) are shown in Table 5.7. The Table shows scores for each outcome, 
coefficients, and 95% Cl for the regression of follow-up post MD on physical 
disability, social support, quality of life and mental health functioning. Statistically 
significant p-values are in boldface.
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Table 5.7 Association of disease severit) (ICU admission), physical sequelae, 
social support, quality of life and mental health functioning with 
follow-up
Outcomes Follow-up
Coefficient P
(95% Cl)
Not admitted to ICU 0
Admitted to ICU 0.24 (0.04, 0.43) 0.02
Physical sequelae (ASBIR score) 0.05 (-0.15,0.25) 0.52
Social support (total) score 0.04 (-.06, 0.13) 0.45
Quality o f  life compared with baseline -0.04 (-0.11,0.03) 0.30
Mental health functioning (Beck score) 0 (-0.02, 0.02) 0.95
Those admitted to ICU were more likely to be followed-up after MD. However, 
follow-up was not associated with physical disability, social support, quality of life or 
mental health functioning.
5.3 Longitudinal differences between cases and controls in life stress and 
social support
This section examines whether cases and controls changed differently in life stress 
and social support from Time 1 (baseline) to Time 2 (follow-up).
5.3.1 Differences in Social Support
Associations of status, gender and age at follow-up with social support scores at 
follow-up adjusting for social support scores at baseline are shown in Table 5.8. The 
Table shows coefficients and 95% (Cl) for the regression of social support scores 
(Network, Satisfaction and Total score) from the SSQ6 at follow-up on status, gender 
and age at follow-up, adjusting for baseline scores. Analyses were conducted using 
linear regression. Statistically significant p-values are in boldface.
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Table 5.8 Associations of status, gender, age at follow-up with social support scores at follow-up
Coefficients adjusted for social support scores at baseline
Association with P Association with P Association with P
Satisfaction with value Social Network value Total Support value
quality of support Score Coefficient
Coefficient Coefficient (95%  Cl)
(95%  Ci)
.............. .............
(95%  Cl)
Status Status Status
Controls 0 Controls 0 Controls 0
Cases -0.19 (-0.42,0.04) 0.1 Cases -0.27 (-0.61, 0.07) 0.1 Cases -0.20 (-0.44, 0.04) 0.1
Age at follow up -0.02 (-0.10,0.06) 0.6 Age a t follow up -0.02 (-0.13,0.10) 0.8 Age at follow up -0.01 (-0.10,0.07) 0.7
G ender G ender G ender
Male 0 Male 0 Male 0
Female 0.27(0.03,0.50) 0.03 Female 0.07 (-0.28,0.41) 0.7 Female 0.14 (-0.11,0.38) 0.3
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Social support scores for cases fell between baseline and follow-up after adjusting for 
baseline social support scores, but this failed to reach significance. Females were 
more likely to have higher satisfaction at follow-up regardless of MD.
5.3.2 Differences in life stress
Associations of status, gender and age at follow-up with stress and distress scores 
from the A-FILE at follow up adjusting for stress and distress scores at baseline are 
shown in Table 5.9. The Table shows coefficients and 95% Cl-for the regression of 
stress and distress scores at follow up on status, gender and age at follow-up, 
adjusting for baseline scores. Analyses were conducted using linear regression.
Table 5.9 Associations of status, gender, age at follow up with stress 
and distress scores at follow up
Coefficients are adjusted for stress scores and distress scores at 
baseline
Association with 
Stress 
Coefficient 
(95%  C l)
P
value
Association with 
Distress 
Coefficient 
(95%  C l)
P
value
Status
Controls
Cases
0
-0.82 (-1.9, 0.3) 0.1
Status
Controls
Cases
0
-4.1 (-10.9,2.8) 0.2
Age a t follow 
up
-0.20 (-0.6, 0.2) 0.3 Age a t follow 
up
-0.70 (-3.1, 1.7) 0.5
G ender
Male
Female
0
-0.72 (-1.9, 0.4) 0.2
G ender
Male
Female
0
1.8 (-5.3, 8.9) 0.6
Stress and distress scores for cases fell between baseline and follow-up after adjusting 
for stress and distress at baseline, but failed to reach significance. Age and gender 
were not associated.
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5.3.3 Differences in social and health behaviours
This section examines whether cases and controls changed differently in attendance of 
social and sporting activities, health risk behaviours and living arrangements from 
Time 1 (baseline) to Time 2 (follow-up).
5.3.3.1 Differences in attendance o f social and sporting activities, health risk
behaviours and living arrangements
Associations of status, gender and age at follow-up with attendance of social and 
sporting activities, health risk behaviours, and living arrangements at follow-up 
adjusting for social and sporting activities, health risk behaviours, and living 
arrangements at baseline are shown in Tables 5.10 to 5.12.
The Tables show coefficients and 95% Cl for the regression of attendance at social 
activities (Table 5.10) and health risk behaviours and attendance of sporting activities 
(Table 5.11), and living arrangements (Table 5.12) at follow-up on status, gender and 
age at follow-up, adjusting for baseline scores. Analyses were conducted using linear 
regression. Statistically significant p-values are in boldface.
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Table 5.10 Associations of status, gender, age at follow up with attendance o f social activities at follow up, coefficients adjusted for
social activities at baseline
Association P Association P Association P Association P Association P
w ith value with value with value with value with value
Pub Nightclub Youth club Group Religious
. Attendance Attendance Attendance Activities Attendanee
Coefficient Coefficient Coefficient C’oefficient Coefficient
(95% Cl) (95% Cl) (95% Cl) (95% Cl) (95% Cl)
Status Status Status Status Status
Controls 0 Controls 0 Controls 0 Controls 0 Controls 0
Cases 0.02 0.6 Cases -0.14 0.03 Cases -0.04 0.03 Cases -0.05 0.5 Cases -0.02 0.6
(-0.07, 0.11) (-0.27, -0.02) (-0.08, -0.00) (-0.17, 0.08) (-0.10, 0.05)
Age at 0.00 Age at 0.01 Age at -0.01 Age at -0.04 Age at 0.01
follow (-0.03, 0.03) 0.8 follow (-0.04, 0.05) 0.8 follow (-0.03, -0.00) 0.03 follow (-0.10,0.00) 0.06 follow (-0.01,0.04) 0.3
up up up up up
Gender Gender Gender Gender Gender
Male 0 Male 0 Male 0 Male 0 Male 0
Female 0.02 0.6 Female -0.11 0.11 Female -0.01 0.5 Female 0.06 0.4 Female 0.04 0.3
(-0.10, 0.11) (-0.24, 0.02) (-0.05, 0.03) (-0.07, 0.20) (-0.03, 0.11)
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Tabic 5.11 Associations of status, gender, age at follow up with sporting activities and health risk behaviours at follow up, coefficients
adjusted for sport attendance and health risk behaviours at baseline
•
Association 
with 
Sport 
A ttendance 
Coefficient 
(95%  C l)
P
value
Association 
with 
Smoking 
Status 
C'oefficient 
(95%  C l)
P
value
Association 
with 
Regular use of 
recreational 
drugs 
('ocfficient
(95%  C l)
P
value
1
Association with 
Drinking Alcohol 
Coefficient
! (95%  C l)
P
value
Status
Controls
Cases
0
0.04
(-0.10,0.17)
0.6
Status
Controls
Cases
0
-0.00
(-0.10,0.10)
0.1
Status
Controls
Cases
0
-0.08
(-0.17,0.01)
0.09
Status
Controls
Cases
0
-0.03
(-0.13,0.10)
0.5
Age at 
follow up
-0.02 
(-0.06, 0.03) 0.4
Age at 
follow up
-0.02
(-0.06,0.01) 0.2
Age at 
follow up
-0.00 
(-0.03, 0.03) 0.9
Age at 
follow up
0.02 
(-0.02, 0.05) 0.4
G ender
Male
Female
0
-0.24
(-0.38,-0.11)
<0.0001
G ender
Male
Female
0
-0.05
(-0.15,0.05)
0.4
G ender
Male
Female
0
-0.13 
(-0.23, -0.04)
0.01
G ender
Male
Female
0
-0.01
(-0.11,0.10)
0.9
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Table 5.12 Associations o f status, gender, and age at follow up with living arrangements at follow up, coefficients adjusted for living
arrangements at baseline
»
Association with 
Living with Family 
Coefficient
(95%  Cl)
P
value
Association with 
Living by self o r w ith 
a p a rtn e r  
Coefficient 
(95%  C l)
P
value
Association with 
Living with friend(s) 
Coefficient 
(95%  C l)
P
value
Status
Controls
Cases
0
0.10
(-0.10,0.15)
0.3
Status
Controls
Cases
0
-0.00
(-0.10,0.10)
0.9
Status
Controls
Cases
0
-0.05
(-0.14,0.05)
0.3
Age a t follow up -0.10 
(-0.12, -0.05) <0.001
Age at follow up 0.04 
(0.03, 0.06) 0.001
Age at follow up 0.04
(0.01,0.10) 0.01
G ender
Male
Female
0
-0.01
(-0.12,0.10)
0.8
G ender
Male
Female
0
0.01
(-0.10,0.10)
0.8
G ender
Male
Female
0
-0.00
(-0.10,0.10)
0.9
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Social activities
Cases were significantly less likely to attend a nightclub or a youth club in the two 
weeks prior to interview at follow-up compared to controls, after adjusting for 
baseline attendance.
Age at follow-up predicted less attendance at youth clubs and group activities, after 
adjusting for baseline attendance, regardless of MD. Gender was not associated with 
social activities.
Health Risk Behaviours and Sporting Activities
Females were less likely to attend sporting activities or use recreational drugs on a 
regular basis at follow-up, when adjusting for baseline factors, regardless of MD. 
Cases at follow up were less likely to be regular users of recreational drugs, although 
this failed to reach significance (P=0.08). Age at follow-up was not associated with 
sporting activities and health risk behaviours when adjusting for baseline factors.
Living arrangements
Younger age at follow-up was associated with living at home with family and older 
age was associated with living alone or with a partner or friends, after adjusting for 
baseline factors, regardless of MD. Status and gender were not associated with living 
arrangements at follow-up, when adjusting for baseline factors.
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5.4 Chapter summary
Greater physical disability was predicted by seroGroup C. Disease factors were not 
associated with fatigue and mental health functioning, although females were likely to 
have more depressive symptoms. The cognitive summary score was not associated 
with disease factors however, greater cognitive deficit was associated with being 
female and younger age at MD. Those admitted to ICU were more likely to be 
followed up after MD. Follow-up was not associated with physical disability, social 
support, QOL, or mental health functioning.
In assessing longitudinal differences between cases and controls from baseline to 
follow-up, it was found that social support scores and stress and distress scores fell 
between baseline and follow-up for cases, but they failed to reach significance, with 
females more satisfied with social support at follow up regardless of MD. In terms of 
longitudinal differences in social and health behaviours between cases and controls, 
the analyses revealed that cases were less likely to attend nightclubs or youth clubs, 2 
weeks prior to follow up interview, and less likely to be regular users of recreational 
drugs, although this failed to reach significance. No further differences were found 
between the two groups.
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SECTION D
CHAPTER 6 -  DISCUSSION
6.1 Introduction
This is the first study to evaluate a comprehensive range of outcomes of MD in 
adolescents aged 15 to 19 years. Data were obtained from a population-based matched 
cohort. Survivors were followed prospectively 18 to 36 months after disease and 
compared with highly matched controls. As well as outcomes, demographic and 
disease factors associated with outcome were investigated. This study addressed an 
important and previously under explored area in medical research. The research 
conducted to date has shown that MD leaves a proportion of survivors with some 
degree of physical sequelae. However, studies vary widely in their methodological 
quality and the populations studied making it difficult to compare results.
Data revealed that adolescent survivors of MD have persisting physical, social, 
cognitive and psychological sequelae. Survivors were found to have greater 
depression, fatigue, less social support, poorer educational outcomes and reduced 
quality of life post MD, compared with well-matched controls. These problems are in 
addition to deficits in short and long-term memory and attention as well as slowed 
psychomotor speed. Those with seroGroup C disease had greater disease severity and 
physical disability. Key findings are shown in Table 6.1.
The adolescent years are marked by many psychosocial changes. When these changes 
are complicated by illness, the results can be highly problematic for many young 
people who survive MD. However, despite marked deficits, only half the sample had 
been followed-up medically post MD by any health professionals including the 
participants’ GP. It is crucial that sequelae of MD are investigated in this age group, 
as these data show that the burden of continuing morbidity from MD in adolescence 
remains high. Careful follow-up of young people post MD is necessary to detect any 
problems they might be having and to facilitate their early resolution.
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This section critically evaluates the methods used in the study and examines its 
findings in the light of published literature.
Table 6.1 Key findings of outcomes in MD survivors
Outcome Findings Level of 
Significance
CrossRef 
to 
sub­
sections in 
Discussion
Survivors com pared to controls
Social
Support
• Fewer people in social support network
• Lower satisfaction with available support
***
***
6.3.1
M ental
health
• A trend for cases to have poorer Mental Health 6.3.2
Quality of 
life (QOL)
• Poorer QOL at follow-up compared to before MD
• Poorer QOL compared to peers
*
**
6.3.3
Physical • Poorer General Health Perception
• Greater total mental and physical fatigue
• Higher mental fatigue
** 
* * * 
***
6.3.4
Education • Fewer GCSEs achieved
• Failed more exams in year prior to interview
***
***
6.3.5
Cognitive Deficits found in:
• Short-term verbal memory
• Long-term visual memory
• Sustained attention
• Selective attention
• Psychomotor speed
*** 
** 
* * * 
*** 
***
6.3.6
In survivors separately
• Poorer mental health functioning is associated with 
greater physical disability ***
6.3.2
• Greater physical disability is associated with higher 
social support
*** 6.3.4
• Cognitive deficit is associated with poorer educational 
achievement **
6.3.6
• Lower premorbid intellectual ability predicted fewer 
exam passes at GCSE
• Lower premorbid intellectual ability predicted fewer 
exam passes at A level
• Lower premorbid intellectual ability predicted greater 
cognitive deficit post-MD
***
*
*
6.3.6
• Poorer mental health functioning is associated with 
lower social support **
6.3.1
• Greater physical disability is associated with 
seroGroup C ***
6.3.4
• Female survivors are more likely to have depressive 
symptoms ***
6.3.2
• Cognitive deficit is associated with younger age at 
diagnosis **
6.3.6
• Survivors admitted to ICU are more likely to be 
followed-up ***
6.3.7
• MD increases the risk o f  depression *** 6.3.2
<0.0001, **<0.01, <0.05
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6.2 Methodological issues
Data were analysed from a matched group of survivors and controls initially recruited 
for a population-based case-control study investigating the risk and protective factors 
of MD. Case-control studies have been utilised extensively in epidemiologic 
investigations of disease aetiology and outcome with “informativeness” as their major 
strength (Breslow and Day 1983). When the aetiology of a disease is largely 
unknown, the case-control design can be extremely useful in providing information on 
a large number of risk factors for a disease. Whilst subjects were recruited and then 
followed up prospectively, it is acknowledged that case-control studies are susceptible 
to bias (Kelsey 1996) affecting the validity and generalisability of the findings (Sica 
2006).
6.2.1 Causality
Many authors have discussed causality in epidemiology (Bradford-Hill 
1965;Miettinen 1985;Rothman 1986;Schlesselman 1987) and all agree that 100% 
evidence for causality is impossible. The classic scientific technique often seen as the 
gold standard for establishing causality is the randomised controlled experiment 
(Harris et al 2004).
However, epidemiology relies mostly on observational studies, such as the current 
study, where the group assignment is neither manipulated nor randomised and used 
primarily to uncover patterns and formulate hypotheses regarding the cause and effect 
of relationships (Greene 2000). One of the most difficult tasks in epidemiologic 
research is to assess whether associations between exposure and disease derived from 
observational epidemiological studies are of a causal nature or not (Rothman 1986).
To draw sound inferences in observational studies requires identification of potential 
sources of bias and confounding. Many of the limitations in forming causal inferences 
from observational studies are due to three sources: uncontrolled confounding factors, 
selection bias and reverse causality (Greene 2000).
Confounding factors may either lead to spurious associations, where no causal 
relationship exists, or they may obscure a true causal relationship by producing an
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association in the opposite direction. Statisticians have stated that regardless of how 
immaculate the study design is and how perfect the measurements are, it is virtually 
impossible to control completely for all confounders in observational data (Heman 
2006).
However, confounding variables can be adjusted for in statistical analysis. Such 
adjustments require careful consideration because in observational research, not all 
confounders are known by the researcher. Nevertheless, adjusting for confounders is a 
standard approach used in establishing causal effects in observational studies. In the 
current study, all regression analyses were adjusted for age and gender, as these have 
been strongly associated with many of the outcomes under study.
A number of epidemiologists have proposed guidelines for establishing inference of a 
causal relationship (Bradford-Hill 1965;Rothman 1986). The traditional approach and 
one that is commonly used is given by the British statistician Sir Austin Bradford Hill 
(Bradford-Hill 1965). Bradford-Hill suggested that a causal relationship might be 
inferred based on observational data through a number of criteria (see Table 6.2). He 
noted, '‘‘All scientific work is incomplete — whether it be observational or 
experimental. All scientific work is liable to be upset or modified by advancing 
knowledge” (Bradford-Hill 1965).
Table 6.2 Explanation of the Bradford Hill criteria for inferring causation 
when association is observed
* Source: (Holt and Peveler 2006)
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One of Bradford-Hill’s guidelines is consistency o f association. This means that the 
greater the number of studies that observe a similar relation, preferably in different 
populations and perhaps with different study designs until all but the suspected cause 
can be ruled out, the more likely the association is causal. Based on this guideline 
alone causal inference cannot be drawn from the data collected cross-sectionally in 
the current study (self-report questionnaires as well as neuropsychological data). This 
does not allow determinations to be made about the directionality of relationships 
between variables as they are all measured at the same point in time, thereby limiting 
any conclusions that can only be tentatively accepted. Therefore, causal factors of 
group differences and their effects cannot be ascertained as conclusions cannot be 
drawn from a single study (Cox and Wermuth 2001).
In contrast, the longitudinal data collected in the current study at baseline and again at 
follow-up minimised some of the limitations of the cross-sectional data. It is generally 
accepted that longitudinal designs significantly enhance the interpretation of causality, 
and, specifically guard against the problems of reverse causation (Kessler 
1987;Spector 1994). The longitudinal findings allowed for the assessment of the 
contribution of change and stability to be quantified between survivors and controls, 
establishing more clearly the temporal nature of the association, hence providing a 
much stronger basis upon which to infer causality. However, the observational nature 
of the study precludes definitive causal inferences.
In any investigation-assessing outcome, it is essential to reduce the effects of bias. 
Below, the potential sources of bias in this study are discussed together with the steps 
undertaken in the study to minimise their effect.
6.2.2 Potential sources of bias
Several potential sources of bias in this study fall into two main categories: selection 
bias and information bias. Particularly important is bias in subject selection 
(Schlesselman 1982) which is considered below.
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6.2.2.1 Selection bias
Selection of controls is one of the most difficult and most heavily criticised aspects of 
case-control studies. Indeed, it has been suggested that the ideal control probably does 
not exist (Wacholder et al. 1992b). However, a crucial requirement is that the controls 
be comparable to the source population of the survivors (Olson et al. 2002;Wacholder 
et al. 1992a) as the most appropriate study sample is one that most closely reflects the 
characteristics of the population of interest (Sica 2006).
6.2.2.2 Sample bias
Prospective designs have been shown to minimise selection bias (Sica 2006). In this 
study, care was taken to minimise selection bias. MD survivors and controls were 
drawn from the baseline study prospectively recruited randomly from the general 
population from six regions of England.
Controls at baseline were recruited through the same general practice as the case, 
selected to serve as the normal population. Controls were individually drawn to 
optimally match each case based on several potentially confounding variables, sex, 
age and small geographical area of residence. The widely accepted strategy in the 
scientific community is to choose the most appropriate control group within the study 
context (Wacholder er a/. 1992a).
A systemic disease such as MD is likely to have wide-ranging complications that will 
overlap with any number of conditions. Therefore, the choice of healthy controls was 
made in this study for comparative purposes in order to undertake a comprehensive 
evaluation of MD outcomes in survivors. As age, gender and socioeconomic status 
affect many of the outcomes under study, it was appropriate to match controls for 
these factors.
A valid set of controls was included in this study to test the hypothesis that survivors 
of MD in adolescence have poorer outcomes than in healthy age and sex-matched 
controls. However, in order to assess whether the outcomes reported in the current 
study are specific to adolescent MD survivors and not just the result of a life- 
threatening illness would require a different set of controls. For example, young 
people exposed to some form of extreme traumatic stressor such as admission to ICU
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with an acute life-threatening event following injury, infection or cancer would enable 
comparisons of Post Traumatic Stress symptoms. Such symptoms have been found in 
adolescents and children undergoing cancer treatment (Nir 1985) and in children who 
have been exposed to other life threatening situations (Sturms et al. 2005). Other 
studies have reported similar findings in children and adolescents after unexpected 
and life-threatening incidents compared to chronic diseases such as diabetes (Bronner 
et at. 2008;Landolt et al. 2003;Murray et al. 2008;Yule et al. 2000). Indeed, to 
identify whether the outcomes reported in the current study are specific to MD 
survivors only, further studies could be undertaken in the future using specific control 
groups who would have experienced other life-threatening events.
Baseline study: With regard to case selection at baseline, it is acknowledged that the 
exclusion of a small number of survivors that died (16 survivors of 91 not recruited 
plus some of the 9 survivors recruited but not interviewed) biased the baseline study 
sample towards less severe survivors, although this was unavoidable. This was not an 
issue for the follow-up study of outcomes necessarily excluding death. Moreover, 
although at baseline 63% of recruited controls either were the first or second 
approached, 20% were the fourth or greater approached. This is a source of selection 
bias, as these secondary controls may well be different from those not willing to 
participate.
Follow-up study: From the 144 case-control pairs recruited at baseline (Tully et al. 
2006) the first 115 pairs on the recruitment list were approached for follow-up in 
order to minimise selection bias and to correct for attrition. Four new controls were 
also recruited at follow-up to replace original controls that either refused participation 
at follow-up or could not take part for reasons outlined in Chapter 3 -  Methods of this 
thesis. The four new controls were recruited through the general practitioner of the 
case and matched for age, gender, and place of residence. No differences were found 
in the four new controls compared to the original controls in terms of gender, 
ethnicity, age, occupation and socio-economic status, although the number is very 
small.
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The follow-up sample did not differ from the baseline sample in terms of age, 
occupation, ethnicity, employment status, seroGroups, and type of MD. Also, both 
male and females were approximately equally represented (baseline, 51% male, 
follow-up, 46% male).
6.2.23 Loss to follow-up bias
Loss to follow-up in longitudinal studies is potentially a major threat to validity. This 
is mainly because if participants have moved or refuse to participate at follow-up, 
selective attrition may be a factor. This results in the research findings being 
compromised, threatening both the internal and external validity of the research (Flick 
1988;MacMahon and Pugh 1970). Loss to follow-up rates of 30 to 40 percent can 
raise serious doubts about the validity of the study results in cohort studies 
(Hennekens and Buring 1987). In this study, the loss to follow-up rate was low with 
less than 10% of the total approached, refusing or unable to participate for reasons 
outlined in Section C -  Results thereby, limiting the room for bias. At baseline, 
attrition was also low with only 4.5% of eligible case patients refusing participation 
(Tully et al. 2006).
To establish whether selective attrition may have been a source of bias in survivors 
and controls, lost to follow-up comparisons were made with those who were recruited 
at follow-up. No differences were found between survivors and controls recruited and 
not recruited in terms of gender, ethnicity, age and occupation. However, survivors 
who were approached but not recruited were slightly proportionally more likely to 
come from a lower social class (less home and car ownership) than survivors not 
recruited. This reflects the commonly seen tendency for those of lower socio­
economic status to be more difficult to follow-up in research. This may have biased 
the study towards an under-estimate of the psychosocial sequelae of MD, (e.g. 
depression, low social support and stress), although it is unlikely to have affected 
longitudinal findings.
6.2.2.4 Observation (Information) bias
Observation or information bias results from differences in the methods in which 
information is collected from study subjects and may represent a threat to the validity
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of a study (Szklo and Nieto 2000). Recall bias is a classic form of information bias 
(Grimes and Schulz 2002a).
Recall bias
Recall bias was minimised by gathering information using validated and reliable self- 
report questionnaires for mental and physical health, social support, stress, and fatigue 
and by applying standardised neuropsychological tests. The concept of measuring 
adolescent health through standardised self-report is well established (Starfield 1995). 
Young people were also asked about health risk behaviours, educational achievement 
and quality of life. Recall for these was minimised by using time-lines, (a short recall 
period of 2 weeks prior to interview regarding health risk behaviours), and memory 
aides such as calendars and personal diaries.
Nevertheless, it could be argued that survivors may have had a different attitude to the 
questionnaires than controls because of their previous illness and therefore it is 
acknowledged that measuring health on a range of self-report items is open to recall 
bias. However, firstly, this is unavoidable; secondly, validated instruments were used; 
and thirdly, differences based upon perceptions are actually key outcomes (e.g. 
depression, QOL, and social support).
There is always a risk that respondents do not correctly remember things that were 
asked for in a questionnaire. However, the main interest was in adolescents' 
experiences of MD during the past twelve months and daily functioning during the 
past two to four weeks. Moreover, at interview young people were encouraged to 
take their time to reflect before answering questions, and to think through the 
sequence of events that they were being asked about. Such techniques have been 
shown to reduce recall bias in surveys (Auriat 1993;Bradbum et al. 1987).
A further limitation is the use of proxies for disease severity (admission to ICU and 
number of days admitted to ICU) rather than a validated ICU score. Thus, the control 
for severity may have been suboptimal.
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Interviewer bias
Blind assessment is the best way to ensure comparability of information in survivors 
and controls (Hennekens and Buring 1987). However, blinding was not possible in 
this study for two reasons. Firstly, given that some survivors had visible signs of 
disease (e.g. scarring or amputations), and as certain instruments were only completed 
by survivors, it was not possible to be blinded to case-control status of the subject. 
Secondly, as the researcher who managed the study on a day-to-day basis and the only 
researcher collecting data, I was aware of the main hypotheses under study. 
Accordingly, for practical reasons it was not possible to be blinded to the status of the 
subjects interviewed.
If blinding is not feasible it is recommended that standardised, uniform data collection 
procedures are used in all subjects (Kopec and Esdaile 1990). In this study, test 
instruments were standardised and validated where possible and standard data 
collection procedures were followed for all participants as recommended (Grimes and 
Schulz 2002a), resulting in minimal interviewer bias and greater reliability of the 
findings.
6.2.2.5 Generalisability
Generalisability, also called external validity or applicability is defined as the extent 
to which the findings obtained on a specific sample can be applied to the target 
population (Rothman and Greenland 1998).
The generalisability of the findings in the current study is strengthened by three 
principal factors. Firstly, validated measures were used and standardised data 
collection procedures were implemented. Secondly, recruitment of survivors and 
controls was population-based. Controls were selected from the general population 
and although the selection was not a random sample of the population that gave rise to 
the survivors, they were individually matched for age, gender and area of residence. 
The control subjects should be selected to be comparable to the survivors, and as a 
result will represent not the population of all non-diseased persons but the population 
of non-disease persons who would have been included as survivors had they
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developed the disease (Hennekens and Buring 1987). It has been shown that 
population-based recruitment increases the generalisability or external validity of the 
findings of a study (Szklo 1998).
Thirdly, the success of longitudinal studies depends entirely on the sustained 
cooperation of its participants and generalisability to the target population depends on 
the study's participation rate for example, the percentage of sampled people who are 
willing to participate in the study (Van Ommeren 2003). In the current study 
participation was high, with less than 10 % of the total approached not participating.
A minor limitation is that the most disadvantaged groups may be under-represented in 
this sample. However, low participation rates amongst poorer groups are common in 
epidemiological research (Smith et al. 2004).
The above demonstrates that the findings of the current study are highly generalisable 
to adolescents at least within the United Kingdom, and may be generalisable to other 
comparable industrialised countries.
6.2.2.6 Statistical significance and clinical relevance
This is the first detailed investigation of outcomes of MD in adolescence and it was 
hypothesised that there may be many areas in which deficits may be found. This 
resulted in administering a large number of measures, which was unavoidable in order 
to ascertain all potential outcomes. The comparison of cases with controls was 
therefore, based on multiple statistical tests thus inflating the risk of Type I error. Due 
to the descriptive and exploratory nature of the study the post hoc Bonferroni 
correction test (Bonferroni 1935) for multiple comparisons was not applied. It was felt 
that the application of the Bonferroni correction would inflate the probability of a 
Type II error. Therefore, significance levels are presented without correction with the 
conventional alpha level of .05 maintained for comparative purposes.
Power analysis was carried out a priori during the design stage of the study. Although 
there was sufficient power to examine the three hypotheses (as noted in the Methods 
Section), it was relatively underpowered overall due to the difficulty of recruiting 
sufficient survivors in a comparatively rare disease. Other outcome studies of MD
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have also not corrected for multiple tests, possibly due to the same reason (Fellick et 
al. 2001;Moss 1982;Naess e/a/. 1994).
Bias due to multiple comparisons may have resulted in an overestimation of the 
significance of the results found and that some differences might reflect chance 
observations. The inferences that can be made based on the data are therefore limited 
by this lack of statistical power.
Accordingly, the approach adopted in this study was not to use a Bonferroni or other 
correction, as there are a number of issues that may be used to examine whether 
identified relationships are ‘real’ or not, of which significance is only one. For 
example, by examining whether the associations identified were biologically or 
psychologically plausible, whether there was a consistent pattern of deficits and 
whether the findings were consistent with clinical experience, patient perspective and 
previous publications can all be considered.
Some authors argue that the focus should not be on small P-values alone to make 
decisions about whether a study is useful and that clinical relevance is also essential 
(Javitt 1989;Sheps 1993). By focusing on the P-value exclusively can mistakenly 
classify clinically important effects as non-significant (Sterne and Davey 2001), and 
clinically important differences can be ignored. Alternatively, a significant P-value, 
in and of itself, may or may not be evidence of a clinically meaningful result.
The idea of significance testing was initially introduced by R A Fisher who argued 
that the P-value was an index measuring the strength of evidence against the null 
hypothesis. However, he also wrote that this fixed level of significance was “absurdly 
academic” and that it should be flexible based on the evidence and that interpretation 
of the P-value was ultimately for the researcher (Fisher 1950).
By reducing the level of significance associated with each test, one can reduce the 
power of the test, thereby increasing the chance of incorrectly keeping the null 
hypothesis or increasing chance of a Type II error (Kramer 1988). Real differences 
can be missed by merely focusing on the P-values. Statistically non-significant results 
can sometimes be highly significant clinically.
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Bonferroni correction concerns an issue about which there is much ongoing debate in 
the biostatisticai and epidemiologic literature and not wholly accepted for a number of 
reasons (Pemeger 1998). The main argument centres around concerns when (if ever) 
adjustment for multiple testing is warranted (Aiken and Gensler 1996). Some authors 
have pointed out that this method of controlling Type I error comes at a cost. It leads 
to less sensitive comparisons and is perhaps too conservative, when the number of 
comparisons grows large and true associations are masked (Aiken and Gensler 
1996;Jaccard and Wan 1996).
Pemeger (1998) in the British Medical Journal makes the important point that there 
is an important difference between what the data say and what the researcher believes 
to be true \ The latter depends not only on statistical significance but also on 
biological significance (Pemeger 1998). Indeed the ""absence o f evidence is not 
evidence o f absence” (Altman and Bland 1995).
In an explorative approach as undertaken by this study, the risk of inference errors 
should be balanced against the possibility that more accentuated group differences 
would have appeared had the study group been larger. The findings of the current 
study are clinically relevant. In general, knowledge about complications of MD in 
adolescence could be useful in clinical practice because it enables health care 
providers to support young people and develop coordinated services to ultimately 
improve young people’s quality of life post MD.
Strengths
In addition to the measures taken to minimise bias, discussed previously, the strengths 
of the study include its prospective design, population-based recmitment of highly 
matched case-control pairs, the narrow age range of participants, data collected by one 
researcher and the use of a comprehensive protocol using standardised and validated 
measurements for assessing outcomes. An additional strength of this study includes 
the large numbers of survivors affected by different seroGroups with varying levels of 
disease severity and type.
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6.3 Sequelae of MD
Few published data are available on outcomes of MD in adolescents other than 
physical disability. The majority of studies have examined outcomes of bacterial 
meningitis of all causes, on a very wide age-range, or in much younger children 
(Baraffe^a/. 1993).
6.3.1 Social outcomes
Self-report measures used to collect information on social functioning in participants 
included the Social Support Questionnaire (SSQ6) (Sarason et al. 1987) and elements 
of a questionnaire developed for the baseline study (previously modified from the 
West Country Meningitis Study [Stanwell-Smith, personal communication]) to assess 
social functioning and health risk behaviours. For the latter measure, a short recall 
period of 2 weeks was used as it was deemed more likely that adolescents would 
remember habitual behaviours and events within such a short time span. One 
limitation of self-report measures is bias. For example, social desirability bias refers 
to the tendency to answer self-report items in such a way as to deliberately or 
unconsciously represent oneself in a favourable light (Edwards 1953). Further, 
survivors may have had a different attitude to the questionnaires than controls because 
of their previous illness.
6.3.1.1 Social support
Findings: MD survivors at follow-up identified significantly fewer people within their 
social network on whom they could rely for support than controls. Survivors were 
also less satisfied with the quality of support available to them. When stratifying by 
gender, this was observed more specifically in male survivors rather than female 
survivors.
In terms of longitudinal change in social support network and satisfaction scores 
between baseline and follow-up, scores fell for survivors compared to controls but this 
failed to reach significance. Females were more likely to have higher satisfaction with 
support scores at follow-up than males regardless of MD.
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Further exploration of social support in survivors found that poorer mental health 
functioning was associated with lower social support. One somewhat surprising 
finding was that young people with physical sequelae had higher social support 
scores.
Comparisons with the literature: This is the first controlled study to have assessed 
levels of social support after MD in adolescence and it is thus difficult to make 
comparisons. Social support is a widely used concept in the field of mental health, as 
well as in medicine and the social sciences (Sarason et a l 1990). It is a 
multidimensional construct and has been shown to have two basic elements: (a) the 
perception that there is a sufficient number of others to whom one can turn in times of 
need; and (b) a degree of satisfaction with the available support (Sarason et al. 1983).
Social support has been shown to be an important component in the recovery process 
after illness such as cancer, which can be influenced significantly by a person’s access 
to supportive others (Henderson er a/. 1981;Nuckolls e/a/. 1972;Sosa a/. 1980). 
Smaller social support networks are associated with poorer health outcomes after 
illness (Berkman 1995;Cohen 1992).
Social support systems may act indirectly on physical health by easing emotional or 
physical symptoms of illness (Wills and Cleary 1996), providing a sense of well­
being, serving as a source of information and acting as a form of coping (Thoits,
1986), and enhancing self-esteem (Bowling, 1991; Weber, 1998). People comprising 
a social support network can help provide solutions to problems, provide comfort and 
the opportunity to listen and validate one’s feelings (Cauce et al 1996).
Support for' the argument that social support protects against illness comes from 
epidemiological studies, however, these studies have rarely considered satisfaction 
with social support. Therefore asking adolescent MD survivors how satisfied they are 
with available support in the current study provides new important data.
Academic achievement in adolescents has been shown to be affected negatively with 
low social support (Barone et a l 1998;Gamefski and Diekstra 1996;Richman et al 
1998). In this the current study, survivors achieved fewer GCSEs and A Levels than
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controls and poorer social support was associated with poorer educational 
achievement.
Low rates of social support are related to increased levels of depressive symptoms and 
anxiety in adolescence (Barrera and Garrison-Jones 1992;Demeray and Malecki 
2002;Kaltiala-Heino et al. 2001;Mazza and Reynolds 1998;Paykel 1994). In the 
current study, it was found that survivors have a higher risk of depression and poor 
mental health function.
Low social support has been associated with difficulty in focusing attention on a 
particular task, and specifically on demanding tasks as well as increased levels of 
cognitive interference (Sarason et al. 1983). In the current study, while deficits in 
selective and sustained attention were found in MD adolescent survivors, social 
support was not associated with cognitive function.
The findings in this study are comparable with other published findings with regard to 
gender differences in social support (Geckova et al. 2003;Mazza and Reynolds 
1998;Piko 1998;Vaux 1985). Females tend to report larger social networks than males 
and have been shown to be more able than males in seeking others for emotional 
support in stressful circumstances (Ashton and Fuehrer 1993;Seiffge-Krenke 
1995;Taylor et al. 2000). This may be due to the fact that females normally have 
higher rates of self-disclosure with regards to feelings and problems than males and 
place greater emphasis on mutual support (Bemdt 1982). Differences may also be 
explained by tendencies of females having better skills at identifying and/or engaging 
supportive persons, and having the ability to benefit from support (Vaux 1985).
There are a number of possible explanations for the lower social support reported by 
MD survivors. One explanation could be that an illness such as MD limits social 
activity after discharge due to physical complications and that low social support is a 
consequence of poor health status, possibly not having enough energy to socialise 
with friends or perform normal activities. The current study found that survivors were 
significantly more fatigued than controls. A second explanation is that they may also 
experience a swell of parental and peer support in hospital but upon discharge, peers 
may avoid them, as they may not know how to react if physical sequelae are severe.
A third explanation is that survivors could also push away their social support system.
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as they may cease to be interested in social activities and in maintaining friends, and 
may not have yet begun to come to terms with their own mortality.
Implications o f the findings: The findings of poorer social support in adolescent MD 
survivors have a number of implications for further research, particularly developing 
strategies to identify factors that facilitate or hamper support post MD.
Social network analysis would be helpful in order to focus on a number of 
characteristics of the network, including not only size as in this study, but also 
composition and types of relationships as well as the perceived value or helpfulness of 
the support provided. Such analysis would determine the effectiveness of available 
support (Bowling, 1991). Research into these processes may assist in being able to 
clarify when and how to provide support for young people post MD. Young people 
value opportunities to express their feelings about their experience in a safe 
environment that encourages openness in communication and support, which can in 
turn serve to strengthen the young person and build resilience in dealing with the 
ensuing months after discharge from hospital (Greenberg 2006).
It is well known that young people are naturally resilient and able to cope with 
extremely difficult circumstances. This is supported by a recent qualitative study, 
which explored the psychosocial adjustment of the impact of meningococcal 
septicaemia in 11 survivors (aged 10-20 years at MD) who had MD up to five years 
previously (Wallace et al. 2007). The study found that participants demonstrated a 
high degree of resilience in response to their experiences of MD despite enduring 
serious after-effects. The study focused on their adjustment to appearance changes 
resulting from MD and concluded that overall the young people had come to accept 
their new appearance and had adapted satisfactorily. Interestingly, awareness of their 
close escape from death had been protective and facilitated adjustment to an altered 
appearance from scarring. Notwithstanding, participants had varied experiences of 
psychosocial support post-discharge from hospital, with some offered counselling 
whilst others left unsupported.
In the current study, despite the majority of cases affected in multiple domains of 
functioning some survivors were more resilient than others. For example, one young
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man I visited (aged 17 yrs at interview) had bilateral amputations below the knee. He 
was cheerful through the interview and proceeded to show me his two new prostheses 
which he just recently had fitted followed by a tour of his newly adapted living 
quarters within the family home, with which he was very happy. His parents had also 
purchased a car for him, which was also adapted to accommodate his disability. He 
said that he had received tremendous support from the hospital and was followed up 
frequently in the ensuing months post-MD. Having the support of caring adults 
outside of family is an important contributor to resilience in young people (Blum 
1998). This young man had clearly received support and guidance to adapt his life to 
his disability. Several years later I had to re-contacted him for another study and he 
informed me that he had “recently moved in with his girlfriend', indicating that he had 
clearly ‘moved on’ with his life. This implies that co-ordinated support after MD may 
be a potentially protective factor to adverse after-effects in adolescent survivors of 
MD, which in turn may enhance resilience.
In contrast, other adolescent survivors in the current study did not feel well supported 
following MD as demonstrated by the findings that social support was significantly 
lower in cases than controls with only 52% followed up by health professionals after 
MD. The role of support has been found to be a buffering or protective agent in 
alleviating the effects of stressful life events. For example, research in children 
surviving cancer has indicated that social support is positively related to children’s 
level of adjustment to any after-effects (Neville 1998; Rait et al. 1992; Stem et al. 
1993). Despite being naturally resilient, adolescents need support from health 
professionals and school following MD which may prove beneficial in their recovery, 
helping to mitigate the adverse effects of MD.
6.3.1.2 Social functioning and health behaviours
Social functioning
A knowledge of adolescents’ leisure time and social activities and their interests are 
important for understanding the adolescents’ social world and individual needs 
(Garton and Pratt 1987). Fulfilling social activities are considered to be important for 
healthy psychological development during adolescence (Hendry 1983). The current
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study found no significant group differences at follow-up between MD survivors and 
controls in any measures of social function such as social activities, religious 
attendance, and leisure and sporting activities, with the exception of survivors 
attending fewer parties or nightclubs in the two weeks prior to interview compared to 
controls.
In assessing longitudinal change from baseline to follow-up, survivors were less likely 
to attend nightclubs or youth clubs compared to controls. Survivors were also less 
likely to use recreational drugs on a regular basis, although this failed to reach 
significance. With respect to age-appropriate independent tasks, survivors lived on 
their own at follow-up to an equal extent as did controls. This suggests that for 
survivors the experience of their illness had not hindered their progress towards a 
normally expected level of independence.
Research on social functioning post MD is scant. Only one previous study explores 
this issue. The findings of the current study are supported by a Canadian outcome 
study of MD survivors of all ages (which included a large sample of 10-19 year olds 
[n=231]) (Erickson and De Wals 1998). A reduction in leisure activities in MD 
survivors was found however, data were collected using an unvalidated postal 
questionnaire.
Health behaviours
Adolescents are typically regarded as an especially high-risk group for engaging in 
health compromising behaviours such as cigarette smoking and illicit dug use. These 
behaviours may place at risk the health of an individual in either the short or long 
term, and consequently they have been examined by several authors interested in 
adolescent behaviour (Jessor et al. 1980;Kann 2001).
In this current study, no differences were found between survivors and controls in 
reported health risk behaviours including smoking, alcohol consumption or drug use 
in the two weeks before interview. Further, MD status had no effect or change in 
health risk behaviour between baseline and follow-up.
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6.3.2 Psychological complications
Four measures were used to assess psychological functioning in survivors and 
controls: the SF36 MCS, Beck Depression Inventory (BDI-II), the Clinical Outcomes 
in Routine Evaluation (CORE-OM) for assessment of mental health functioning and 
the A-FILE for the assessment of stress. All four measures have demonstrated high 
reliability and validity however, the possibility of self-report bias is acknowledged. 
Notwithstanding, self-report questionnaires are considered important in the 
assessment of depression, given the internal and subjective nature of the symptoms 
(e.g. feelings of guilt and hopelessness). Data on mental health functioning was 
collected cross-sectionally and accordingly, findings should be treated with caution. 
Data on stress were collected longitudinally (both at baseline and again at follow-up). 
All regression models were adjusted for age at follow-up and gender.
Findings on Mental Health Functioning: There were no significant differences 
between survivors and controls on the four dimensions of the CORE psychological 
scale. However, nearly twice as many survivors as controls (20% vs. 12%) reported 
depressive symptoms on the Beck in the clinical range, although this was not 
significant (P=0.1). However, MD increased the risk of depression significantly after 
adjustment for other known risk factors, including life stress, SES and gender.
Further, there was a trend for survivors to have a lower score than controls (P=0.07) 
on the SF36 Mental Health Component Summary Score (MCS), denoting poorer 
mental health.
In survivors only, poorer mental functioning was associated with lower social support, 
higher levels of physical sequelae, and being female. However, poorer mental 
functioning was not associated with cognitive deficit.
Findings on Stress: At follow-up the total stress score on the A-FILE for survivors 
was significantly lower than controls, denoting less stress. This was an unexpected 
finding, and was explored further in order to assess if increased protection by the 
family and peers following MD had acted to reduce stressful events. Life events were 
divided into potentially controllable events (i.e. starting a new school or starting a new 
job) and largely uncontrollable life events (i.e. deaths, legal problems, and family
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illness). Survivors reported fewer controllable events in the year preceding interview 
than controls at borderline significance (p=0.05) but not fewer uncontrollable events 
(p=0.07). This supports the hypothesis that survivors were exposed to fewer 
controllable events post MD. Stress and distress scores for survivors fell between 
baseline and follow-up, but failed to reach significance.
Low stress levels found in survivors could also suggest that post MD the focus of 
concern was on themselves and their own recovery rather than events within the 
family. It has been shown that difficulties experienced in the home situation are 
clearly important to the domain of adolescent stress (Call and Mortimer 2001) so it is 
surprising that survivors experienced less stress than controls. Furthermore, the stress 
finding may explain why in initial unadjusted analyses an association between MD 
and depression was not found.
Comparison with the literature'. Depression is currently recognised as a significant 
health issue for adolescents due to its relatively high prevalence in the general 
population and the importance of stress in the understanding of adolescent health and 
well-being has been widely reported. Almost 30% of all adolescents will have 
experienced major depression by 19 years of age (Lewinsohn et al. 1998) with less 
than half ever seeking treatment (Ustun 2000).
Rates of depression and stress following MD in adolescents have not been formally 
measured in published studies. Only two studies have anecdotally examined 
psychological outcomes of MD.
A retrospective study examined anxiety post MD in survivors of all ages (including a 
large sample of 10-19 year olds, n=101) and found that 23% of 231 survivors reported 
increased anxiety at a mean of 38 months after the acute illness (Erickson and De 
Wals 1998). Despite using a self-administered non-validated postal questionnaire to 
assess anxiety, the finding from this study is important as anxiety can also be a 
symptom experienced by depressed young people (Puura et al. 1998).
In a more recent study, examining the complications of MD in 25 US college students 
(Erickson et al. 2001), the authors provided quotes from survivors regarding the
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negative psychological impact that MD has had on their lives. For example, 
“Psychologically, Ifind this disease hard to understand or accepf\ was recalled by 
one young man while a young woman said “/  just don’t know why it happened to 
me... or why... I  was under a psychiatrist’s care for 6 weeks for depression”. These are 
indeed useful insights into how young people feel post MD however mental health 
function was not formally assessed in this study.
Experiencing the perceived and real losses that have resulted from MD (e.g. loss of 
future and career aspirations) in some survivors as recalled in the study on US 
students (Erickson et al. 2001) can result in feeling isolated and lonely. In the current 
study, poorer mental health functioning was associated with lower social support. 
Some people will be supportive, other people will not, and some may simply avoid 
survivors resulting in feelings of sadness, anger and anxiety. There may be feelings of 
grief or feelings about the loss of the normalcy of adolescence.
If physical sequelae are not visible and they appeared to have recovered, survivors are 
often expected to catch up and keep up with their school or college work if they are in 
education or maintain a normal level of performance at work. Adolescents who are 
depressed are less likely to complete education, and are more likely to experience 
stressful life events (Lewinsohn et al. 1994).
Anniversaries of important dates, such as the date of diagnosis, could possibly bring 
on a variety of emotions, including relief, sadness, painful memories, or a 
combination of such feelings. A number of young people whom I interviewed stated 
that they felt "^anxious and down” when the anniversary of their illness came around 
each year.
Alternatively, survivors may feel "invincible” and believe that since they survived 
MD, they can survive anything, which may lead to the development of unhealthy or 
risky behaviours, although an increase in health risk behaviours in survivors 
compared to controls was not found in the current study. A number of young people I 
had interviewed however started to pursue high-risk sports as they said “/  need to live 
for today, you never know what can happen in the future”.
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Other survivors may feel especially vulnerable because of the experiences they have 
had. Coming to terms with a traumatic event such as MD is hard to do at any age but 
in adolescence, it is potentially more burdensome. It can take months to recover from 
MD. Young people who have suffered such a life threatening illness, as MD may also 
fear and worry about the recurrence of infection and subsequent death. In the current 
study a number of young people said, they "Aave times when they feel good and other 
times when they feel depressed andfear they are becoming ill again.'''’ Moreover, 
acquired physical impairment because of MD, even if relatively minor, could possibly 
have a major impact on the young person’s self-worth leading to exclusion from 
activities. Accepting permanent disabilities coupled with the frustration of slow 
recovery could possibly be the reason for the presence of depressive symptomatology 
in some survivors. This is supported by the findings from the current study where 
poorer mental health functioning was associated with higher levels of physical 
sequelae.
Scarring from tissue damage in those that have experienced severe septicaemia may 
require skin grafts and it has been shown in adolescents that even minor disfigurement 
is a major problem for self-image (Kish and Lansdown 2000). At a time when most 
young people are concerned with appearance, wearing the right clothes, and adopting 
the latest hairstyles, young people post MD may become significantly concerned with 
complications, which in some survivors are very severe, such as amputation, 
extensive scarring and other disabilities. Being accepted and fitting-in is a significant 
concern for any young person but even more so for young people after MD.
Similarly, seizures, subtle visual problems, hearing loss or impairment, increased 
tiredness and amputation of digits (fingers or toes) or limbs due to septicaemia can 
have a material impact on young people’s psychological, social and academic 
functioning, as well as on how they feel about themselves.
It is difficult to separate the normal difficulties experienced in adolescence from the 
sample in the current study as adolescence is a time of emotional turmoil.
Admission to Intensive Care can have far-reaching psychological effects. It has been 
reported in a British study that children (aged 2-15 years) treated on a Paediatric
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Intensive Care Unit (PICU) and followed up 3-12 months post MD suffer post 
traumatic stress symptoms. In that uncontrolled study, 62% of children had symptoms 
of post-traumatic stress with 10% having the features of a stress disorder (Judge, et al. 
2002). Without a control group, it is difficult to discern whether MD results in post- 
traumatic symptoms or is simply the consequence of a severe illness or ICU 
admission. Furthermore, the study only included children with severe illness that 
required PICU admission.
A meta-analysis identified a lack of social support after trauma as one of the major 
risk factors for Post Traumatic Stress Disorder (PTSD) (Brewin et a l 2000). PTSD is 
a constellation of psychological and physiologic symptoms that are persistent in some 
individuals who have been exposed to a traumatic event (Stuber and Shemesh 2006) 
and certainly contracting MD could constitute a traumatic experience. In this current 
study, PTSD diagnosis was not assessed but it was found that survivors had fewer 
social supports than controls.
Other studies have shown that life-threatening illness in adolescence such as cancer 
can precipitate symptoms of post-traumatic stress (Alter et a l 1996;Pelcovitz et al 
1996). Stressful events are thought to increase risk for a wide range of psychological 
problems among adolescents, including depression and anxiety (Johnson and Bradlyn 
1988;Monroe and Peterman 1988).
In the current study, MD was negatively associated with stress and positively 
associated with depression which could be a psychological reaction to having 
experienced a life threatening illness or to being treated differently afterwards because 
of it. Depressive symptoms could also be triggered by any social problems that 
survivors may experience post MD, for example not being able to keep up with 
friends physically due to fatigue. In fact, a number of survivors I interviewed said that 
they often had to leave social gatherings early, as they felt exhausted very quickly.
It is unsurprising that in the current study it was found that poorer mental health 
functioning is associated with being female as it is well known that females generally 
record higher prevalence rates than males of both depressive symptomatology and 
diagnoses (Cohen et al 1993).
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Implications o f the findings: An important finding is that MD increases the risk of 
depression in survivors post MD. Young people need to talk about their own reaction 
to the illness, their anxieties and fears for the future and possible depression and 
future hopes they may have lost (McCabe and Green 1987).
Support from others can help survivors cope with their emotions in a positive way. 
Charities such as the Meningitis Trust and Meningitis Research Foundation offer 
support with a Helpline open 24 hours a day led by nurses who are willing to listen 
and offer support and talk through any concerns. The Meningitis Trust also runs a free 
professional counselling service in the UK and Ireland to support sufferers and their 
families and anyone directly affected and can put the young MD survivors and their 
family in touch with support groups to help them come to terms with the experience.
The finding that MD increases the risk of depression in MD survivors in the current 
study demonstrates that young people post MD may need access to emotional and 
other types of support both at home and by health care professionals, as depression 
has been shown to have strong continuity into adulthood (Martin and Cohen 2000). 
Depressive symptomatology in adolescence can confer an increased risk for illness 
and interpersonal and psychosocial difficulties that persist (Weissman et al. 1999). 
One study found a direct linkage between early depressive symptomatology and 
increased risk of later major depression or anxiety disorders, nicotine dependence, 
alcohol abuse or dependence, suicide attempts, educational underachievement, 
unemployment, and early parenthood. These associations were similar for girls and 
boys (Fergusson and Woodward 2002).
6.3.3 Quality of life
Health related quality of life was measured with two instruments that assessed 
different aspects of participants’ personal and social function and quality of life. No 
adequate scales cover the age range 15 to 19 years, so one validated adult-oriented 
scale (SF-36 11) was used and a simple unvalidated adolescent-oriented set of 
questions was formulated. Data on QOL were collected at follow-up only and 
accordingly it is not possible to state with precision whether poor QOL preceded MD 
or vice versa.
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Findings'. MD Survivors reported that overall quality of life (QOL) was significantly 
worse than their peers and unlike controls had not improved since the baseline study. 
Survivors also reported descriptively that home life, friendships, academic and 
vocational achievements, leisure activities, and physical ability have been affected 
since MD.
On the SF36, there was a trend (P=0.07) for cases to have a lower Mental Health 
Component Score (MCS) than controls, denoting problems in dimensions of mental 
health: role limitation with work or other daily activities due to emotional problems 
and social function and vitality. On the Physical Component Score (PCS) no 
significant differences were noted except general health perception which was 
significantly poorer in cases compared to controls. A single item of the SF36 related 
to change in subjects’ health over the past year. This item is scored separately and is 
not included in the PCS or MCS scores. Forty-four percent of cases compared to 23% 
of controls reported that overall their health status had improved in the year preceding 
interview. QOL was not associated with physical sequelae or cognitive deficit.
QOL is increasingly acknowledged as an important health outcome measure in 
epidemiologic research. Subjective QOL among adults is thought to be generally 
stable on a population basis, while QOL has been found to be lower and unstable in 
adolescence (Petito and Cummins 2000). There is no consensus about the meaning of 
QOL and thus no generally accepted definition although it is accepted as a useful 
concept. Nevertheless, it is important to establish if QOL is affected post MD as 
adolescence and young adulthood are characterised by attempts to establish autonomy 
and independence, close personal relationships, educational goals and financial 
security. The additional impact of a life-threatening illness such as MD renders those 
tasks even more difficult.
Comparison with the literature: QOL post MD has been poorly studied in young 
people with just a handful of studies exploring this subject. Poorer QOL found in our 
survivors is supported by a Canadian study, which although it focused mainly on 
physical sequelae, also examined briefly QOL using an unvalidated postal 
questionnaire that included 12 statements concerning different aspects of QOL. An
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overall impairment score was calculated providing an estimate of the magnitude of 
reduction of QOL. The study noted that 23% of 231 survivors reported poor QOL 
since MD (Erickson and De Wals 1998). It found that a number of different 
psychosocial factors compromised QOL, including reduced energy, increased anxiety, 
and a reduction in leisure activities and ability to work. Although these findings are 
useful, the authors did however pose QOL questions that were not specific to MD.
The same authors proceeded to examine outcomes of MD in 25 college students in the 
US (Erickson et al. 2001), using the EuroQOL EQ5D questionnaire (EuroQol Group. 
1990) to evaluate QOL. This uncontrolled study found that 20% of these 25 young 
people reported a reduction in QOL compared to normative data. This reduction in 
QOL was primarily seen in those who had physical sequelae.
In contrast, a recent Dutch study assessed the outcomes of bacterial meningitis of all 
aetiologies and included a sample of 25 MD survivors (aged 15-60 years at illness) 
with good recovery and controls (Van De Beek D. et al. 2002). Subjects were 
followed up 6-24 months post-discharge. The RAND 36-Item Health survey (Ware 
and Sherboume 1992) was administered to subjects to evaluate QOL and general 
health and included the same items as those in the SF-36 questionnaire used in the 
present study. MD survivors reported significantly lower energy levels in the Dutch 
study than controls, which is consistent with the findings of the current study.
The findings from the above studies provide support of reduced QOL following MD 
in young people however, none compared QOL in survivors with matched controls.
A Norwegian case-control outcome study of 71 young adult male survivors of MD 
noted that survivors anecdotally reported more general health complaints, including 
fatigue, increased irritability, poorer perceived memory and concentration, and a 
perceived reduction in work capacity compared to controls, and believed that MD had 
affected their educational success and vocational choices (Sander et al. 1984). 
Twenty-nine percent of the meningitis survivors and seventy percent of the septicemia 
survivors believed their vocational choice and educational success had been affected 
post MD.
230
Implications o f the findings: These data suggest that poorer QOL occurs in MD 
survivors as previously reported. Specific instruments to measure QOL post MD in 
young people were not developed when this study was conducted. As a direct result of 
finding that adolescent survivors reported poorer QOL post MD we have undertaken a 
detailed study of QOL in MD survivors using validated generic instruments with the 
purpose of developing an MD-specific QOL (in preparation).
6.3.4 Physical health and injury
Findings:
Phvsical Iniurv: Fifty-seven percent of survivors reported physical sequelae ranging 
from minor skin scarring to bilateral amputations, with some young people suffering 
multiple sequelae. Hearing problems were reported in 12% of survivors. The most 
frequently reported physical injuries were symptoms consistent with Raynaud’s 
disease, with nearly half reporting such problems, followed by skin scarring, with the 
least reported sequelae being epileptic episodes and amputation.
The majority of survivors reporting physical sequelae presented with mixed disease 
and MD caused by seroGroup B. However, the average impairment score was highest 
for survivors with seroGroup C. Over half of those reporting physical injuries, 
including amputees, were admitted to ICU and a higher number reported scarring and 
symptoms consistent with Raynaud’s disease. Greater physical disability was 
predicted by seroGroup C. In addition, physical disability predicted fewer A Level 
passes although this failed to reach significance (P=0.06). Quality of life, fatigue or 
the number of passes at GCSE were not associated with physical sequelae. A positive 
effect was that physical sequelae predicted a higher social support score.
Phvsical Health and Fatigue: Survivors reported significantly poorer general health 
perception and greater fatigue compared to controls. More specifically, greater mental 
fatigue and problems in making more slips of the tongue, and poorer memory were 
noted. Despite these problems, more survivors reported that their overall health status 
had improved in the year prior to interview.
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Limitations
Follow-up focused on neuropsychological, psychological and social outcomes, not on 
physical sequelae, which were assessed only by self-report. A clinical examination 
was not performed and injuries were not crosschecked with medical records.
As stated previously, self-report is susceptible to response bias, however this largely 
depends on the psychometric properties of the measures, in particular their reliability 
and validity (Nunnally and Berstein 1994). Both the SF36 and the Chalder Fatigue 
Scale are used to assess physical outcomes and have been used extensively in research 
and clinical settings and both have been found to be highly reliable and valid. The 
ASBIR has demonstrated similar validity, having been used to assess physical injury 
and disability in two previous studies of outcomes of MD in Canada and the United 
States (Erickson and De Wals 1998; Erickson et al. 2001).
Questions on physical injuries were asked in cases only by self-report using the 
ASBIR, and as stated above were not crosschecked with medical records. Therefore, 
the results reported here need to be seen in light of the lack of comparable data with 
healthy controls. This is important when considering the findings in cases where 28% 
reported symptoms consistent with Raynaud’s disease, which are common symptoms 
in the general population (Wigley and Flavahan 1996). Such symptoms occur in up to 
5% of a healthy population and predominately in young people less than 25 years of 
age (Isenberg and Black 1995).
A further limitation is that proxies were used for disease severity (admission to ICU 
and number of days spent in ICU) rather than a validated ICU score. Thus, the control 
for severity may have been sub-optimal.
Further, the sample in this follow-up study may be biased in favour of more severe 
disease and survivors from a lower socioeconomic group, as survivors recruited were 
proportionally more likely to have been admitted to ICU than survivors not 
approached for recruitment at follow-up. Notwithstanding, the ratio of sepsis and 
meningitis in this cohort [27% had septicaemia alone, 40% had mixed disease and 
33% had meningitis] is similar to other outcome studies of MD. In a recent UK study 
(Fellick et al. 2001) 24% had septicaemia alone, 62% had mixed disease and 14% had
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meningitis. The Canadian cohort of 452 survivors had 38% septicaemia, 47% mixed 
and 12% meningitis only (Erickson and De Wals 1998) with 3% unspecified; (the data 
for the current study and the Canadian data were both collected at times with high 
prevalence of a new clone of Group C meningococcus that was associated with higher 
rates of septicaemia). Lastly, there was less car and home ownership (i.e. lower 
socioeconomic status) in survivors who were approached for follow-up, but not 
recruited compared to survivors recruited for the current study.
Comparison with the literature
Phvsical Iniurv: The finding that greater physical sequelae was reported in survivors 
with seroGroup C disease is supported by a retrospective study of outcomes of MD in 
all ages in Canada (n=452) (Erickson and De Wals 1998). This Canadian study was 
the first study to examine the impact of MD using an objective physical injury scale - 
the ASBIR. Follow-up was at an average of 38 months after the acute illness. The 
study found the highest number of physical complications in adolescents and young 
adults with seroGroup C.
Higher proportions with physical sequelae in survivors with seroGroup C disease 
were also noted in a more recent retrospective study of MD amongst US college 
students (n=25) using the ASBIR. It found that 20% of survivors had permanent 
physical sequelae resulting from seroGroup C, mainly due to complications of 
septicaemia. No physical sequelae was noted in those with serogroup B disease 
(Erickson 2001).
The findings in this current study confirmed previous reports that significant physical 
sequelae are more common in adolescents than younger children. A study of 194 child 
survivors of MD (aged <18 years) conducted in the US, reported that only 5 (2.6%) 
had amputation or scarring (Wang et al. 2001) compared with 5% and 31% who had 
amputations and significant scarring respectively in the current series.
In the current study, 12% of survivors reported hearing problems that were assessed 
by self-report, which will likely under-estimate such problems. This finding is in 
contrast to the results of a Norwegian controlled outcome study of 71 young male MD
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survivors (aged 18 and 24 years of age at MD), where only 7% reported reduced 
hearing (Sander et al. 1984), with no significant differences noted between survivors 
and controls. Sander et al, used both audiology assessment and a self-report 
questionnaire to assess hearing problems, which may explain the differences in results 
compared to the current study.
However, Naess et al examined survivors of MD of all ages one year after discharge 
from hospital and found that 19% of adults and 14% of children had some degree of 
sensorineural loss however no control group was used (Naess et al. 1994). Survivors 
had also undertaken an audiological examination.
One explanation for higher rates of physical sequelae found in adolescents in the 
current study compared to younger children is that the septicaemic form of the disease 
incurs greater physical damage (Erickson and De Wals 1998), and occurs with higher 
frequency during adolescence (Harrison et al. 2001). This is supported by the findings 
of the Canadian study (discussed above) where the majority of sequelae was 
secondary to septicaemia rather than meningitis (Erickson and De Wals 1998).
Phvsical Health and Fatigue: The finding that survivors perceive their health to be 
significantly poorer than controls and that they have greater fatigue is supported by 
the Norwegian study of 71 young male military recruits (Sander et al. 1984). This 
study noted that survivors anecdotally reported more general health complaints, 
including fatigue, than controls. It found that 13% had “relevant” complaints about 
their health deemed to be related to MD, whilst only 2% of controls had similar 
complaints. Such complaints included tinnitus, dizziness, visual disturbance, 
headache, irritability, sleeplessness and fatigue. The proportion of patients treated in 
ICU was not stated. Further, in the Canadian MD outcome study mentioned above, 
survivors reported reduced energy levels (Erickson and De Wals 1998).
A Dutch prospective study (Van De Beek et al. 2002) assessed the outcomes of 
bacterial meningitis of all aetiologies and included a sample of 25 MD survivors (aged 
15-60 years at illness) with good recovery and controls. Subjects were followed up 6- 
24 months post-disease. Survivors reported significantly lower energy levels than 
controls, which is consistent the findings from the current study.
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In contrast to studies reporting greater fatigue in female adolescents compared to 
males in the general population (Ghandour et al. 2004;Wolbeek et al. 2006), 
there were no gender differences found in the current study with both male and 
females reporting fatigue.
Fatigue can be difficult to define because it is loosely divided into physical and 
mental components and is a common complaint amongst adolescents for a number for 
reasons (hormonal, educational and social demands and psychological struggles) 
(Wolbeek et al. 2006). Moreover, fatigue is also a disabling consequence of many 
medical conditions for example, psychiatric disorders and syndromes of unknown 
aetiology, accounting for approximately 15% of medical care visits to infectious 
disease clinics (Carter et al. 1995).
There are a number of possible reasons why survivors in the current study reported 
greater fatigue than controls. For example, fatigue is a key symptom of depressive 
symptomatology (Nolen-Hoeksema and Girgus 1994;Wilson et al. 2005). In the 
current study, it was found that MD increases the risk of depression in adolescent 
survivors. Another possible reason for greater fatigue post MD in adolescent survivors 
is that an infectious illness, such as MD may play a role in the development of fatigue 
in some adolescents as part of an acute post-infectious fatigue syndrome. Fatigue has 
been shown to occur in later adolescence and young adulthood for example, after an 
acute febrile illness (Carter et al. 1995;Feder et al. 1994;Krilov et al. 1998;Smith et 
al. 1991). It has also been seen in young people after mononucleosis (usually caused 
by the Epstein-Barr virus, referred to as glandular fever) (Buchwald et al. 2000;Smith 
et al. 1991;White et al. 1998). This is interesting as more survivors than controls 
were positive for Epstein-Barr virus antiviral capsid antibody IgG (53% of survivors 
vs. 31% of controls) at baseline which has been linked to fatigue (Rea et al. 
2001;Straus et al. 1985). However, in regression analyses performed in the current 
study no association was found with fatigue at follow-up (data not shown).
A positive finding from the current study is that more survivors than controls reported 
an improvement in their health status in the previous year prior to interview. No 
previous outcome studies have examined this subject. It is reasonable to suggest that 
although survivors experience physical sequelae, they may make a greater effort at
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improving their health to combat the effects of MD, although they still perceive their 
general health to be poor.
Implications o f the findings: Adolescence alone can be a stressful developmental 
process and a time of emotional and physical change. Fatigue and physical 
complications can potentially have negative educational, occupational, and social 
repercussions, which together could affect quality of daily life. However, in the 
current study physical disability was not associated with a reduction in QOL.
Illness in adolescence is a risk factor for the development of mental disorders in 
young people (Patel et al 2007). In the current study physical disability post MD is 
associated with poorer mental health functioning. There are many possible reasons for 
this. For example, physical complications such as scarring and amputation could lead 
to body-image dissatisfaction and low self-esteem in young MD survivors, although 
self-esteem was not examined in survivors using an objective measure. Body image 
dissatisfaction in adolescence has been associated with depression (Ohring et al.
2002) and low self-esteem (Harter 1986;Rosenberg 1986).
A meta-analysis of 13 studies examining the effect of physical diability on self-esteem 
in young people found that young people with major physical disabilities are less 
affected compared to those with minor physical disabiliy (Miyahara and Pick 2006). 
This may be due to the high level of support that is provided to those with major 
physical disability, which is supported by the current findings as greater physical 
sequelae predicted a higher level of social support.
Nevertheless, the stigma of any disfigurement, especially when unrealistic images of 
‘attractiveness’ exist across our society today, could potentially pose considerable 
challenges for young survivors in maintaining self-esteem, self-confidence and coping 
effectively with the possible negative reactions of others. Young people may feel 
uncomfortable with disfigurement in social situations; and find it hard to deal with 
comments and questions from other people. They might feel isolated or believe that 
they have little chance of leading a successful life. Counselling could be beneficial in 
assisting survivors deal with such problems and situations effectively.
236
The subjective report by survivors of mental fatigue, more specifically problems in 
memory, is confirmed by the findings from the objective neuropsychological tests, 
which demonstrated that survivors have deficits in short-term verbal and long-term 
visual memory. Mental fatigue refers to the effects that people may experience after 
or during prolonged periods of cognitive activity (Boksem et al. 2005). Furthermore, 
survivors also demonstrated deficits in attention (selective and sustained) and studies 
have shown that attention is specifically affected by mental fatigue (Bartlett 
1943;Boksem et al 2005;Brown 1994). However, in the current study the total fatigue 
(mental and physical) score was not associated with the cognitive summary score of 
deficit, which included attentional test scores.
The finding that physical disability was associated with fewer A Level passes (a trend, 
P=0.06) in MD survivors suggests that physical sequelae may be hampering 
educational progress by disrupting schooling. This may be particularly true for those 
young people with severe sequelae who would require ongoing treatment with visits 
to hospital or outpatient departments, thereby reducing attendance at school, which in 
turn would interfere with the preparation for and completion of exams. Survivors may 
be simply unable to attend school due to amputation or severe scarring, or may be 
psychologically unprepared to return to school due to disabilities, and lastly deafness 
has been reported to be a major cause of educational failure (Byrd 2005). A high rate 
(12%) of survivors in this study reported hearing problems.
6.3.5 Educational outcomes
In this study, young people were asked a series of short questions on educational 
achievement as part of the Questionnaire for Young People (previously modified from 
the West Country Meningitis Study [Stanwell-Smith, personal communication]). 
Educational achievement was assessed by the number of GCSE and A Level passes 
the young person had obtained, which are two crucial measures of educational 
attainment in Britain. Additional information included the number of days missed 
from education in the 3-month period before interview, exams failed in the year 
before interview and how participants rated their level of achievement during the 
school or college year subsequent to the MD. Data were collected cross-sectionally
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and accordingly, findings should be treated with caution. All regression models were 
adjusted for age at follow-up and gender.
Findings: MD survivors achieved fewer passes at GCSE level compared to controls 
and were more likely to have failed an exam in the 12 months prior to interview. Of 
those who had completed their secondary education after the baseline study, 64% of 
survivors compared to 50% of controls did not attain any A Levels (P=0.07).
Greater cognitive deficit was associated with poorer educational achievement (fewer 
passes at GCSE and A Level) and there was a trend for physical sequelae to also be 
associated with poorer educational achievement (fewer A Level passes; P=0.06).
There were no differences between survivors and controls in the number of days 
missed from education, and work in the 3-month period preceding interview. More 
survivors rated their academic achievement at interview below average or average 
(75%) compared to 62% of controls, although this failed to reach significance.
Comparisons with the literature: I am unaware of studies that have formally assessed 
educational outcomes after MD in adolescence, although outcome studies of MD and 
bacterial meningitis of all causes have found poorer educational performance in 
younger children (Grimwood a/. 1995;Grimwood ef (z/. 1996;Taylor er a/. 1984) 
with persisting effects (Grimwood et a l 2000). In one study survivors of early 
childhood MD were approximately 3 times more likely to have a formal statement of 
special educational need (Fellick et a l 2001).
The finding that educational achievement was affected in MD survivors in the follow- 
up study is supported by a Norwegian case-control study (Sander et a l 1984) which 
examined outcomes in 71 male survivors of adult MD (aged 18-24 years at MD). 
However, standardised measures were not used and reliance was placed on the 
subjective experience of participants with 15% of survivors anecdotally reporting that 
educational plans had changed post MD and 7% stating the disease had influenced 
their choice of profession.
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The fact that survivors are under-achieving academically is an important finding given 
the strong and well established association between school achievement and positive 
outcomes over the life span in terms of employment, occupational class, income, 
social exclusion and wider quality of life (Marsh 1990;Santrock 2002). This has 
important implications for MD survivors as self-esteem and academic achievement 
have been shown to be positively correlated: as self-esteem increases so does the level 
of academic achievement (Covington 1989;Schmidt and Padilla 2003).
The academic difficulties young people may experience post MD may be the result of 
a combination of factors. For example, well over half of all survivors reported 
physical sequelae, which was found to be associated with poorer educational 
achievement (trend) and poorer mental health functioning. Physical sequelae may 
inhibit a speedy recovery resulting in frequent absenteeism from school or college, 
contributing significantly to school under-performance and interference with the 
preparation for and completion of exams. As stated previously deafness has a major 
impact on academic success (Byrd 2005).
Poorer educational achievement has been linked to absenteeism from school in 
adolescents with chronic illness (Berg 1992;Breuner et al 2004;van de Putte et al 
2005; Weitzman 1986).
Additionally, parents and teachers may alter their attitudes toward the young person 
because of the seriousness of MD, which may result in decreasing their academic 
expectations of the young person. Furthermore, it is possible that some survivors may 
be experiencing Post Traumatic Stress symptomatology as a result of MD, which has 
shown to have deleterious impact on academic achievement in adolescents (Saigh et 
al 1997). In addition, greater fatigue was found in survivors compared to controls, 
which could have also contributed to poorer academic performance. However, the 
association of PTSD and fatigue in relation to educational achievement was not 
examined in this study.
Notwithstanding, no difference was found between survivors and controls for time 
taken off school in the 3 months prior to interview. However, this is a short time 
frame in which to deduce that absenteeism from education was not a problem.
239
However, cognitive deficit was found to be associated with poorer educational 
achievement in this study. Cognitive ability has long been strongly associated with 
educational attainment (Batty and Deary 2004;Deary et al. 2004). The presentation of 
cognitive deficits may not be immediately obvious to teachers and parents as the 
effects on learning may be subtle, manifesting as poor performance at school.
Implications o f the findings: It is important that poorer educational achievement in 
young people post MD is identified. If it is not taken into account by teachers, the 
educational setting can potentially become a place of failure, both academically and 
socially, which may in turn strongly influence the young person’s development of a 
sense of self-esteem, and his/her ability to perform and cope effectively after MD. 
There is also evidence that young people’s desire to continue in further education is 
positively related to subsequent attainment at school (Ermisch and Francesconi 
2001;0'Brien and Jones 2001). This is consistent with the findings of the current 
study as there was a trend for MD survivors to have fewer A Level passes than 
controls. Poor educational achievement in the long-term may impact on vocational 
choices and in turn loss of financial independence later in life.
Improving educational outcomes for young people post MD requires a multi-faceted 
approach that addresses the emotional and academic needs of the young person easing 
the transition back into education after MD. Providing a supportive educational 
setting coupled with teacher-support and medical support where necessary are 
essential elements to improve educational achievement in adolescent MD survivors. 
Survivors may benefit from individualised educational support from teachers to help 
them ‘catch-up’ with their peers when they return to school post MD as falling behind 
their peers may result in anxiety, placing additional strain on them, which may further 
interfere with their ability to concentrate and achieve academically or vocationally. 
The support of teachers has been found to be beneficial for adolescents returning to 
school after treatment with cancer (Klopovich et al. 1981). It is important that 
survivors do not feel isolated on their return to school. Research has shown that social 
support has positive effects on academic achievement (Vaux 1985). If physical 
sequelae are extensive, there may be ongoing medical treatments, which together with 
the resulting complications are constant reminders of their dependence on medical
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support and their segregation from peers. Supportive friendships at school have been 
shown to have a positive effect on attitudes to school (Bemdt 1996).
The results of this study also have implications for school counselling practice as MD 
survivors may benefit from one-to-one counselling to express and share their 
concerns.
These findings draw attention to the need for the provision of educational support for 
young people post MD. Without such support they may be rendered educationally 
disadvantaged which is likely to impact on their ability of finding suitable jobs and 
achieving financial independence as adults. It is incumbent upon teachers, school 
counsellors and medical health professionals to support survivors post MD and 
identify those with problems. The absence of support may leave survivors with 
diminished confidence in their ability to achieve future success.
6.3.6 Neuropsychological outcomes
An extensive neuropsychological test battery was administered to MD survivors and 
controls to examine a wide range of abilities. All tests used have demonstrated high 
reliability. Measures and procedures were standardised, thereby increasing the 
reliability of the findings. Adjustments were made in analyses for possible 
confounding variables such as age and gender.
However, it is important to note that the neuropsychological data are cross-sectional 
and any causal conclusions must be viewed with caution. In addition, bias due to 
multiple comparisons is possible. Adjustment for multiple significance testing could 
have been done by the Bonferroni method however, this was considered excessively 
conservative given the explorative nature of the study. Further, tests within each of the 
eight domains of cognitive functioning are closely correlated, for example, attentional 
mechanisms are not localised to specific brain regions (Scheibel and Scheibel 1958), 
and can be assumed to be more or less dependent on each other.
To reduce the number of statistical tests and avoid Type I error in investigating 
potential mechanisms for poor QOL, fatigue and psychological and educational
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outcomes in survivors only, a Cognitive Summary Score (CSS) was derived to 
produce a single variable (see Chapter 3 -  Methods).
Findings: The results demonstrate selective cognitive deficits in survivors not 
observed in matched controls. No differences were found between survivors and 
controls in general intellectual ability (premorbid and current estimates) with both 
groups falling in the normal range. Similarly, no differences between the two groups 
were noted with regards to handedness. Cognitive performance was not associated 
with scores on mental health measures.
The neuropsychological profile of MD survivors is one of diffuse impairment with 
deficits observed across a range of domains. Although, a generalised memory problem 
was not found, survivors did demonstrate problems in short-term verbal memory 
skills, cognitive flexibility and storage of verbal information. The ability to encode 
verbal material and retrieve it from long-term memory was unaffected. Impairment 
was also found in long-term visual memory, indicating a problem in recalling 
complex visual information from long-term storage.
Significant deficits were also found in sustained and selective attention tasks. There 
was also some suggestion of minimal impairment in executive functioning, where 
survivors demonstrated a trend (P=0.06) to commit more errors in attempting the 
attentional set-shifting task, which has been found to be attributed to problems in 
cognitive flexibility (Elliott et al. 1995). MD survivors also demonstrated 
significantly slower psychomotor speed compared to controls. Slowed psychomotor 
speed has been reported previously in patients sustaining mild (Katz and DeLuca 
1992) and moderate to severe brain injury (Ponsford and Kinsella 1992).
However, survivors were not impaired in their response latencies on any other test in 
the battery. Furthermore, no impairment was observed on tests assessing visuospatial 
construction ability and visual recognition memory. Planning ability was also 
relatively well preserved.
The pattern of cognitive impairment found in survivors may essentially be due to 
slowed processing speed causing attentional problems, and memory dysfunction. For
242
example, slow processing may result in survivors failing to effectively organise and 
encode the Rey Osterrieth Complex Figure in time and store into long-term memory 
to facilitate later retrieval. Slow processing has been shown to often underlie 
attentional deficits (Gronwell and Wrightson 1981;Klove 1987).
Cognitive deficit (lower CSS) was associated with poorer educational achievement 
(fewer passes at GCSE and A Level), younger age at diagnosis and being female but 
not with quality of life, mental health functioning, fatigue, social support or any other 
disease factor.
In addition, higher educational achievement and premorbid IQ were found to play a 
protective role against greater cognitive deficit, indicating that survivors with higher 
cognitive reserve prior to MD experience less cognitive deficit post MD. This 
suggests that young people with higher premorbid IQ may represent a ‘cognitively 
resilient’ group. The factors underlying their cognitive resiliency remain unclear and 
further longitudinal research is required to assess if cognitive deficits persist and 
clarify the specific cognitive domains that are associated with poorer functional 
outcomes in MD survivors.
Cognitive reserve theory proposes that higher education and psychometric intelligence 
may preserve functional capacity following brain injury or disease, providing a buffer 
against brain dysfunction enabling individuals to compensate more effectively (Stem
2003). Support for cognitive reserve theory has been found in various conditions 
(Glatt et al 1996) (Stem 2003). Further research is required to investigate the 
mechanisms that yield cognitive differences among survivors of MD and controls to 
improve understanding of the cognitive sequelae of MD in adolescence.
Screening young people post MD and assessing pre-morbid intellectual ability could 
be useful for identifying young people that are particularly vulnerable to cognitive 
deficit and therefore to target the necessary support.
Comparison with the literature: This is the first controlled study to specifically 
evaluate cognitive outcomes of MD in adolescence. Research is scant on cognitive 
outcomes of MD in all ages and the limited number of studies that have been
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conducted have primarily focused on meningococcal meningitis in adults, including 
older adolescents in the sample. Therefore, a consistent and specific profile of 
neuropsychological abnormalities has not been established in adolescent survivors of 
MD. Accordingly, no direct comparisons can be made. More specifically, cognitive 
outcomes and the septicaemic form of MD have not been studied. Only three studies 
are relevant to this discussion.
Perhaps the most closely comparable data to support the findings in the current study 
are from a recently published Dutch study examining cognitive outcome in adults 
with good recovery after bacterial meningitis (Hoogman et al. 2007). This study 
included 76 adult survivors of meningococcal meningitis aged >16 years (mean age 
38.9 years). Survivors were drawn from three long-term follow-up studies assessed 2- 
10 years post MD (mean 68.8, SD 49.4). The authors found significant deficits in 
survivors in short-term memory, attention, executive function and psychomotor speed. 
Being male was found to be a risk factor for cognitive impairment. These findings 
support the current study results, where a diffuse pattern of cognitive impairment was 
found with the same specific deficits. These findings are interesting although 
survivors with severe MD and septicaemia were not included. Further, controls were 
not randomly recruited but were mainly partners, relatives or close friends of the 
survivors.
The memory problems found in survivors in the current study is consistent with the 
findings from a Norwegian case-control outcome study of 71 young adult male MD 
survivors and matched controls. Although the study did not report specifically on the 
nature of neuropsychological disturbances, it found that 15% of survivors anecdotally 
reported impaired memory compared to controls (Sander et al. 1984) Unfortunately, 
standardised neuropsychological tests were not administered making comparison with 
the current study difficult.
The only other outcome study of MD that is relevant to this discussion assessed 
children and adults, including teenagers 1 year after the acute stage of MD (n=93, [52 
adults and 41 children]) (Naess et al. 1994). This was a controlled study with only 
nine participants neuropsychologically assessed using the Halstead test battery. Only 
two patients were reported to have deficits (mild to severe), one of whom was a young
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girl of 17 years with deficits found in attention and concentration. These findings are 
useful and comparable to the current study in terms of attentional deficits found in 
adolescent survivors however, the study sample is far too small for drawing 
meaningful conclusions.
Mechanisms'. There are a number of possible mechanisms, by which MD might 
contribute to cognitive deficits. Attributing specific cognitive deficits in the presence 
of widespread disease is difficult. Furthermore, performance on any one measure 
typically reflects multiple underlying cognitive processes, and therefore it may be 
difficult to isolate specific mechanisms responsible for deficient performance in 
adolescents post MD. Nonetheless, advances in imaging technology are allowing 
researchers to construct a detailed picture of how the brain is affected by MD. For 
example, when meningococci bacteria access the central nervous system, their 
multiplication triggers a complex host response causing vasculitis and areas of 
infarction (Snyder et al 1981). Generalised cerebral oedema is commonly found to 
occur in meningitis causing increased intracranial pressure (Ashwal et a i 1990) 
resulting in global and focal ischemic-hypoxic brain injury (Leib and Tauber 
1999;Nau and Bruck 2002). The damage caused by MD at the acute stage of the 
illness may in part explain why a pattern of diffuse cognitive impairment was found in 
survivors in this current study.
The younger adolescents demonstrate a greater degree of deficit. This finding that 
younger age at MD was associated with greater cognitive deficit is consistent with 
brain biology. Recent research indicates that in contrast to previous assumptions, the 
brain continues to undergo a considerable amount of development throughout 
adolescence and into young adulthood. Research has found that during adolescence 
the refinement of neural circuitry occurs with changes in the volume of several brain 
regions, including the frontal and temporal cortex, amygdala and hippocampus (Giedd 
et al 1996; Giedd et al 1999; Giedd 2004; Sowell and Jemigan 1998). This increased 
plasticity of the brain during adolescence whilst facilitating learning, also appears to 
increase vulnerability to the damaging effects of acute infections such as MD and 
other illnesses. Studies have shown that subtle functions such as concentration, 
aspects of memory and attention remain sensitive to trauma beyond childhood 
(Christie et al 1995). The pattern of diffuse damage found in MD survivors is
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consistent with other infectious diseases that affect the brain for example, measles 
encephalitis or tuberculous meningitis (Berg 1989;Gelb 1990).
Implications o f the findings: The findings suggest that adolescent MD survivors 
demonstrate deficits principally encompassing attention, mnemonic functions, and 
psychomotor retardation. The profile of deficits suggests it is consistent with diffuse 
brain damage (Lezak 1995).
In terms of practical implications, such deficits may affect aspects of daily life in 
adolescent survivors. For example, survivors with long-term visual problems may 
have difficulty with mathematics and geometric figures at school. In addition, 
survivors with such deficit may have difficulty in memorising geographical 
information such as charts and graphs.
Short-term memory problems may mean survivors have difficulty retaining 
information for a long enough time to manipulate it mentally. An example of this 
deficit might be the following: during a lesson or lecture at school or university, when 
a teacher states a key principle and then proceeds to give an illustrative example, the 
young person with a short-term memory deficit may lose track of the principle while 
listening to the example. The same thing may happen when reading, doing 
mathematical calculations or following directions.
Processing speed problems mean that young people may have difficulty 
understanding lengthy directions or lessons, completing reading or written 
assignments on time and completing any tests or assignments under timed condition, 
especially those involving extensive retrieval or organisation of information. 
Processing speed deficits may also impact negatively on other academic skills for 
mathematical calculations, and even tests or assignments, which are not timed. In 
daily life, depending on the severity of the processing speed deficit, there may be 
problems in taking phone messages, driving skills and any tasks involving rapid hand- 
eye coordination (e.g. sports, video games).
Attention problems manifest in difficulty focusing attention on a task when mental or 
physical distractions are present and competing for their attention. In school.
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survivors would have difficulty attending to a lesson where there are environmental 
distractions. They may also find it difficult to apply themselves to school work for a 
long enough period to complete assignments well. In daily life, they may often be late 
and seem disorganised, inconsistent or unreliable. They may become very frustrated 
and tired due to the effort required to focus their attention. This is supported by 
survivors reporting significantly greater mental fatigue compared to controls.
Any of the above problems suggest that young people may benefit from cognitive 
rehabilitation post MD in order to improve their long-term outcome or from being 
taught compensatory strategies (e.g. audiotaping for note taking) for functional 
academic purposes. Therefore, screening young people post MD for cognitive 
impairment will identify those young people with deficits who may require support, 
particularly if severely affected. Cognitive rehabilitation has been demonstrated to be 
effective in reducing cognitive disability following brain injury (Laatsch et al. 
2004;Pizzamiglio et al 1998).
Rehabilitation may be more beneficial if it was integrated and coordinated with 
educational and vocational based support programmes. In particular, as young age at 
diagnosis was associated with greater cognitive deficit post MD, indicating that 
younger survivors may need more support, as they are more likely to be in full-time 
education. The fact that cognitive deficits persist long after the acute phase of the 
illness lends support for rehabilitation to extend beyond the immediate post­
hospitalisation period as possible cognitive recovery is likely to evolve at a different 
pace for each young person.
In terms of the real-world impact of these deficits on everyday life, for a number of 
young people interviewed, memory and attention problems were reported to be a 
source of their frustration affecting their daily activities and in particular occupational 
and educational achievement. For example, I interviewed one young man who was in 
his first year at Oxford. Prior to MD, he was an excellent student who achieved high 
grades in most exams. However, post MD, he complained of memory and 
concentration problems and subsequently had difficulties maintaining the level of 
work required of the course. As a result, he started to fall behind and was eventually 
referred privately for neuropsychological assessment, which confirmed impairment in
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aspects of his memory. At interview, he had undergone rehabilitation for several 
months and said that he had already seen some improvement. If support such as this 
was routinely offered to young people post MD, the long-term outcome may improve 
for those severely affected. Comments such as this, although anecdotal, correspond 
with objective data in this study of poor memory and attention problems.
6.3.7 Follow-up
Verification of medical follow-up was not undertaken in this study and the use of self- 
report data for medical follow-up may have led to an over or under-estimate of actual 
follow-up. However, recall of medical appointments after MD is likely to be high in 
this population with normal mean IQ and no deficits in long-term episodic memory. 
Further, subjective perception of follow-up is itself an important patient-centred 
measure of quality in health services (Cleary 2003). Data were collected cross- 
sectionally and accordingly, findings should be treated with caution.
Findings: Of the 101 survivors, only 53 reported contact with a health professional 
post illness. There were no significant geographical variations in the proportion 
followed-up between regions. Follow-up was predicted by disease severity, with those 
admitted to ICU more likely to be followed-up than survivors who were not.
However, follow-up was not associated with the degree of physical disability, social 
support, quality of life or mental health functioning. MD survivors stated that they 
were not referred to a mental health professional at any time between the baseline 
study and the current study.
Of greater concern, two fifths of those admitted to intensive care did not receive 
continuing medical care and none of the 20% of survivors who were in the clinical 
range for depressive symptoms had been seen by their GP or received a referral to a 
mental health professional.
There is no national database that documents the use of outpatient services by patients 
after MD. Therefore, it is impossible to compare this cohort of adolescents with 
national follow-up rates after MD in patients of differing ages. Further, comparative 
data on health service use after meningococcal disease is not available. While follow-
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up data were cross-sectional, it may suggest that follow-up, where it occurs, is not 
currently well targeted to those with the greatest deficit.
The current study was not set-up to examine whether follow-up improved outcome. 
This can introduce bias of course as those perceiving themselves as having problems 
are more likely to seek follow-up.
A number of survivors interviewed for the current study were found to have severe 
depression, in some cases suicidal ideation, which was ascertained by the Beck 
Depression Inventory. These survivors were encouraged to approach their GP for 
support and a number of organisations were recommended for additional help and 
assistance.
Currently there is no formal policy for follow-up in the UK for survivors of MD. 
While follow-up of younger children post MD by paediatricians has been reported to 
be routine, this was not found to be the case for the adolescents (survivors in this 
study). Many were discharged directly home from ICU by busy adult medical 
services. The dangers of poor services for adolescents at the intersection of 
paediatrics and adult medicine, and the importance of improving these transitions 
(Viner and Barker 2005) has been emphasised by the recent UK National Service 
Framework for Children and Young People (Department of Health 2004b). Classic 
paediatric or adult outpatient services often poorly serve young people with acute 
illnesses ignoring their unique developmental needs (Royal College of Paediatrics and 
Child Health 2003).
The need for better follow-up has also been emphasised by MD survivors. In a 
recently conducted study to develop a specific QOL questionnaire for young people 
post MD, I held focus groups with 16-24  year old survivors of MD during which 
participants stated that they wanted regular medical follow-up after discharge from 
hospital in order to monitor their emotional as well as physical health (unpublished 
data).
Routine follow up post MD in adolescent survivors is therefore essential for offering 
reassurance, monitoring the severity of late effects of MD and linking them in to other
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services for example arranging hearing tests, eye tests, and visits to specialised clinics 
if necessary. GPs are best placed to offer support and initial screening and their 
service is not cost-prohibitive (£17.42 per visit) (DOH 2004) considering the long­
term health and cost implications to the NHS and the individual if outcomes are not 
monitored. GPs may be more cost effective than attendance at an outpatient clinic, the 
costs of which are approximately £276 for a first visit to an Infectious Diseases 
Outpatient Department and approximately £190 for each appointment thereafter 
(DOH 2004).
Implications o f the findings: Survivors of MD in adolescence have a disturbing series 
of deficits including significant fatigue, poorer quality of life, cognitive function and 
educational achievement compared to controls. Medical care is poor after discharge 
from hospital and routine follow up is important for preventing treatable morbidity 
after MD, which may go unrecognised and untreated in some survivors. Follow-up 
support services can help young people come to terms with their experience of a life- 
threatening illness and provide the opportunity for them to access further intervention 
if required. In addition, follow-up can ensure that the young person and their families 
are provided with accessible and realistic information, to help them gain an 
appropriate understanding of the illness and its possible effects. Health care providers 
therefore need to seek interventions at both the individual and policy level that 
address young people’s needs post MD and enhance their quality of life.
The present study found that all cases were impaired in at least one domain of 
functioning post-MD. Nearly half of cases were impaired across multiple domains of 
functioning (social, psychological, cognitive, and physical function as well as QOL 
and academic achievement -  with the principal domains affected being physical 
function, QOL and cognitive function). These findings, which were previously 
unknown, have important implications for clinicians and families in supporting 
adolescents post-MD. Firstly, they alert clinicians to potential adverse areas of 
function in adolescent MD survivors and will prompt them to further enquire with 
survivors and their families on areas of functioning such as social support, depression, 
memory problems, and disability, with a view to therapeutic intervention where 
possible. Secondly, clinicians can inform adolescent survivors and their families about 
the possible after-effects of MD, providing guidance on how to access comprehensive
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follow-up care. Therefore, the findings of this study will guide clinicians in their 
assessment of young people post-MD, ultimately leading to better after-care, which in 
turn ensures an improvement in quality of life for adolescent MD survivors.
For survivors with severe after-effects, a more intensive, multidisciplinary approach 
may be required and it is important that service delivery is coordinated. For example, 
some young people may be unable to continue full-time work or education for some 
time with recovery disrupting school or university studies. A team approach 
accompanied by an understanding of how MD impairs the quality of life may improve 
the management of the adolescent's health problems post MD, both in health-care 
services and in educational institutions. Successful return to work or school requires a 
support programme, incorporating medical treatments, psychological support and 
occupational therapy for young people with severe complications. Prolonged absence 
from school may lead to anxiety about falling behind with class work, and young 
people may become frustrated and/ or anxious about their inability to participate in 
sporting and social activities if physical sequelae are severe. For survivors 
experiencing cognitive problems a referral to a clinical Neuropsychologist may be 
highly beneficial in order to identify appropriate educational support and identify 
potentially effective rehabilitation strategies.
For some young people post-MD joining a support group may be valuable. Charities 
can offer individual and group support, education on MD, and advice. Individuals 
may also benefit from the opportunity to exchange information on how to cope with 
the many practical day-to-day difficulties that arise for young people after MD.
A systemic disease such as MD is likely to have wide-ranging complications that will 
overlap with any number of conditions. Therefore, it is not possible to state with 
certainty if the range of outcomes found in adolescent survivors in the current study, 
are specific to MD. Further, this is the first study to explore outcomes in adolescent 
survivors so there are few comparisons.
However, the pattern of deficits found in survivors in the current study, more 
specifically physical injuries caused by sepsis and cognitive impairment are specific
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to MD. The physical injuries reported in survivors in this study are consistent with 
the findings from other MD outcome studies which have included adolescents and 
young people (Erickson and De Wals 1998;Erickson et al. 2001). Both studies 
conclude that physical sequelae were primarily due to complications of 
meningococcal sepsis.
Meningococcal Sepsis may cause cerebral insult due to vasculitis and cerebral 
hypotension, the release of inflammatory factors within the brain, and the occurrence 
of small septic infarcts. Such damage may have resulted in the pattern of diffuse 
cognitive deficits found in this study, including deficits in attention, aspects of 
memory, cognitive flexibility, and psychomotor speed.
Certainly, compared to viral meningitis, which is rarely life-threatening, bacterial 
meningitis more specifically pneumococcal and meningococcal meningitis cause 
greater cognitive impairment (Schmidt et al 2006). In survivors of pneumococcal 
meningitis cognitive deficits have been greater than those found in survivors of 
meningococcal meningitis (van de Beek et al 2002). However, this study included 
adult MD survivors with good recovery and therefore comparisons cannot be made to 
adolescent MD survivors where the brain is still maturing and is more vulnerable to 
damage.
Other life-threatening illnesses may not cause the specific cognitive deficits as found 
in adolescent MD survivors in the current study. However, greater reduction in quality 
of life, poorer social support and lower educational attainment could potentially be 
outcomes of any life-threatening illness.
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CHAPTER 7 -  CONCLUSIONS AND FUTURE DIRECTIONS
This prospective population-based matched cohort study is the first to explore 
outcomes of MD in adolescent survivors. The study provides insight into the full 
extent of the sequelae among a representative sample of adolescent MD survivors, 
including a detailed and careful assessment of neuropsychological function. Few 
comparable data are available on outcomes other than physical disability.
7.1 Conclusions
The results show that 57% of cases had physical sequelae ranging from minor scarring 
to bilateral amputations. Survivors had greater mental fatigue, lower social support, 
greater reduction in quality of life, and lower educational attainment compared with 
controls. Cognitive testing revealed no overall change in intellectual ability; however, 
cases had deficits in aspects of memory (short and long-term), attention (selective and 
sustained), cognitive flexibility and psychomotor speed. Greater cognitive deficit was 
associated with a younger age at diagnosis. Cases with SeroGroup C disease had 
greater physical sequelae than those with B disease. MD status increased the risk of 
depression. Medical follow-up and educational support for cases was poor. Only 
53/101 cases reported any medical follow-up after MD. I am not aware of 
comparative data on health service use after meningococcal disease. Furthermore, I 
found no associations between reported follow-up and the degree of physical deficit 
or other sequelae.
The mechanisms by which MD produces these adverse educational, cognitive, 
psychological and social outcomes is not well understood. Some deficits may directly 
result from central nervous system vascular damage or hypoperfusion during the acute 
illness (Pathan et al. 2003). Some deficits may be a more indirect consequence of 
psychological responses by the individual or their family to having a life-threatening 
illness (Benzer et al. 1983) to treatment in intensive care (Rees et al. 2004), or to 
ensuing physical disability (Erickson and De Wals 1998). The findings suggest that
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poorer mental health functioning is related to the impact of physical complications 
after MD, and that poorer educational outcomes are related to cognitive deficits. 
However, these particular associations are cross-sectional and causality cannot be 
assumed. Whilst the impact of MD on cognitive function appears to be independent of 
mental health function, it has an impact on subsequent educational achievement.
The findings indicate that MD continues to impact upon the lives of adolescent 
survivors 18-36 months post-disease. The implications of the physical sequelae noted 
are significant. In particular, survivors with high rates of physical sequelae were more 
likely to have poorer mental health functioning. It is possible that the experience of 
physical sequelae by adolescent survivors would have interrupted progression in 
schooling.
The study noted that MD increased the risk of depression, and demonstrates that 
young people post-MD may need access to emotional and other types of support both 
at home and by health care professionals. Encouraging adolescents to share their 
concerns and discuss ways to help them cope with the effects of MD will assist them 
in their return to normal life and daily functioning and dispel any anxiety and 
uncertainty they may feel about the future after MD. Depression may be due to the 
difficulties found in achieving educationally and vocationally and by the fact, they 
feel under-supported or simply coming to terms with a life-threatening disease. The 
study also found that life stress levels were lower in survivors than controls. This 
finding was unexpected, and may reflect a reduction of exposure of cases to avoidable 
stress, by themselves or by their family, after MD.
Another important finding of the study is that MD leads to poorer quality of life. The 
implications of this, many of which are connected to other findings of the study as 
noted previously, are that a number of areas of the survivors’ lives are impacted upon 
post MD. For example, survivors may feel that in addition to poorer educational 
achievement and less support, their general health overall was poor which may in turn 
impact on aspects of their lives. The implication of this is that it may exacerbate many 
of the effects discussed above.
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The study also found that survivors with greater cognitive deficit had poor educational 
achievement. The study noted that such deficits were experienced most by survivors 
who were younger at MD, which possibly explains the impact these would have on 
educational and vocational achievement as well as social relationships. These impacts 
would also likely to have been made worse by the fact that many survivors are not 
followed-up after MD.
It is important that poorer educational achievement in young people post-MD is 
identified, which in the long-term may affect vocational choices and in turn could lead 
to loss of financial independence later in life. The absence of support may leave 
survivors with diminished confidence in their ability to achieve future success.
In terms of practical implications, cognitive deficts may affect aspects of daily life in 
adolescent survivors. For example, memory and attention problems are likely to affect 
educational and career progression. Survivors may become very frustrated and tired 
due to the effort required to focus their attention. This is supported by survivors 
reporting significantly greater mental fatigue compared to controls. These problems 
imply that adolescent survivors may benefit from cognitive rehabilitation post MD in 
order to improve their long-term outcome. Although, compared with paediatric 
survivors, adolescents showed a relatively milder degree of neuropsychological 
dysfunction, the clinical relevance of these impairments should not be discounted. 
Indeed, their presence was associated with clear evidence of educational 
underachievement.
Many adolescent survivors of MD may function well and appear to live a normal life. 
However, as the results demonstrate there will be survivors who may continue to 
experience problems that can affect materially various aspects of their lives.
Therefore, community-based paediatricians should routinely follow-up adolescents 
who have had MD to identify those that require support. Young people post MD in 
focus groups, as part of a separate study, expressed a strong unmet desire for 
continued medical review.
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From an applied perspective, the results of this study are encouraging in that they 
suggest potential areas for intervention in order to improve adolescents’ quality of life 
post-MD.
7.2 Future directions
A number of directions for future research that expand upon the work undertaken in 
this study are discussed below:
Continued investigation of outcomes of MD in survivors is vitally important for 
determining the nature and scope of their problems in the longer-term and evaluating 
possible interventions. This study is a critical first step in identifying and 
understanding outcomes of MD in adolescents. Cross-sectional assessment provides 
an indication of outcomes but does not provide complete understanding. Therefore, 
the next logical step is the further longitudinal assessment of outcomes at multiple 
time points to assess whether the deficits reported here persist beyond the medium- 
term. Furthermore, combining neuropsychological measurements and functional brain 
imaging would also enable a more comprehensive assessment and establish the 
important linkage between neurological insult, the mechanisms and function.
Development of a disease specific QOL measure for voung people post MD 
Survivors reported a number of areas affected post MD and global reduction in quality 
of life (QOL). Although this is an important finding, it did not indicate which areas 
are of significant subjective concern for survivors. Available adolescent QOL 
instruments judged to be of high quality do not assess the unique impairments that 
adolescents suffer following MD. The results of the outcome study directed the team 
towards the development of a screening tool for adolescent MD survivors’ in order to 
identify those who are at increased risk of developing problems and to target the 
necessary support accordingly. Accurate assessment of subjective as well as objective 
impacts of MD in adolescence requires the development of a disease-specific QOL 
instrument that focuses on areas of function relevant to young people post MD, and as 
a result, most responsive to small but important changes. Deficits, which have the 
most impact on the life of an individual and the costs to the State of survival from 
MD, are those that have a subjective as well as objective impact on functioning.
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We have recently completed the development of a 39-item measure of QOL for 
survivors of MD in adolescence and young adulthood (ages 15-26). The measure, 
called the ^Satisfaction o f Life After Meningitis (SLAM) is likely to be a valuable tool 
for clinicians and researchers in assessing QOL in young people.
Further work is also under consideration in the following areas:
Developing interventions for adolescent MD survivors
Findings regarding QOL post MD will be linked to the results of the outcome study to 
identify areas of significant deficit associated with QOL for young people after MD. 
As the outcome study and QOL study were undertaken in the same population, this 
analysis can be done both cross-sectionally and longitudinally within subjects. A 
sample of young people identified as having objective deficits (as measured on the 
outcome study) e.g. memory or processing difficulties, functional deficits and/or poor 
QOL (as measured on the QOL instrument) will be invited to meet with the researcher 
and investigator (Consultant Clinical Psychologist). This clinical assessment will 
identify possible interventions that will address those difficulties identified by the 
young persons as having the greatest impact on their lives. These strategies will be 
used in conjunction with previous studies of interventions in conditions closely related 
to MD. This will help define relevant components of interventions and demonstrate 
the feasibility of delivery as well as acceptability. Different interventions may need to 
be piloted to achieve optimal effectiveness in both neurorehabilitation and 
psychological support for survivors of MD. This will inform specific 
recommendations to health professionals and carers, and provide information for 
families and young people through support charities.
A phvsical iniuries measure
A questionnaire specific to adolescent survivors of MD will be designed for future 
research purposes. The questionnaire used in this study was adapted from a physical 
injuries and disabilities questionnaire developed by the Quebec Occupational Health 
and Safety Commission for work-related injuries. An age and MD specific 
questionnaire would be more appropriate for use in future studies.
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Rev Auditory Verbal Learning Test
The large quantity of data collected from controls during this test, conducted as part of 
the outcome study will be published separately, providing the largest set of normative 
data on this age range.
Item discrimination analyses of mental health measures
As MD was found to increase the risk of depression in survivors, item discrimination 
analyses (not planned for in this study) on the CORE and Beck Depression Inventory 
(BDI-II) would provide further insight into individual responses to items between the 
survivors and controls and thus specific areas causing depression.
In conclusion, the findings of this study are both clinically and scientifically important 
and have implications for future research directions, after-care delivery and planning 
of supportive interventions. The findings revealed that medical care for adolescent 
MD survivors was poor following discharge from hospital suggesting that a high 
proportion of morbidity in survivors goes unrecognised and therefore untreated. 
Adolescent survivors of MD have a disturbing series of deficits. MD due to 
seroGroup B disease remains a major cause of morbidity and mortality in adolescents. 
Therefore, routine follow-up of adolescent survivors should become standard, in order 
to prevent or ameliorate physical and psychosocial morbidity after MD and to offer 
adolescent survivors the support they desire and deserve.
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